VAN KAMPEN FOCUS PORTFOLIOS SERIES 225, 487, 2000-05-02

VAN KAMPEN FOCUS PORTFOLIOS SERIES 225
487, 2000-05-02

Previous: WAGNER INVESTMENT MANAGEMENT INC, 13F-HR/A, 2000-05-02

Next: SONIC INNOVATIONS INC, 424B4, 2000-05-02

MEMORANDUM OF CHANGES
VAN KAMPEN FOCUS PORTFOLIOS, SERIES 225

The Prospectus filed with Amendment No. 1 of the Registration Statement
on Form S-6 has been revised to reflect information regarding the deposit of Van
Kampen Focus Portfolios, Series 225 on May 2, 2000. An effort has been made to
set forth below each of the major changes and also to reflect the same by
blacklining the marked counterparts of the Prospectus submitted with the
Amendment.

Cover Page. The date of the Prospectus has been completed.

Pages 2-3. "The Summary of Essential Financial Information" section and
"Fee Table" have been completed.

Pages 4-21. Revisions have been made and the portfolios have been
completed.

Pages 22-40. The descriptions of the Securities issuers have been
completed.

Pages 41-43. The Report of Independent Certified Public Accountants and
Statements of Condition have been completed.

FILE NO. 333-35158
CIK #1104556

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549-1004

Amendment No. 1
to
Form S-6

For Registration under the Securities Act of 1933 of Securities of Unit
Investment Trusts Registered on Form N-8B-2.

A. Exact Name of Trust: VAN KAMPEN FOCUS PORTFOLIOS, SERIES 225

B. Name of Depositor: VAN KAMPEN FUNDS INC.

C. Complete address of Depositor's principal executive offices:

One Parkview Plaza
Oakbrook Terrace, Illinois 60181

D. Name and complete address of agents for service:

CHAPMAN AND CUTLER VAN KAMPEN FUNDS INC.
Attention: Mark J. Kneedy Attention: A. Thomas Smith III, General Counsel
111 West Monroe Street One Parkview Plaza
Chicago, Illinois 60603 Oakbrook Terrace, Illinois 60181

E. Title of securities being registered: Units of proportionate interest

F. Approximate date of proposed sale to the public:

AS SOON AS PRACTICABLE AFTER THE EFFECTIVE DATE OF THE
REGISTRATION STATEMENT

/ X / Check box if it is proposed that this filing will become effective at 8:00
a.m. on May 2, 2000 pursuant to Rule 487.

Van Kampen
Focus Portfolios(SM)
A Division of Van Kampen Funds Inc.

Bandwidth &
Telecommunications Trust
Series 10A
Series 10B

Biotechnology &
Pharmaceutical Trust
Series 10A
Series 10B

Global Wireless Trust
Series 3A
Series 3B
Great International Firms Trust
Series 12

The Roaring 2000sSM Trust
Series 6A
Series 6B

Semiconductor Trust
Series 2A
Series 2B

- --------------------------------------------------------------------------------

Van Kampen Focus Portfolios, Series 225 includes the unit investment trusts
described above (the "Trusts"). Each Trust seeks to increase the value of your
investment by investing in a diversified portfolio of stocks. With the exception
of the Great International Firms Trust, we offer each portfolio in two separate
Trusts with different maturity options. Series A Trusts terminate in 15 months
for investors with shorter investment horizons. Series B Trusts terminate in
five years for investors with longer investment horizons. Of course, we cannot
guarantee that a Trust will achieve its objective.

May 2, 2000

You should read this prospectus and retain it for future reference.

- --------------------------------------------------------------------------------

The Securities and Exchange Commission has not approved or disapproved of the
Units or passed upon the adequacy or accuracy of this prospectus. Any contrary
representation is a criminal offense.

Summary of Essential Financial Information
May 2, 2000

Great
International
Series A Series B Firms
Public Offering Price Trusts Trusts Trust
------------ ------------ ------------
<S> <C> <C> <C>
Aggregate value of Securities per Unit (1) $ 9.900 $ 9.900 $ 9.900
Sales charge 0.295 0.450 0.450
Less deferred sales charge 0.195 0.350 0.350
Public offering price per Unit (2) $ 10.000 $ 10.000 $ 10.000
</TABLE>

General Information
Initial Date of Deposit May 2, 2000
Mandatory Termination Date - Series A Trusts August 7, 2001
Mandatory Termination Date - All Other Trusts May 3, 2005
Record Date - Series A Trusts February 10, 2001
Distribution Date - Series A Trusts February 25, 2001
Record Dates - All Other Trusts (4) June 10 and December 10
Distribution Dates - All Other Trusts (4) June 25 and December 25
<TABLE>
<CAPTION>

Trust Information
Estimated Estimated Estimated
Aggregate Initial Annual Redemption Organizational
Initial Value of Distribution Dividends Price per Costs per
Trust Units (3) Securities (1) per Unit (4)(5) per Unit (5) Unit (6) Unit (1)
----------------------- -------------- ------------- ------------- ------------- ------------- -------------
Bandwidth & Tele-
<S> <C> <C> <C> <C> <C> <C>
communications Series A 14,964 $ 148,135 N/A $ .00846 $ 9.705 $ .00917
Bandwidth & Tele-
communications Series B 14,964 $ 148,135 N/A $ .00846 $ 9.550 $ .01565
Biotechnology &
Pharmaceutical Series A 15,461 $ 153,054 $ .02 $ .02728 $ 9.705 $ .00914
Biotechnology &
Pharmaceutical Series B 15,461 $ 153,054 $ .02 $ .02728 $ 9.550 $ .01526
Global Wireless Series A 15,195 $ 150,429 $ .01 $ .01432 $ 9.705 $ .00917
Global Wireless Series B 15,195 $ 150,429 $ .01 $ .01432 $ 9.550 $ .01565
Great International
Firms Trust 39,765 $ 393,672 $ .07 $ .11130 $ 9.530 $ .00380
Roaring 2000s Series A 14,979 $ 148,286 $ .06 $ .08340 $ 9.705 $ .02374
Roaring 2000s Series B 14,979 $ 148,286 $ .06 $ .08340 $ 9.550 $ .02484
Semiconductor Series A 14,891 $ 147,412 N/A $ .00076 $ 9.705 $ .01512
Semiconductor Series B 14,891 $ 147,412 N/A $ .00076 $ 9.550 $ .03072

</TABLE>

- --------------------------------------------------------------------------------

(1) Each Security principally traded in North or South America (including
American Depositary Receipts) is valued at the most recent closing sale
price as of the close of the New York Stock Exchange on the last business
day before the Initial Date of Deposit. All other securities are valued at
the most recent closing sale price on the Initial Date of Deposit. You will
bear all or a portion of the expenses incurred in organizing and offering
your Trust. The public offering price includes the estimated amount of
these costs. The Trustee will deduct these expenses from your Trust at the
end of the initial offering period (approximately three months). The
estimated amount for each Trust is described above and is included in the
"Estimated Costs Over Time" on the next page.

(2) The public offering price will include any accumulated dividends or cash in
the Income or Capital Accounts of a Trust.

(3) At the close of the New York Stock Exchange on the Initial Date of Deposit,
the number of Units may be adjusted so that the public offering price per
Unit equals $10. The number of Units and fractional interest of each Unit
in a Trust will increase or decrease to the extent of any adjustment.

(4) The initial Record Date for the Series B Trusts and the Great International
Firms Trust is February 10, 2001 and the initial Distribution Date for such
Trusts is February 25, 2001. Thereafter, the record and distribution dates
for these Trusts will occur in June and December of each year.

(5) This estimate is based on the most recently declared quarterly dividends or
interim and final dividends accounting for any foreign withholding taxes.
Actual dividends may vary due to a variety of factors. See "Risk Factors".

(6) The redemption price is reduced by any remaining deferred sales charge. See
"Rights of Unitholders--Redemption of Units". The redemption price includes
the estimated organizational and offering costs. The redemption price will
not include these costs after the initial offering period.

Fee Table
Great
Series A Series B International
Trusts Trusts Firms Trust
---------- ---------- ----------
Transaction Fees (as % of offering price)
<S> <C> <C> <C>
Initial sales charge (1)..................................... 1.00% 1.00% 1.00%
Deferred sales charge (2).................................... 1.95% 3.50% 3.50%
---------- ---------- ----------

Maximum sales charge......................................... 2.95% 4.50% 4.50%
========== ========== ==========

Maximum sales charge on reinvested dividends................. 0.00% 0.00% 0.00%
========== ========== ==========
</TABLE>
<TABLE>
<CAPTION>

Trustee's Fee Supervisory Estimated Total
and Operating and Evaluation Annual Expenses
Estimated Annual Expenses per Unit Expenses Fees per Unit
-------------- ------------- ------------
<S> <C> <C> <C>
Bandwidth & Telecommunications Series A........... $ 0.00932 $ 0.00500 $ 0.01432
Bandwidth & Telecommunications Series B........... $ 0.01088 $ 0.00500 $ 0.01588
Biotechnology & Pharmaceutical Series A........... $ 0.00932 $ 0.00500 $ 0.01432
Biotechnology & Pharmaceutical Series B........... $ 0.01088 $ 0.00500 $ 0.01588
Global Wireless Series A.......................... $ 0.00932 $ 0.00500 $ 0.01432
Global Wireless Series B.......................... $ 0.01088 $ 0.00500 $ 0.01588
Great International Firms Trust................... $ 0.06120 $ 0.00500 $ 0.06620
Roaring 2000s Series A............................ $ 0.01593 $ 0.00500 $ 0.02093
Roaring 2000s Series B............................ $ 0.02016 $ 0.00500 $ 0.02516
Semiconductor Series A............................ $ 0.01002 $ 0.00500 $ 0.01502
Semiconductor Series B............................ $ 0.01428 $ 0.00500 $ 0.01928
</TABLE>
<TABLE>
<CAPTION>

Estimated Costs Over Time (3) One Year Three Years Five Years Ten Years
-------------- ------------- ------------- --------------
<S> <C> <C> <C> <C>
Bandwidth & Telecommunications Series A........... $ 32 $ 77 N/A N/A
Bandwidth & Telecommunications Series B........... $ 48 $ 52 $ 56 N/A
Biotechnology & Pharmaceutical Series A........... $ 32 $ 77 N/A N/A
Biotechnology & Pharmaceutical Series B........... $ 48 $ 52 $ 56 N/A
Global Wireless Series A.......................... $ 32 $ 77 N/A N/A
Global Wireless Series B.......................... $ 48 $ 52 $ 56 N/A
Great International Firms Trust................... $ 52 $ 66 $ 81 N/A
Roaring 2000s Series A............................ $ 34 $ 83 N/A N/A
Roaring 2000s Series B............................ $ 50 $ 56 $ 62 N/A
Semiconductor Series A............................ $ 33 $ 79 N/A N/A
Semiconductor Series B............................ $ 50 $ 54 $ 58 N/A
</TABLE>

This fee table is intended to assist you in understanding the costs that you
will bear and to present a comparison of fees. The "Estimated Costs Over Time"
example illustrates the expenses you would pay on a $1,000 investment assuming a
5% annual return and redemption at the end of each period. This example assumes
that you reinvest all distributions at the end of each year. The Series A Trust
examples assume that you reinvest your investment into a new trust when the
Trust terminates at the end of each 15-month period. Of course, you should not
consider this example a representation of actual past or future expenses or
annual rate of return which may differ from those assumed for this example. The
sales charge and expenses are described under "Public Offering" and "Trust
Operating Expenses".

- --------------------------------------------------------------------------------

(1) The initial sales charge is the difference between the maximum sales charge
and the deferred sales charge.

(2) The deferred sales charge for Series A Trusts is actually equal to $0.195
per Unit. The deferred sales charge for Series B Trusts and the Great
International Firms Trust is actually equal to $0.35 per Unit. These
amounts will exceed the percentages above if the public offering price per
Unit falls below $10 and will be less than the percentage above if the
public offering price per Unit exceeds $10. The deferred sales charge
accrues daily from August 10, 2000 through January 9, 2001. Your Trust pays
a proportionate amount of this charge on the 10th day of each month
beginning in the accrual period until paid in full.

(3) These examples include the estimated expenses incurred in establishing and
offering your Trust. The amount of these expenses is described on the
preceding page.

Bandwidth & Telecommunications Trusts

Each Trust seeks to increase the value of your Units over time by investing
in a portfolio of common stocks of companies diversified within the
communications industry. Technological advancements have made it possible for
people to communicate in ways that were not possible in the past. We designed
these Trusts to benefit from companies leading in these advancements. Cellular
phones, the Internet, e-mail and personal pagers have rapidly changed the way
people communicate.

Bandwidth measures the connection that links data from one place to another.
With the popularity of the telecommunications and internet sectors increasing,
the demand to send data over these connections is increasing. Greater bandwidth
makes it possible for these industries to operate by passing digital signals
through a medium such as glass fibers at higher capacities. The greater the
bandwidth, the greater the information carrying capacity.

o We believe that in the next few years the telecommunications industry could
develop in a manner similar to that of the computer industry since the late
1970s. This is partly due to deregulation and increased competition but is
primarily due to the increase in demand for greater bandwidth resulting
from the growth of the Internet. (Source: Canada NewsWire, 1999).

o Revenue from the integration of voice and data on a single network is
estimated to exceed $2 billion in 2003. (Source: Jupiter Communications,
1999).

o Telecommunications speed is currently doubling every 150 days. (Source:
PricewaterhouseCoopers Technology Center).

o The volume of Internet traffic is currently doubling every 100 days. If
this trend continues, the total volume of data carried over the world's
telecommunications infrastructure will exceed that of voice by 2002.
(Source: PricewaterhouseCoopers Technology Center; A.D. Little).

There is no assurance that these trends will continue or that expectations
will actually occur. If these trends do not continue or if current expectations
are not realized, your investment could be adversely affected. Of course, we
cannot guarantee that your Trust will achieve its objective. The value of your
Units may fall below the price you paid for the Units. You should read the "Risk
Factors" section before you invest.

Two Maturity Options. Because different investors have different investment
horizons, we offer two portfolios with different maturities that invest in the
same companies. You should consider Series A if you intend to hold your
investment for 15 months or less. You should consider Series B if you intend to
hold your investment for approximately five years. In either case, you should
consider the impact of price volatility when selecting the appropriate Series.
While Series A and Series B invest in the same companies, they are separate
portfolios and have different sales charges and expenses. As a result, the
performance and exact composition of each Trust may differ.

Series A Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
Bandwidth
<S> <C> <C> <C> <C>
33 Applied Micro Circuits Corporation $ 126.188 0.00% $ 4,164.19
24 Broadcom Corporation 174.375 0.00 4,185.00
33 Brocade Communications Systems, Inc. 133.000 0.00 4,389.00
61 Cisco Systems, Inc. 71.438 0.00 4,357.69
71 Conexant Systems, Inc. 60.250 0.00 4,277.75
49 Copper Mountain Networks, Inc. 84.125 0.00 4,122.13
22 Corning, Inc. 199.625 0.36 4,391.75
70 Extreme Networks, Inc. 59.750 0.00 4,182.50
41 GlobeSpan, Inc. 107.625 0.00 4,412.63
55 Harmonic, Inc. 84.000 0.00 4,620.00
41 JDS Uniphase Corporation 104.250 0.00 4,274.25
19 Juniper Networks, Inc. 219.000 0.00 4,161.00
+ 76 Nokia Oyj 59.000 0.28 4,484.00
3 37 Nortel Networks Corporation 118.688 0.13 4,391.44
22 PMC-Sierra, Inc. 188.250 0.00 4,141.50
21 Powerwave Technologies, Inc. 218.750 0.00 4,593.75
41 QLogic Corporation 102.375 0.00 4,197.38
39 QUALCOMM, Inc. 109.813 0.00 4,282.69
63 Scientific-Atlanta, Inc. 69.125 0.06 4,354.88
22 SDL, Inc. 202.688 0.00 4,459.13
49 Sycamore Networks, Inc. 86.250 0.00 4,226.25
+ 48 Telefonaktiebolaget LM Ericsson AB 91.063 0.22 4,371.00
47 TranSwitch Corporation 88.625 0.00 4,165.38
40 TriQuint Semiconductor, Inc. 109.875 0.00 4,395.00
61 Vitesse Semiconductor Corporation 69.438 0.00 4,235.69
Telecom/Carriers
92 AT&T Corporation 48.625 1.81 4,473.50
+ 29 China Telecom (Hong Kong), Limited 149.000 0.00 4,321.00
+ 25 COLT Telecom Group plc 174.625 0.00 4,365.63
172 McLeodUSA, Inc. 27.563 0.00 4,740.75
38 Nextel Communications, Inc. 114.688 0.00 4,358.13
51 NEXTLINK Communications, Inc. 91.375 0.00 4,660.13
99 Qwest Communications International, Inc. 44.250 0.00 4,380.75
78 Sprint Corporation (PCS Group) 56.938 0.00 4,441.13
43 VoiceStream Wireless Corporation 106.000 0.00 4,558.00
- ---------- ------------
1,712 $ 148,135.00
========== ============

</TABLE>

See "Notes to Portfolios".

Series B Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
Bandwidth
<S> <C> <C> <C> <C>
33 Applied Micro Circuits Corporation $ 126.188 0.00% $ 4,164.19
24 Broadcom Corporation 174.375 0.00 4,185.00
33 Brocade Communications Systems, Inc. 133.000 0.00 4,389.00
61 Cisco Systems, Inc. 71.438 0.00 4,357.69
71 Conexant Systems, Inc. 60.250 0.00 4,277.75
49 Copper Mountain Networks, Inc. 84.125 0.00 4,122.13
22 Corning, Inc. 199.625 0.36 4,391.75
70 Extreme Networks, Inc. 59.750 0.00 4,182.50
41 GlobeSpan, Inc. 107.625 0.00 4,412.63
55 Harmonic, Inc. 84.000 0.00 4,620.00
41 JDS Uniphase Corporation 104.250 0.00 4,274.25
19 Juniper Networks, Inc. 219.000 0.00 4,161.00
+ 76 Nokia Oyj 59.000 0.28 4,484.00
3 37 Nortel Networks Corporation 118.688 0.13 4,391.44
22 PMC-Sierra, Inc. 188.250 0.00 4,141.50
21 Powerwave Technologies, Inc. 218.750 0.00 4,593.75
41 QLogic Corporation 102.375 0.00 4,197.38
39 QUALCOMM, Inc. 109.813 0.00 4,282.69
63 Scientific-Atlanta, Inc. 69.125 0.06 4,354.88
22 SDL, Inc. 202.688 0.00 4,459.13
49 Sycamore Networks, Inc. 86.250 0.00 4,226.25
+ 48 Telefonaktiebolaget LM Ericsson AB 91.063 0.22 4,371.00
47 TranSwitch Corporation 88.625 0.00 4,165.38
40 TriQuint Semiconductor, Inc. 109.875 0.00 4,395.00
61 Vitesse Semiconductor Corporation 69.438 0.00 4,235.69
Telecom/Carriers
92 AT&T Corporation 48.625 1.81 4,473.50
+ 29 China Telecom (Hong Kong), Limited 149.000 0.00 4,321.00
+ 25 COLT Telecom Group plc 174.625 0.00 4,365.63
172 McLeodUSA, Inc. 27.563 0.00 4,740.75
38 Nextel Communications, Inc. 114.688 0.00 4,358.13
51 NEXTLINK Communications, Inc. 91.375 0.00 4,660.13
99 Qwest Communications International, Inc. 44.250 0.00 4,380.75
78 Sprint Corporation (PCS Group) 56.938 0.00 4,441.13
43 VoiceStream Wireless Corporation 106.000 0.00 4,558.00
- ---------- ------------
1,712 $ 148,135.00
========== ============

</TABLE>

See "Notes to Portfolios".

Biotechnology & Pharmaceutical Trusts

Each Trust seeks to increase the value of your Units over time by investing
in a portfolio of common stocks of companies diversified within the
biotechnology and pharmaceuticals industry. Van Kampen designed each Trust to
benefit from companies that are positioned for growth in these industries.
Biotechnology and pharmaceuticals have increased the length and quality of life
for millions of people. The Biotechnology Industry Organization estimates that
over 80 biotech drugs and vaccines have helped more than 200 million people
worldwide over the last 25 years. According to this organization, more than 350
drugs and vaccines are currently in human clinical trials, including treatments
for cancer, AIDs, Alzheimer's and heart disease. Biotechnology also appears to
be revolutionizing other areas such as medical diagnostics, agriculture,
forensics and environmental cleanup and preservation.

The pharmaceutical industry is highly developed in the United States where
demand for many drugs appears to remain constant. However, worldwide drug sales
may have the potential for increased demand. Factors that could potentially
contribute to the growth of this industry include discoveries in drug design and
molecular biology, more favorable treatment by the Food and Drug Administration
in drug reviews, and accelerated demand for drugs in Third World countries.

Two worldwide trends appear to be providing growth potential for the
biotechnology and pharmaceutical industries: the aging of the baby boom
generation and an increase in life expectancy. A recent study by the World
Health Organization, estimates that the over-60 age population could rise
globally from 580 million in 1998 to over one billion by 2020. This segment of
the current U.S. population accounts for more than one-third of the total
consumption of prescription medicines but represents less than 15% of total U.S.
population. Developments in biotechnology and pharmaceuticals that target major
ailments of the elderly may cause growth in these sectors in the years ahead.
Consider these factors:

o Standard & Poor's estimates that total industry-wide revenues in
biotechnology could increase to $26 billion in 2000.

o Total drug delivery is estimated to grow from $12 billion to nearly $60
billion over the next decade.

o Worldwide sales of all pharmaceutical products are estimated to exceed $360
billion in 2000.

(Sources: Standard & Poor's Industry Survey, September 9, 1999 and December 16,
1999)

There is no assurance that these trends will continue or that expectations
will actually occur. Your investment could be adversely affected if these trends
do not continue or if current expectations are not realized.

Of course, we cannot guarantee that your Trust will achieve its objective.
The value of your Units may fall below the price you paid for the Units. You
should read the "Risk Factors" section before you invest.

Series A Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
Biotechnology
<S> <C> <C> <C> <C>
38 Abgenix, Inc. $ 98.000 0.00 % $ 3,724.00
65 Amgen, Inc. 55.938 0.00 3,635.94
43 Celera Genomics 97.500 0.00 4,192.50
134 Cephalon, Inc. 58.063 0.00 7,780.38
98 COR Therapeutics, Inc. 84.938 0.00 8,323.88
59 Genentech, Inc. 129.000 0.00 7,611.00
73 Gilead Sciences, Inc. 55.750 0.00 4,069.75
45 Human Genome Sciences, Inc. 89.188 0.00 4,013.44
91 Immunex Corporation 41.688 0.00 3,793.56
62 Medarex, Inc. 62.000 0.00 3,844.00
48 MedImmune, Inc. 159.000 0.00 7,632.00
87 Millennium Pharmaceuticals, Inc. 92.500 0.00 8,047.50
64 QLT PhotoTherapeutics, Inc. 59.375 0.00 3,800.00
Generic Drugs
95 Alpharma, Inc. 41.188 0.44 3,912.81
264 IVAX Corporation 27.625 0.00 7,293.00
Medical/Dental Distributors
71 Andrx Corporation 54.313 0.00 3,856.19
Pharmaceuticals
131 Allergan, Inc. 59.000 0.54 7,729.00
67 American Home Products Corporation 55.875 1.65 3,743.63
78 Biovail Corporation 47.000 0.00 3,666.00
161 Celgene Corporation 47.375 0.00 7,627.38
+ 88 Elan Corporation Plc 42.125 0.00 3,707.00
89 Forest Laboratories, Inc. 85.250 0.00 7,587.25
54 Merck & Company, Inc. 67.563 1.72 3,648.38
269 Pfizer, Inc. 41.813 0.86 11,247.56
227 Pharmacia Corporation 49.500 0.97 11,236.50
+ 172 Teva Pharmaceutical Industries, Limited 42.625 0.45 7,331.50
- ---------- ------------
2,673 $ 153,054.15
========== ============
</TABLE>

See "Notes to Portfolios".

Series B Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
Biotechnology
<S> <C> <C> <C> <C>
38 Abgenix, Inc. $ 98.000 0.00 % $ 3,724.00
65 Amgen, Inc. 55.938 0.00 3,635.94
43 Celera Genomics 97.500 0.00 4,192.50
134 Cephalon, Inc. 58.063 0.00 7,780.38
98 COR Therapeutics, Inc. 84.938 0.00 8,323.88
59 Genentech, Inc. 129.000 0.00 7,611.00
73 Gilead Sciences, Inc. 55.750 0.00 4,069.75
45 Human Genome Sciences, Inc. 89.188 0.00 4,013.44
91 Immunex Corporation 41.688 0.00 3,793.56
62 Medarex, Inc. 62.000 0.00 3,844.00
48 MedImmune, Inc. 159.000 0.00 7,632.00
87 Millennium Pharmaceuticals, Inc. 92.500 0.00 8,047.50
64 QLT PhotoTherapeutics, Inc. 59.375 0.00 3,800.00
Generic Drugs
95 Alpharma, Inc. 41.188 0.44 3,912.81
264 IVAX Corporation 27.625 0.00 7,293.00
Medical/Dental Distributors
71 Andrx Corporation 54.313 0.00 3,856.19
Pharmaceuticals
131 Allergan, Inc. 59.000 0.54 7,729.00
67 American Home Products Corporation 55.875 1.65 3,743.63
78 Biovail Corporation 47.000 0.00 3,666.00
161 Celgene Corporation 47.375 0.00 7,627.38
+ 88 Elan Corporation Plc 42.125 0.00 3,707.00
89 Forest Laboratories, Inc. 85.250 0.00 7,587.25
54 Merck & Company, Inc. 67.563 1.72 3,648.38
269 Pfizer, Inc. 41.813 0.86 11,247.56
227 Pharmacia Corporation 49.500 0.97 11,236.50
+ 172 Teva Pharmaceutical Industries, Limited 42.625 0.45 7,331.50
- ---------- ------------
2,673 $ 153,054.15
========== ============
</TABLE>

See "Notes to Portfolios".

Global Wireless Trusts

Each Trust seeks to increase the value of your Units over time by investing
in a portfolio of U.S. and foreign stocks of companies diversified within the
wireless telecommunications industry. In an age of constant technological
advances, people want convenient and affordable items to make their lives
easier. Improvements in technology seek to make tools faster, more powerful,
smaller, and more user-friendly. While initially cost prohibitive, Van Kampen
believes that wireless phones and service providers have witnessed growth in
recent years because competition and improved technologies have brought the
price of airtime and phones down.

The wireless telecommunication industry is truly global. Wireless companies
have seen new opportunities due to strong growth in subscriber demand in many
regions around the world. In developing countries where communication systems
either do not exist or are very primitive, wireless systems have been growing
and are expected to continue to grow because they are more cost effective to set
up than traditional wireline systems.

The industry is beginning to use developing technologies to provide more
services. It is already possible to get Internet access through some wireless
phones and data and information delivery may be available in the future. As
bandwidth and digital information processing technologies continue to improve
and grow, wireless communications will reap the benefits. Consider the
following:

o Industry reports estimate that nearly 250 million subscribers worldwide
have moved to forms of wireless technology. The number of subscribers has
nearly tripled over the past three years. (Standard & Poor's Industry
Surveys, Telecommunications: Wireless).

o Only the growth of the Internet has been faster than wireless service
companies and equipment manufacturers recently. Revenues for U.S. based
wireless services are projected to be nearly $50 billion in 2000. (Standard
& Poor's Industry Surveys, Telecommunications: Wireless).

o The role of wireless should expand over time until it becomes a commonplace
part of everyday life. Wireless is the ideal solution in a data rich
environment reliant on fast-paced communications.

o Industry reports project that global wireless subscribers could grow from a
projected 469 million at the end of 1999 to 1,26 billion in 2005 -- a
global penetration of nearly 20% up from about 7.5% today. (The Yankee
Group 1999).

o By 2004, one-third of all Europeans are estimated to regularly use their
mobile phones to access Internet services. (Forrester Research 1999).

o Standard & Poor's estimates that the percentage of U.S. consumers using
wireless services will grow from 4.30% in 1992 to 35% by the end of 2000.
(Standard & Poor's Industry Surveys, Telecommunications: Wireless, July
1999. Based on Census Bureau and Cellular Telecommunications Industry
Association data).

We cannot guarantee that your Trust will achieve its objective. The value of
your Units may fall below the price you paid for the Units. You should read the
"Risk Factors" section before you invest.

Series A Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
Carriers
<S> <C> <C> <C> <C>
91 AT&T Corporation $ 48.625 1.81% $ 4,424.88
+ 29 China Telecom (Hong Kong), Limited 149.000 0.00 4,321.00
+ 63 Deutsche Telekom AG 68.188 0.85 4,295.81
+ 27 France Telecom S.A. 162.500 0.54 4,387.50
+ 77 Millicom International Cellular S.A. 57.063 0.00 4,393.81
38 Nextel Communications, Inc. 114.688 0.00 4,358.13
+ 130 SK Telecom Company, Limited 32.813 0.00 4,265.63
77 Sprint Corporation (PCS Group) 56.938 0.00 4,384.19
+ 100 Tele Sudeste Celular Participacoes S.A. 45.125 0.00 4,512.50
+ 30 Telecom Italia SpA 144.750 0.00 4,342.50
+ 63 Telefonica S.A. 70.250 0.00 4,425.75
+ 90 Vodafone AirTouch Plc 47.063 0.44 4,235.63
42 VoiceStream Wireless Corporation 106.000 0.00 4,452.00
Infrastructure
80 Alpha Industries, Inc. 52.625 0.00 4,210.00
55 ANADIGICS, Inc. 76.500 0.00 4,207.50
32 Applied Micro Circuits Corporation 126.188 0.00 4,038.00
+ 129 ARM Holdings plc 33.500 0.00 4,321.50
24 Broadcom Corporation 174.375 0.00 4,185.00
60 Cisco Systems, Inc. 71.438 0.00 4,286.25
21 Corning, Inc. 199.625 0.36 4,192.13
56 Harmonic, Inc. 84.000 0.00 4,704.00
60 InfoSpace.com, Inc. 67.375 0.00 4,042.50
40 JDS Uniphase Corporation 104.250 0.00 4,170.00
54 Kopin Corporation 81.188 0.00 4,384.13
35 Motorola, Inc. 121.625 0.39 4,256.88
+ 74 Nokia Oyj 59.000 0.28 4,366.00
3 37 Nortel Networks Corporation 118.688 0.13 4,391.44
47 Phone.com, Inc. 86.563 0.00 4,068.44
22 PMC-Sierra, Inc. 188.250 0.00 4,141.50
20 Powerwave Technologies, Inc. 218.750 0.00 4,375.00
39 QUALCOMM, Inc. 109.813 0.00 4,282.69
38 RF Micro Devices, Inc. 107.250 0.00 4,075.50
21 SDL, Inc. 202.688 0.00 4,256.44
+ 47 Telefonaktiebolaget LM Ericsson AB 91.063 0.22 4,279.94
40 TriQuint Semiconductor, Inc. 109.875 0.00 4,395.00
- ---------- ------------
1,888 $ 150,429.17
========== ============

</TABLE>

See "Notes to Portfolios".

Series B Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
Carriers
<S> <C> <C> <C> <C>
91 AT&T Corporation $ 48.625 1.81% $ 4,424.88
+ 29 China Telecom (Hong Kong), Limited 149.000 0.00 4,321.00
+ 63 Deutsche Telekom AG 68.188 0.85 4,295.81
+ 27 France Telecom S.A. 162.500 0.54 4,387.50
+ 77 Millicom International Cellular S.A. 57.063 0.00 4,393.81
38 Nextel Communications, Inc. 114.688 0.00 4,358.13
+ 130 SK Telecom Company, Limited 32.813 0.00 4,265.63
77 Sprint Corporation (PCS Group) 56.938 0.00 4,384.19
+ 100 Tele Sudeste Celular Participacoes S.A. 45.125 0.00 4,512.50
+ 30 Telecom Italia SpA 144.750 0.00 4,342.50
+ 63 Telefonica S.A. 70.250 0.00 4,425.75
+ 90 Vodafone AirTouch Plc 47.063 0.44 4,235.63
42 VoiceStream Wireless Corporation 106.000 0.00 4,452.00
Infrastructure
80 Alpha Industries, Inc. 52.625 0.00 4,210.00
55 ANADIGICS, Inc. 76.500 0.00 4,207.50
32 Applied Micro Circuits Corporation 126.188 0.00 4,038.00
+ 129 ARM Holdings plc 33.500 0.00 4,321.50
24 Broadcom Corporation 174.375 0.00 4,185.00
60 Cisco Systems, Inc. 71.438 0.00 4,286.25
21 Corning, Inc. 199.625 0.36 4,192.13
56 Harmonic, Inc. 84.000 0.00 4,704.00
60 InfoSpace.com, Inc. 67.375 0.00 4,042.50
40 JDS Uniphase Corporation 104.250 0.00 4,170.00
54 Kopin Corporation 81.188 0.00 4,384.13
35 Motorola, Inc. 121.625 0.39 4,256.88
+ 74 Nokia Oyj 59.000 0.28 4,366.00
3 37 Nortel Networks Corporation 118.688 0.13 4,391.44
47 Phone.com, Inc. 86.563 0.00 4,068.44
22 PMC-Sierra, Inc. 188.250 0.00 4,141.50
20 Powerwave Technologies, Inc. 218.750 0.00 4,375.00
39 QUALCOMM, Inc. 109.813 0.00 4,282.69
38 RF Micro Devices, Inc. 107.250 0.00 4,075.50
21 SDL, Inc. 202.688 0.00 4,256.44
+ 47 Telefonaktiebolaget LM Ericsson AB 91.063 0.22 4,279.94
40 TriQuint Semiconductor, Inc. 109.875 0.00 4,395.00
- ---------- ------------
1,888 $ 150,429.17
========== ============

</TABLE>

See "Notes to Portfolios".

Great International Firms Trust

The Trust seeks to provide the potential for capital appreciation by
investing in a portfolio of foreign stocks. In selecting the portfolio, we
targeted industry-leading companies in countries around the world. The Trust
seeks to benefit from companies that are well known, have solid balance sheets
and occupy strong positions in their markets and industries. The companies
represented in the portfolio may share a variety of traits, among others:

o Headquartered in a developed and industrialized country outside the United
States

o Leading market share in their industry

o Attractive stock price valuation

o Diversified line of products and/or services

o Well-capitalized

o Leading company in their country

The Trust will seek to maintain, as nearly as practicable, an equal dollar
amount of each of the stocks in the portfolio as new Units are issued. The Trust
may not be able to achieve this goal because some foreign markets require that
stock transactions be executed in round lots (for example, 1000 shares).

From 1989 through 1999, the U.S. stock market (as represented by the Standard
& Poor's 500 Index) has ranked among the top five markets in total return only
four times and has never ranked first. International firms across the globe are
expanding their businesses, exporting to more countries and becoming better
known to the investment community. By investing in international stocks, you may
benefit from greater growth potential and added diversity than by concentrating
in U.S. securities alone.

The table below illustrates that no single stock market has dominated over
time and that foreign markets have generally offered returns superior to those
available in the U.S. The table shows the total returns of the top performing
stock markets in developed coun- tries for each of the years indicated (as
represented by Morgan Stanley Capital International indices) compared with the
U.S. market (as represented by the Standard & Poor's 500 Index).

Total Return Total Return
Top Performing Market United States Market
---------------------- --------------------

1989 101% (Austria) 31%
1990 6% (United Kingdom) (3%)
1991 43% (Hong Kong) 30%
1992 27% (Hong Kong) 7%
1993 110% (Hong Kong) 10%
1994 51% (Finland) 1%
1995 42% (Switzerland) 37%
1996 41% (Spain) 23%
1997 45% (Switzerland) 33%
1998 122% (Finland) 29%
1999 151% (Finland) 21%

The table represents historical performance of unmanaged indices which are
composites of equity securities considered representative of equity performance
in the countries specified. The historical performance is shown for illustrative
purposes only, represents past performance which is not indicative of future
performance of the Trust and does not include sales charges or expenses which
are imposed on Trust Units.

As with any investment, we cannot guarantee that the Trust will achieve its
objective. The value of your Units may fall below the price you paid for the
Units. You should read the "Risk Factors" section before you invest.

Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
<S> <C> <C> <C> <C>
369 Akzo Nobel N.V. $ 40.327 1.91% $ 14,880.78
65 Alcatel 233.284 0.72% 15,163.43
102 Axa 149.736 1.03% 15,273.02
1,000 The Bank of Tokyo-Mitsubishi, Ltd 13.166 0.51% 13,166.38
1,766 BP Amoco Plc 8.585 2.24% 15,160.28
851 British Telecommunications Plc 18.151 1.80% 15,446.91
225 Deutsche Bank AG 67.363 1.39% 15,156.65
1,885 Diageo Plc 8.031 3.90% 15,138.32
+ 108 FUJITSU, Limited 153.420 0.21% 16,569.36
494 Glaxo Wellcome Plc 29.987 1.92% 14,813.76
341 Koninklijke (Royal) Philips Electronics N.V. 45.210 2.04% 15,416.61
1,222 Marconi Plc 12.522 0.22% 15,301.92
+ 107 NEC Corporation 141.961 0.15% 15,189.86
1,183 News Corporation, Limited 13.068 0.11% 15,459.25
1,000 Nikko Securities Company, Limited 12.154 0.19% 12,153.58
264 Nokia Oyj 58.637 0.26% 15,480.27
+ 86 NTT DoCoMo, Inc. 174.550 0.02% 15,011.27
852 Reuters Group Plc 18.619 1.23% 15,863.65
265 Royal Dutch Petroleum Company 58.212 1.99% 15,426.29
+ 65 SONY Corporation 231.141 0.15% 15,024.13
2,744 Telecom Argentina Stet - France Telecom S.A. 5.551 4.18% 15,232.25
170 Telefonaktiebolaget LM Ericsson AB 92.141 0.21% 15,663.92
681 Telefonica S.A. 24.178 0.00% 16,465.43
+ 148 Toyota Motor Corporation 103.811 0.30% 15,364.04
60 UBS AG 248.332 2.06% 14,899.91
3,326 Vodafone Airtouch Plc 4.495 0.45% 14,950.33
- ---------- ------------
19,379 $ 393,671.60
========== ============
</TABLE>

See "Notes to Portfolios".

Unless otherwise noted, all of the Securities listed above are issued by foreign
companies and are traded on foreign securities exchanges.

The Roaring 2000sSM Trusts

Each Trust invests in a separate portfolio of stocks selected using concepts
outlined in The Roaring 2000s written by Harry S. Dent, Jr. Each Trust seeks to
increase the value of your investment over its life.

The Roaring 2000s is the third book written by Harry S. Dent, Jr. analyzing
economic, technological and demographic trends in society. We designed the
Trusts to take advantage of the insights, philosophies and strategies discussed
in this book. Based on Mr. Dent's current analysis, each portfolio focuses on
stocks from four sectors: Technology, Financials, Health Care and U.S.-based
Multi-Nationals. Each Trust seeks to leverage demographic, economic and
lifestyle trends that may develop over the next 10-15 years. According to Mr.
Dent, some significant changes that may potentially impact the future economy
include:

o Aging Baby Boomers reaching their peak spending years

o Internet usage and new technologies becoming more mainstream

o A shift in the business and organizational structure brought on by the
Information Age

o Rising importance of small- to medium-sized, high growth companies

o Growth opportunities from continued global economic development

Mr. Dent believes that the coming years may bring an era of economic
prosperity and lifestyle changes. For instance, Mr. Dent believes that the
Internet may be as important a catalyst for change in business as the
assembly-line once was for production. Mr. Dent applies the principle of the
"S-curve" in analyzing technologies and social trends in the economy. This
concept shows how products move into mainstream acceptance. The S-curve shows
how products develop in three stages over time: Innovation, Growth and Maturity.
Mr Dent also focuses on the "spending wave". This analysis illustrates how our
economy has correlated closely with birth rates. Over time, the level of births
lagged for peak in family spending has almost paralleled the Dow Jones
Industrial Average adjusted for inflation.

About Mr. Dent. Using extensive research developed from years of hands-on
business experience, Mr. Dent seeks to offer a positive and understandable view
of trends in society. He proposes practical applications at all levels: from
personal investments, to business strategies, to jobs and changes in the
workplace, to growth areas for real estate. Mr. Dent received his MBA from
Harvard Business School where he was a Baker Scholar. He graduated number one in
his class at the University of South Carolina with a degree in accounting and
finance. Mr. Dent has worked as a consultant with several Fortune 100 companies
to develop and innovate competitive business strategies. He has been CEO of
several growth companies and has acted as consultant to several leading edge
companies.

Mr. Dent is the author of the 1993 book, The Great Boom Ahead (revised in
1995). His second book, Job Shock: Four New Principles Transforming Our Work and
Business, was published in 1995 and then re-released in 1996 as The Great Jobs
Ahead. The Roaring 2000s updates key principles of these books, and focuses on
the Internet's rapid move into the mainstream and how our work, organizations,
and living circumstances may change. Mr. Dent also publishes the H.S. Dent
Forecast newsletter. Since 1988 he has been speaking to executives around the
world. He has appeared on "Good Morning America", PBS, CNBC, "The Business
Channel", and has been featured in Fortune, Success, The Wall Street Journal,
and Omni.

</TABLE>

See "Notes to Portfolios".

</TABLE>

See "Notes to Portfolios".

Semiconductor Trusts

Each Trust seeks to increase the value of your Units over time by investing
in a portfolio of common stocks of companies diversified within the
semiconductor industry. Semiconductors support equipment that allows your
personal computers, mobile phones, VCRs, DVD players, automobiles, stereos,
personal digital assistants, home appliances, and some children's toys to
function. Semiconductors are the microchips and microprocessors that enable
electronic devices to process millions of bits of data in a fraction of a
second. These chips and processors are also responsible for remembering the
information stored in your electronic devices after you turn them off.
Semiconductors were the critical factor that ignited the computer industry
revolution and they are the key to the development of almost every technology
today. Without continued development in this industry, technological tools will
go no further.

The pace of change in the semiconductor industry is rapid, driven by fierce
competition and ever-improving technology. Innovations are constantly improving
chips and enable them to perform ever more powerful computing tasks at ever
increasing speeds.

The emergence of a global, networked economy that values rapid exchanges of
information is changing the face of the industry. The development of the
networking infrastructure, the proliferation of the Internet and wireless
communications and the need for greater bandwidth all suggest continued demand
for semiconductor devices upon which the information age relies. Consider the
following:

o In a study released in 1998, the Semiconductor Industry Association (SIA)
reported that among all manufacturing sectors, the chip industry has become
the leading contributor to the nation's Gross Domestic Product. This figure
is 20% higher than that of the motor vehicle parts and accessories
industry.

o The Semiconductor Industry Association's 1999 forecast calls for the
industry to grow 21% with sales of $174 billion in 2000, with continued
growth of 20% in 2001 and $209 billion in sales.

o Standard & Poor's believes that the semiconductor industry is in the early
stages of a multi-year recovery. (Standard & Poor's Industry Surveys,
Semiconductors).

o Van Kampen believes that semiconductor unit volume sales have grown
sufficiently to offset the impact of falling prices. Since 1974, this
relationship between falling prices and unit volume growth has produced
annual industry sales growth averaging 17%. (Standard & Poor's Industry
Surveys, Semiconductors).

o Market research firm International Data Corp. predicts that computers
selling for less than $1,500 could grow from a recent 39% of the U.S.
consumer market to nearly 50% in 2001.

Series A Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
Analog Semiconductors
<S> <C> <C> <C> <C>
54 Analog Devices, Inc. $ 77.688 0.00% $ 4,195.13
+ 22 STMicroelectronics N.V. 196.750 0.04 4,328.50
Application Specific Integrated
Circuits (ASICs)
42 GlobeSpan, Inc. 107.625 0.00 4,520.25
67 LSI Logic Corporation 61.375 0.00 4,112.13
39 QUALCOMM, Inc. 109.813 0.00 4,282.69
Communication Integrated Circuits (ICs)
32 Applied Micro Circuits Corporation 126.188 0.00 4,038.00
24 BroadCom Corporation 174.375 0.00 4,185.00
71 Conexant Systems, Inc. 60.250 0.00 4,277.75
52 Exar Corporation 82.563 0.00 4,293.25
22 PMC-Sierra, Inc. 188.250 0.00 4,141.50
46 TranSwitch Corporation 88.625 0.00 4,076.75
61 Vitesse Semiconductor Corporation 69.438 0.00 4,235.69
Digital Signal Processors (DSPs)
26 Texas Instruments, Inc. 160.000 0.11 4,160.00
Flash/SRAM
83 Cypress Semiconductor Corporation 51.500 0.00 4,274.50
45 SanDisk Corporation 95.813 0.00 4,311.56
Foundries
+ 81 Taiwan Semiconductor Manufacturing
Company, Limited 51.125 0.00 4,141.13
Microprocessors
33 Intel Corporation 127.188 0.09 4,197.19
Programmable Logic Devices (PLDs)
41 Altera Corporation 104.000 0.00 4,264.00
58 Xilinx, Inc. 71.625 0.00 4,154.25
Radio Frequency ICs
80 Alpha Industries, Inc. 52.625 0.00 4,210.00
55 ANADIGICS, Inc. 76.500 0.00 4,207.50
53 Kopin Corporation 81.188 0.00 4,302.94
38 RF Micro Devices, Inc. 107.250 0.00 4,075.50
40 TriQuint Semiconductor, Inc. 109.875 0.00 4,395.00
Semiconductor Capital Equipment
42 Applied Materials, Inc. 99.938 0.00 4,197.38
3 107 ASM Lithography Holding N.V. 40.000 0.00 4,280.00
47 Brooks Automation, Inc. 85.688 0.00 4,027.31
31 Credence Systems Corporation 141.563 0.00 4,388.44
57 KLA-Tencor Corporation 71.625 0.00 4,082.63
92 Lam Research Corporation 44.125 0.00 4,059.50
31 Newport Corporation 141.625 0.03 4,390.38
63 Novellus Systems, Inc. 65.313 0.00 4,114.69
39 Teradyne, Inc. 109.313 0.00 4,263.19
Silicon Carbide
29 Cree, Inc. 146.063 0.00 4,235.81
Storage ICs
39 Qlogic Corporation 102.375 0.00 3,992.63
- ---------- ------------
1,742 $ 147,412.17
========== ============

</TABLE>

See "Notes to Portfolios".

Series B Portfolio
- --------------------------------------------------------------------------------------------------------------
Current Cost of
Number Market Value Dividend Securities
of Shares Name of Issuer (1) per Share (2) Yield (3) to Trust (2)
---------- ----------------------------------- --------------- ----------- ------------
Analog Semiconductors
<S> <C> <C> <C> <C>
54 Analog Devices, Inc. $ 77.688 0.00% $ 4,195.13
+ 22 STMicroelectronics N.V. 196.750 0.04 4,328.50
Application Specific Integrated
Circuits (ASICs)
42 GlobeSpan, Inc. 107.625 0.00 4,520.25
67 LSI Logic Corporation 61.375 0.00 4,112.13
39 QUALCOMM, Inc. 109.813 0.00 4,282.69
Communication Integrated Circuits (ICs)
32 Applied Micro Circuits Corporation 126.188 0.00 4,038.00
24 BroadCom Corporation 174.375 0.00 4,185.00
71 Conexant Systems, Inc. 60.250 0.00 4,277.75
52 Exar Corporation 82.563 0.00 4,293.25
22 PMC-Sierra, Inc. 188.250 0.00 4,141.50
46 TranSwitch Corporation 88.625 0.00 4,076.75
61 Vitesse Semiconductor Corporation 69.438 0.00 4,235.69
Digital Signal Processors (DSPs)
26 Texas Instruments, Inc. 160.000 0.11 4,160.00
Flash/SRAM
83 Cypress Semiconductor Corporation 51.500 0.00 4,274.50
45 SanDisk Corporation 95.813 0.00 4,311.56
Foundries
+ 81 Taiwan Semiconductor Manufacturing
Company, Limited 51.125 0.00 4,141.13
Microprocessors
33 Intel Corporation 127.188 0.09 4,197.19
Programmable Logic Devices (PLDs)
41 Altera Corporation 104.000 0.00 4,264.00
58 Xilinx, Inc. 71.625 0.00 4,154.25
Radio Frequency ICs
80 Alpha Industries, Inc. 52.625 0.00 4,210.00
55 ANADIGICS, Inc. 76.500 0.00 4,207.50
53 Kopin Corporation 81.188 0.00 4,302.94
38 RF Micro Devices, Inc. 107.250 0.00 4,075.50
40 TriQuint Semiconductor, Inc. 109.875 0.00 4,395.00
Semiconductor Capital Equipment
42 Applied Materials, Inc. 99.938 0.00 4,197.38
3 107 ASM Lithography Holding N.V. 40.000 0.00 4,280.00
47 Brooks Automation, Inc. 85.688 0.00 4,027.31
31 Credence Systems Corporation 141.563 0.00 4,388.44
57 KLA-Tencor Corporation 71.625 0.00 4,082.63
92 Lam Research Corporation 44.125 0.00 4,059.50
31 Newport Corporation 141.625 0.03 4,390.38
63 Novellus Systems, Inc. 65.313 0.00 4,114.69
39 Teradyne, Inc. 109.313 0.00 4,263.19
Silicon Carbide
29 Cree, Inc. 146.063 0.00 4,235.81
Storage ICs
39 Qlogic Corporation 102.375 0.00 3,992.63
- ---------- ------------
1,742 $ 147,412.17
========== ============

</TABLE>

See "Notes to Portfolios".

Notes to Portfolios

(1) The Securities are initially represented by "regular way" contracts for the
performance of which an irrevocable letter of credit has been deposited
with the Trustee. Contracts to acquire Securities were entered into on May
1, 2000 and May 2, 2000 and have settlement dates ranging from May 3, 2000
to May 31, 2000 (see "The Trusts").

(2) The market value of each Security principally traded North or South America
(including American Depositary Receipts) is based on the most recent
closing sale price as of the close of the New York Stock Exchange on the
business day prior to the Initial Date of Deposit. The market value of all
other Securities is based on the most recent closing sale price as of the
Initial Date of Deposit. Other information regarding the Securities, as of
the Initial Date of Deposit, is as follows:
<TABLE>
<CAPTION>

Profit
Cost to (Loss) To
Sponsor Sponsor
-------------- --------------
<S> <C> <C>

Bandwidth & Telecommunications Series A $148,150 $ (15)
Bandwidth & Telecommunications Series B $148,150 $ (15)
Biotechnology & Pharmaceutical Series A $153,077 $ (23)
Biotechnology & Pharmaceutical Series B $153,077 $ (23)
Global Wireless Series A $150,431 $ (2)
Global Wireless Series B $150,431 $ (2)
Great International Firms Trust $396,244 $ (2,572)
Roaring 2000s Series A $148,293 $ (7)
Roaring 2000s Series B $148,293 $ (7)
Semiconductor Series A $147,401 $ 11
Semiconductor Series B $147,401 $ 11
</TABLE>

"+" indicates that the stock is held in the form of American Depositary
Receipts or similar receipts.

"3" indicates that the stock is a foreign common stock traded on a U.S.
securities exchange.

(3) Current Dividend Yield for each Security is based on the estimated annual
dividends per share and the Security's market value as of the times
described in the previous note. Estimated annual dividends per share are
calculated by annualizing the most recently declared dividends or by adding
the most recent interim and final dividends declared and reflect any
foreign withholding taxes.

The Securities. A brief description of each of the issuers of the Securities
is listed below.

Bandwidth & Telecommunications Trusts

Applied Micro Circuits Corporation. Applied Micro Circuits Corporation
designs, develops, manufactures, and markets high-performance, high-bandwidth
silicon solutions for the world's communications infrastructure. The company
provides products for the automated test equipment, high-speed computing, and
military markets.

AT&T Corporation. AT&T Corporation offers communication services and
products. The company provides voice, data, and video telecommunications
services to consumers, large and small businesses, and government entities. AT&T
and its subsidiaries furnish regional, domestic, international, and local
telecommunication services. The company also provides cellular telephone and
wireless services, as well as other services.

Broadcom Corporation. Broadcom Corporation provides integrated silicon
solutions that enable broadband digital data transmission of voice, data, and
video content to the home and within the business enterprise. The company
designs, develops, and supplies integrated circuits for cable set-top boxes,
cable modems, high-speed networking, direct satellite and digital broadcast, and
digital subscriber line.

Brocade Communications Systems, Inc. Brocade Communications Systems, Inc.
provides switching solutions for storage area networks (SAN). The company's
switching solutions utilize the fiber channel interconnect protocol. Brocade's
family of SilkWorm switches enables a company to manage growth of its data
storage requirements, improve the data transfer performance, and increase the
size of its SAN.

China Telecom (Hong Kong), Limited. China Telecom (Hong Kong), Limited
provides cellular telecommunications services in the People's Republic of China.

Cisco Systems, Inc. Cisco Systems, Inc. supplies data networking products to
the corporate enterprise and public wide area service provider markets. The
company offers a variety of products including routers, LAN switches, frame
relay/ATM, and remote access concentrators. Cisco's clients include utilities,
corporations, universities, governments, and small to medium-size businesses
worldwide.

COLT Telecom Group plc. COLT Telecom Group plc provides telecommunications
and internet services to commercial and governmental customers in Europe. The
company currently has operations in twenty European cities in nine countries and
plans to be providing serivce in approximately 30 additional cities by the end
of 2001.

Conexant Systems, Inc. Conexant Systems, Inc. provides semiconductor
products for communications electronics. The company offers products for use in
wireless communications, network access, network processing, digital
entertainment, personal imaging, and personal computing. Conexant has design,
engineering, marketing, sales, and service facilities in the United States and
other countries around the world.

Copper Mountain Networks, Inc. Copper Mountain Networks, Inc. supplies
high-speed DSL-based communications products for the broadband access market.
The company's solutions enable telecommunications service providers to provide
high-speed connectivity over the existing copper wire telephone infrastructure
to the business, multi-tenant unit and residential markets.

Corning, Inc. Corning, Inc. conducts operations in the telecommunications,
advanced materials, and information display industries. The company produces
optical fiber, cable, and photonic components for the telecommunications
industry, as well as produces glass panels, funnels, liquid crystal display
glass and projection video lens assemblies for the information display industry.

Extreme Networks, Inc. Extreme Networks, Inc. provides switching solutions
for local area networks (LAN). The company uses its custom ASICs and a common
hardware, software, and management architecture to offer customers LAN
solutions.

GlobeSpan, Inc. GlobeSpan, Inc. develops advanced digital subscriber line
(DSL) integrated circuits. The company's circuits enable high-speed data
transmission over the existing network of copper telephone wires known as the
local loop. GlobeSpan sells its circuits as chip sets to manufacturers of DSL
equipment for incorporation into products that are sold to telecommunications
service providers.

Harmonic, Inc. Harmonic, Inc. designs, manufactures, and markets digital and
fiber optic systems. The company's systems enable cable, satellite, and wireless
operators to deliver video, Internet, telephony, and high-speed data services.
Harmonic's TRANsend digital product line combines and customizes content from a
variety of sources.

JDS Uniphase Corporation. JDS Uniphase Corporation provides advanced
fiberoptic components and modules. The company's products are sold to
telecommunications and cable television system providers worldwide. Products
include semiconductor lasers, high-speed external modulators, transmitters,
amplifiers, couplers, multiplexers, and optical switches. JDS also designs,
manufactures, and markets laser subsystems.

Juniper Networks, Inc. Juniper Networks, Inc. provides Internet
infrastructure solutions for Internet service providers and other
telecommunications service providers. The company delivers next generation
Internet backbone routers that are designed for service provider networks.

McLeodUSA, Inc. McLeodUSA, Inc. provides communications services to business
and residential customers in the Midwestern and Rocky Mountain regions of the
United States. The company's communications services include local, long
distance, data, voice mail, and Internet access.

Nextel Communications, Inc. Nextel Communications, Inc. provides digital and
analog wireless communications services to its customers in the United States.
The company markets its products under the Nextel brand name. Nextel's network
offers an integrated wireless communications tool with digital cellular,
text/numeric paging, and a digital two-way radio feature.

NEXTLINK Communications, Inc. NEXTLINK Communications, Inc. provides local,
long distance, and enhanced communications services to commercial customers. The
company operates facilities based networks providing switched local and long
distance services throughout the U.S. NEXTLINK's products consist of local and
long distance, calling cards, toll-free calling, voice messaging, and other
communications services.

Nokia Oyj. Nokia Oyj is an international telecommunications company. The
company develops and manufactures mobile phones, networks and systems for
cellular and fixed networks. Nokia also develops and supplies access networks,
multimedia equipment and other telecom related products. The company provides
its products and services worldwide.

Nortel Networks Corporation. Nortel Networks Corporation provides telephony,
data, wireless, and wireline products and services for the Internet. The company
serves carrier, service provider, and enterprise customers on a worldwide basis.

PMC-Sierra, Inc. PMC-Sierra, Inc. designs, develops, markets, and supports
semiconductor networking solutions. The company's products are used in the high
speed transmission and networking systems which are used to restructure the
global telecommunications and data communications infrastructure.

Powerwave Technologies, Inc. Powerwave Technologies, Inc. designs,
manufactures, and markets ultra-linear radio frequency power amplifiers for use
in the wireless communications market. The company manufactures both single and
multi-carrier radio frequency power amplifiers for a variety of frequency ranges
and transmission protocols. Powerwave markets its products worldwide.

QLogic Corporation. QLogic Corporation designs and supplies semiconductor
and board-level input/output and enclosure management products. The company's
products provide interface connections between computer systems and their
attached data storage peripherals, such as hard disk drives, tape drives, and
subsystems. QLogic also provides enclosure management products that monitor and
communicate information.

QUALCOMM, Inc. QUALCOMM, Inc. develops and delivers digital wireless
communications products and services based on the company's CDMA digital
technology. The company's business areas include integrated CDMA chipsets and
systems software, technology licensing, Eudora email software for Windows and
Macintosh platforms, and satellite based systems including Omnitracs and
Globalstar systems.

Qwest Communications International, Inc. Qwest Communications International,
Inc. provides broadband Internet-based data, voice, and image communications for
businesses and consumers. The company's Qwest Macro Capacity Fiber Network
operates in North America. Qwest is also building a high-capacity European fiber
optic, Internet-based network with its joint venture partner.

Scientific-Atlanta, Inc. Scientific-Atlanta, Inc. provides products and
services for advanced communications networks which deliver voice, data, and
video. The company's products connect information generators with information
users via broadband terrestrial and satellite networks, and include applications
for the converging of cable, telephone, and data networks.

SDL, Inc. SDL, Inc. designs, manufactures, and markets semiconductor lasers,
fiber optic related products, and optoelectronic systems. The company's products
are used in the telecommunications, cable television, dense wavelength division
multiplexing, and satellite communications markets.

Sprint Corporation (PCS Group). Sprint Corporation (PCS Group) operates a
100% digital, 100% personal cellular communication system (PCS) nationwide
wireless network in the United States. The company currently serves the United
States, Puerto Rico and the US Virgin Islands.

Sycamore Networks, Inc. Sycamore Networks, Inc. develops and markets
software-based optical networking products. The company's customers include
local exchange carriers, incumbent local exchange carriers, long distance
carriers, Internet service providers, cable operators, international telephone
companies, and wholesale carriers.

Telefonaktiebolaget LM Ericsson AB. Telefonaktiebolaget LM Ericsson AB
develops and produces advanced systems and products for wired and mobile
communications in public and private networks. The product line includes digital
and analog systems for telephones and networks, microwave radio links, radar
surveillance systems, and business systems. The company produces and markets
worldwide.

TranSwitch Corporation. TranSwitch Corporation designs, develops, markets,
and supports integrated digital and mixed-signal semiconductor solutions for the
telecommunications and data communications markets. The company's customers
primarily include original equipment manufacturers who incorporate its products
into networking equipment. TranSwitch sells its products worldwide.

TriQuint Semiconductor, Inc. TriQuint Semiconductor, Inc. designs, develops,
manufactures, and markets a variety of high performance analog and mixed signal
integrated circuits for the communications markets. The company utilizes its
proprietary gallium arsenide technology to enable its products to overcome the
performance barriers of silicon devices in various applications. TriQuint's
products are sold worldwide.

Vitesse Semiconductor Corporation. Vitesse Semiconductor Corporation
designs, develops, manufactures, and markets digital high-bandwidth
communications and automatic test equipment (ATE) integrated circuits.
The company's products address the needs of telecommunications, data
communications, and ATE equipment manufacturers who demand a combination of
high-speed, high-complexity, and low-power dissipation.

VoiceStream Wireless Corporation. VoiceStream Wireless Corporation provides
personal communications services (PCS) under the VoiceStream brand name. The
company operates in urban areas primarily located in the Western United States.

Biotechnology & Pharmaceutical Trusts

Abgenix, Inc. Abgenix, Inc. is a biopharmaceutical company that develops
antibody therapeutic products for the treatment of a variety of disease
conditions. The company's products treat transplant-related diseases,
inflammatory and autoimmune disorders, and cancer. Abgenix utilizes its
XenoMouse technology to build a diversified product portfolio.

Allergan, Inc. Allergan, Inc. provides eye care and specialty pharmaceutical
products through-out the world. The company's products are marketed to the eye
care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens
care, movement disorder, and dermatological markets. Allergan markets its
products under brand names such as Alphagan, Botox, and Complete.

Alpharma, Inc. Alpharma, Inc. develops, manufactures, and markets specialty
generic and proprietary human pharmaceutical and animal health products. The
company's products include generic liquid and topical pharmaceuticals, specialty
antibiotics, animal health feed additives for poultry and livestock, and
vaccines for farmed fish. Alpharma has operations worldwide.

American Home Products Corporation. American Home Products Corporation
discovers, develops, manufactures, distributes, and sells pharmaceuticals,
consumer health care products, and agricultural products. The company's products
include branded and generic ethical pharmaceuticals, biologicals, nutritionals,
animal biologicals and pharmaceuticals, and crop protection and pest control
products.

Amgen, Inc. Amgen, Inc. discovers, develops, manufactures, and markets human
therapeutics based on cellular and molecular biology. The company focuses its
research on secreted protein and small molecule therapeutics, with particular
emphasis on neuroscience and cancer. Amgen concentrates on the areas of
hematology, cancer, infectious disease, endocrinology, neurobiology, and
inflammation.

Andrx Corporation. Andrx Corporation formulates and commercializes oral
controlled-released pharmaceuticals. The company develops generic versions of
selected high sales volume controlled-release brand name pharmaceuticals, and
develops its own brand name formulations of certain existing drugs. Andrx also
distributes pharmaceutical products manufactured by third parties.

Biovail Corporation. Biovail Corporation is an international,
fully-integrated pharmaceutical company that develops, tests, and manufactures
drugs. The company utilizes controlled-release, rapid dissolve, enhanced
absorption and taste masking technologies. Biovail markets its products directly
in Canada and through strategic licensing partners internationally.

Celera Genomics. Celera Genomics generates, sells, and supports genomic
information and related information management and analysis software. The
company also discovers, validates, and licenses proprietary gene products,
genetic markets, and information concerning genetic variability.

Celgene Corporation. Celgene Corporation develops and commercializes human
pharmaceuticals and agrochemicals. The company employs small molecule
immunotherapeutic compound development and biocatalytic chiral chemistry
technology platforms. Celgene's lead compound, Thalomid, is in clinical trials
for the treatment of a variety of cancers and is being marketed for the
treatment of ENL, a complication of leprosy.

Cephalon, Inc. Cephalon, Inc. discovers, develops, and markets
biopharmaceutical products to treat neurological disorders and cancer. The
company's PROVOGIL treats excessive daytime sleepiness associated with
narcolepsy.

COR Therapeutics, Inc. COR Therapeutics, Inc. discovers, develops, and
commercializes pharmaceutical products for the treatment and prevention of
severe cardiovascular diseases. The company currently has research and
development programs that seek to address the critical needs in unstable angina,
acute myocardial infarction, deep vein thrombosis, and restenosis.

Elan Corporation plc. Elan Corporation plc is a specialty pharmaceutical
company. The Group's drug delivery technologies are designed to aid and control
the absorption and utilization of active pharmaceutical compounds. Elan's
Pharmaceutical division focuses on the discovery, development and
commercialization of products in the areas of acute care, pain management and
neurological disorders.

Forest Laboratories, Inc. Forest Laboratories, Inc. develops, manufactures,
and sells both branded and generic forms of ethical products which require a
physician's prescription. The company also manufactures non-prescription
pharmaceutical products sold over-the-counter, which are used for the treatment
of a wide range of illnesses. Forest's products are marketed in the United
States and eastern Europe.

Genentech, Inc. Genentech, Inc., a biotechnology company, discovers,
develops, manufactures, and markets human pharmaceuticals. The company markets
biotechnology products directly in the United States.

Gilead Sciences, Inc. Gilead Sciences, Inc. discovers, develops, and
commercializes therapeutics for viral diseases. The company markets VISTIDE for
the treatment of CMV retinitis, a sight-threatening viral infection in patients
with AIDS. Gilead is also developing products to treat diseases caused by HIV,
hepatitis B virus, and influenza virus.

Human Genome Sciences, Inc. Human Genome Sciences, Inc. researches and
develops proprietary pharmaceutical and diagnostic products. The company's
products predict, prevent, detect, treat, and cure disease based on the
discovery of human and microbial genes.

Immunex Corporation. Immunex Corporation is a biopharmaceutical company that
discovers, develops, manufactures, and markets therapeutic products. The
company's products are used to treat human diseases, including cancer,
infectious diseases, and immunological disorders. Immunex sells its products
around the world.

IVAX Corporation. IVAX Corporation researches, develops, manufactures, and
markets generic and branded pharmaceuticals in the United States and
international markets. The company's primary focus is pharmaceuticals with an
emphasis on oncology and respiratory products, as well as specialty generic
pharmaceuticals. IVAX also provides veterinary products and diagnostic products.

Medarex, Inc. Medarex, Inc. is a biopharmaceutical company developing
antibody-based therapeutics to fight cancer and other life-threatening and
debilitating diseases. The company has several products in clinical development
for the treatment of cancers and leukemia, autoimmune diseases, and ophthalmic
conditions. Medarex also creates and develops human antibodies for itself and
others.

MedImmune, Inc. MedImmune, Inc. develops and markets products that address
medical needs in areas such as infectious diseases, transplantation medicine,
autoimmune diseases and cancer. The company currently sells Synagis, RespiGam,
and CytoGam primarily in the United States.

Merck & Company, Inc. Merck & Company, Inc. is a global pharmaceutical
company that discovers, develops, manufactures, and markets a broad range of
human and animal health products. The company also provides pharmaceutical
benefit services. Merck's products include Zocor, a treatment for elevated
cholesterol, Pepcid anti-ulcerant, Primaxin antibiotic, and Propecia, a
treatment for male pattern hair loss.

Millennium Pharmaceuticals, Inc. Millennium Pharmaceuticals, Inc. is a drug
discovery and development company. The company incorporates large-scale
genetics, genomics, high throughput screening, and informatics in an integrated
life science and technology platform. The platform is applied in discovering and
developing proprietary therapeutic and diagnostic human healthcare products and
services.

Pfizer, Inc. Pfizer, Inc. is a research-based, global pharmaceutical company
that discovers, develops, manufactures, and markets medicines for humans and
animals. The company's products include prescription pharmaceuticals,
non-prescription self-medications, and animal health products such as
anti-infective medicines and vaccines.

Pharmacia Corporation. Pharmacia Corporation is a global life sciences
company that applies biological sciences to an integrated system of agriculture,
food, and human health. The company manufactures and sells pharmaceuticals,
agricultural products, and food ingredients.

QLT PhotoTherapeutics, Inc. QLT PhotoTherapeutics Inc. develops and
commercializes pharmaceutical products for use in photodynamic therapy. The
company currently provides PHOTOFRIN, a photodynamic therapy drug used in the
treatment of various cancers. QLT is also developing Visudyne, a therapy to
treat the wet form of age-related macular degeneration.

Teva Pharmaceutical Industries, Limited. Teva Pharmaceutical Industries,
Limited is a pharmaceutical company with more than 70% of its sales outside
Israel, primarily in the United States. The company develops, manufactures and
markets branded and generic human pharmaceuticals, bulk pharmaceutical
chemicals, medical disposable and veterinary products.

Global Wireless Trusts

Alpha Industries, Inc. Alpha Industries, Inc. designs, develops,
manufactures, and markets proprietary radio, microwave, and millimeter wave
frequency integrated circuits, as well as discrete semiconductors for wireless
voice and data communications. The company also produces integrated circuits,
discrete components, and ceramic resonators and ferrites.

ANADIGICS, Inc. ANADIGICS, Inc. designs and manufactures radio frequency
integrated circuit solutions for the broadband and wireless communications
markets. The company's products enable manufacturers of communications equipment
to enhance overall system performance, manufacturing costs, and time to market.

ARM Holdings plc. ARM Holdings plc designs RISC microprocessors and related
technology and software, and sells development systems to enhance embedded
applications. The company licenses and sells its technology and products to
international electronics companies, which in turn manufacture, market, and sell
microprocessors and application specific integrated circuits and related
products.

China Telecom (Hong Kong), Limited. China Telecom (Hong Kong), Limited
provides cellular telecommunications services in the People's Republic of China.

Deutsche Telekom AG. Deutsche Telekom AG owns, operates and leases public
telecommunications networks and offers network applications services. The
company provides local and long-distance telephone services, as well as
integrated voice and data digital services and maintains a large cable televison
network. Deutsche Telekom also offers mobile, paging and on-line services to
German and international customers.

France Telecom S.A. France Telecom S.A. provides telecommunications services
in France. The company operates a network of approximately 33.7 million
telephone lines for homes and businesses and a mobile telecommunications service
with over four million subscribers. France Telecom also provides almost all
other aspects of voice, data and image transmission, including television
broadcasting and cable services.

InfoSpace.com, Inc. InfoSpace.com, Inc. provides commerce, information, and
communication infrastructure services to wireless devices, merchants, and Web
sites. The compnay's affiliates include a network of wireless and other
non-personal computer devices, including cellular phones, online kiosks, and
personal digital assistants. InfoSpace's affiliate network also consists of
various Web sites.

Kopin Corporation. Kopin Corporation develops and manufactures semiconductor
materials and small form factor displays. The company uses its proprietary
technology to design, manufacture, and market products used in commercial
wireless communications and high resolution portable applications. Kopin's
principal semiconductor wafer product is a heterojunction bipolar transistor
device wafer.

Millicom International Cellular S.A. Millicom International Cellular S.A.
develops and operates cellular telephone systems worldwide. The company has
interests in 33 cellular systems in 20 countries, primarily in emerging markets
in Asia, Latin America, Europe, and Africa.

Motorola, Inc. Motorola, Inc. provides integrated communications solutions
and embedded electronic solutions. The company offers software-enhanced wireless
telephones, two-way radios, messaging and satellite communications products and
systems, as well as networking and Internet-access products. Customers include
consumers, network operators, and commercial, government, and industrial
customers.

Phone.com, Inc. Phone.com, Inc. provides software that enables the delivery
of Internet-based services to mass-market wireless telephones. The company's
software provides access to Internet- and corporate intranet-based services,
including news, stocks, weather, e-mail, travel, and sports to wireless
subscribers. Subscribers also have access via wireless telephones to
intranet-based telephony services.

RF Micro Devices, Inc. RF Micro Devices, Inc. designs, develops, and markets
proprietary radio frequency integrated circuits. The company's products are used
for wireless communications applications such as cellular and PCS, cordless
telephony, wireless LANs, wireless local loop, industrial radios, wireless
security and remote meter reading.

SK Telecom Company, Limited. SK Telecom Company, Limited provides mobile
telecommunications and paging services in Korea and India. The company provides
subscribers with digital cellular service and business features such as wireless
fax and data transmission.

Tele Sudeste Celular Participacoes S.A. Tele Sudeste Celular Participacoes
S.A. provides cellular telecommunications services to the Brazilian States of
Rio de Janeiro and Espirito Santo. Tele Sudeste Celular operates as a holding
company for Telerj Celular S.A. and Telest Celular S.A.

Telecom Italia SpA. Telecom Italia SpA, through subsidiaries, offers
telecommunications services. The company offers local and long-distance
telephone, data communications, mobile telephone, satellite communications,
teleconferencing, voicemail, Internet access and videoconferencing services.
Telecom Italia retails telecommunications equipment through approximately 100
Telecom Italia and 1,450 Insip stores.

Telefonica S.A. Telefonica S.A. provides telecommunications services to
industrial, residential and municipal customers throughout Spain and in
Argentina, Peru, Brazil, Venezuela, Puerto Rico, Portugal, El Salvador and the
United States. The company retails telephones, mobile phones and telefaxes and
offers videoconferencing and audio-visual communications such as television
broadcasting.

Vodafone AirTouch Plc. Vodafone AirTouch Plc provides mobile
telecommunications services. The company supplies customers with digital and
analogue cellular telephone, paging and personal communications services. The
group offers its services in France, Australia, Egypt, Fiji, Germany, Greece,
Malta, the Netherlands, New Zealand, South Africa, Sweden, Uganda and the United
States.

Great International Firms Trust

Akzo Nobel N.V. Akzo Nobel N.V. produces and markets chemicals, coatings and
pharmaceuticals. The company manufactures polymers, catalysts, pulp and paper
chemicals, salt, base chemicals, paint, automobile finishes, industrial
coatings, resins, oral contraceptives, antidepressants, cardiovascular drugs,
diagnostic kits, home pregnancy kits and veterinary drugs.

Alcatel. Alcatel develops, produces and distributes telecommunications
equipment and cables and offers telecommunications services. The company
manufactures and markets mobile telephones, microwave radio systems, switching
equipment and underwater networks, printed circuit boards, inductive components,
converters and optronics and solutions for utilities, cable TV operators and the
Internet.

Axa. Axa is a French insurance group providing insurance (life and
non-life), reinsurance, financial and real estate services in Europe, Asia,
Africa and North America. The company's insurance activities in the United
States are conducted through Axa Financial.

Bank of Tokyo-Mitsubishi, Limited. Bank of Tokyo-Misubishi, Limited provides
a broad range of financial services to businesses, government, and private
individuals. The bank, through its global subsidiaries, offers commercial,
investment, and trust banking products and services.

BP Amoco Plc. BP Amoco Plc is an oil and petrochemicals company. The company
explores for and produces oil and natural gas, refines, markets, and supplies
petroleum products, and manufactures and markets chemicals. BP Amoco's chemicals
include acetic acid, acrylonitrile, ethylene and polyethylene. The company has
operations in more than 70 countries.

British Telecommunications Plc. British Telecommunications Plc provides
telecommunications services. The company provides local and long-distance
telephone call products and services in the United Kingdom telephone exchange
lines to homes and businesses, international telephone calls to and from the
United Kingdom, telecommunications equipment for customers' premises, and
Internet and data services. BT has operations in approximately 52 countries.

Deutsche Bank AG. Deutsche Bank AG provides a broad range of banking,
investment, fund management, securities, credit card, mortgage, leasing and
insurance services worldwide. The company provides its services to retailers and
private clients, corporations and financial institutions, as well as
multi-national conglomerates. Deutsche Bank also offers a variety of financial
consulting and advisory services.

Diageo Plc. Diageo Plc has operations in food, alcoholic beverages, fast
food restaurants and property management. The company owns "Burger King"
restaurants, and markets food products under the "Pillsbury", "Haagen Dazs" and
"Green Giant" brand names. The company's liquor and beer products include
"Smirnoff", "J&B Rare", "Johnnie Walker", "Jose Cuervo", "Baileys", "Harp", and
"Guinness Stout".

FUJITSU, Limited. FUJITSU, Limited manufactures semiconductor, computer, and
communication equipment. The company provides comprehensive information
technology and network solutions for the global marketplace.

Glaxo Wellcome Plc. Glaxo Wellcome Plc researches, develops, manufactures
and markets pharmaceuticals. The group operates in over 57 countries, with
products manufactured in around 33 countries and sold in over 150. The company's
main products include "Zantac", an anti-ulcer drug, "Serevent", a respiratory
drug, "Imigran", a migraine drug, "Lamictal", a treatment for epilepsy, and
"Epivir", for HIV.

Koninklijke (Royal) Philips Electronics N.V. Koninklijke (Royal) Philips
Electronics N.V. manufactures lighting, consumer electronics, multimedia
devices, domestic appliances and personal care items, semiconductors, medical
devices, communication systems, and industrial electronics. The company sells
its products worldwide.

Marconi Plc. Marconi Plc is an international company which specializes in
the communications marketplace. The group, which markets high technology
products, operates via three divisions: Communications, supplying communications
and data networking equipment and solutions: Systems, which applies electronic
and information solutions in a range of industries: and Capital, providing
funding for investment.

NEC Corporation. NEC Corporation manufactures and markets computers,
telecommunication devices, electric appliances, circuit boards, and medical
equipment instruments. The company also serves as an information provider for
computer communication. NEC operates worldwide.

News Corporation, Limited. News Corporation, Limited is an international
media company. The company's operations include the production and distribution
of motion pictures and television programming. The company provides television,
satellite, and cable broadcasting and the publication of newspapers, magazines,
books and promotional inserts. News Corp. also provides electronic commerce and
aircraft leasing.

Nikko Securities Company, Limited. Nikko Securities Company, Limited
provides investment banking and underwriting services worldwide. The company
also acts as a securities dealer. Nikko operates numerous subsidiaries in
Europe, North America, and the Middle and Far East.

NTT DoCoMo, Inc. NTT DoCoMo, Inc. provides various types of
telecommunication services including cellular phones, personal handyphone
systems (PHS), paging, satelllite mobile communication, and wireless Private
Branch Exchange system services. The company also sells cellular phones, PHS,
car phones, and pagers.

Reuters Group Plc. Reuters Group Plc is an international news and
information organization. The company provides economic and financial
information to the business community, in addition to supplying various news
services. Reuters Financial Television covers world markets and international
news through over 180 bureaus in some 160 countries.

Royal Dutch Petroleum Company. Royal Dutch Petroleum Company owns 60% of the
Royal Dutch/Shell Group of companies. Through this interest, the company
explores for, produces, refines, and markets petroleum products, manufactures
chemicals, mines coal and non-ferrous metals, and produces solar cells. Royal
Dutch operates in approximately 135 countries.

SONY Corporation. SONY Corporation develops and manufactures consumer and
industrial electronic equipment. The company's products include audio and video
equipment, televisions, displays, semiconductors, electronic components,
computers and computer peripherals, and telecommunication equipment.

Telecom Argentina Stet - France Telecom S.A. Telecom Argentina Stet - France
Telecom S.A. provides telecommunications services including local, long-distance
and international service in the northern half of Argentina. The company,
through its subsidiaries, also provides cellular telecommunications service,
publishes telephone directories and provides a paging service within the same
area of Argentina.

Toyota Motor Corporation. Toyota Motor Corporation produces, sells, leases,
and repairs passenger cars, trucks, buses, boats, and airplanes in Japan and
overseas. The company also manages real estate, civil engineering, and insurance
businesses. Toyota Motor has a joint venture with General Motors in the United
States and a passenger car production base in the United Kingdom.

UBS AG. UBS AG provides a wide range of global banking and financial
services. The bank offers corporate and institutional banking, retail banking
and basic banking services, corporate finance, merchant banking, investment
counseling, asset and portfolio management, trading and risk management.

Vodafone AirTouch PLC. Vodafone AirTouch PLC provides mobile
telecommunications services. The company supplies customers with digital and
analogue cellular telephone, paging and personal communications services. The
group offers its services in France, Australia, Egypt, Fiji, Germany, Greece,
Malta, the Netherlands, New Zealand, South Africa, Sweden, Uganda and the United
States.

Roaring 2000's Trusts

Anheuser-Busch Companies, Inc. Anheuser-Busch Companies, Inc. produces and
distributes beer under brand names such as Budweiser, Michelob, and Busch. The
company also manufactures beverage cans, recycles aluminum cans for conversion
into new can sheet, manufactures labels, and operates rice milling and barley
seed processing plants. In addition, Anheuser-Busch owns and operates theme
parks.

Bank of America Corporation. Bank of America Corporation is the holding
company for Bank of America and NationsBank. The company provides retail banking
services, asset management, financial products, corporate finance, specialized
finance, capital markets, and financial services. Bank of America operates
throughout the United States as well as throughout the world.

Chase Manhattan Corporation. Chase Manhattan Corporation is a bank holding
company that conducts domestic and international financial services through
various bank and non-bank subsidiaries. The company provides corporate finance,
wholesale banking, and investment services, as well as emphasizes originations,
underwriting, distribution, risk management products, and private banking.

Citigroup, Inc. Citigroup, Inc. is a diversified financial services holding
company that provides a broad range of financial services to consumer and
corporate customers around the world. The company's services include investment
banking, retail brokerage, corporate banking, and cash management products and
services.

Colgate-Palmolive Company. Colgate-Palmolive Company is a consumer products
company that markets its products throughout the world. The company's products
include toothpaste, toothbrushes, shampoos, deodorants, bar and liquid soaps,
dishwashing liquid, and laundry products, among others. Colgate-Palmolive's
products are sold under brand names such as Colgate, Palmolive, Mennen, Ajax,
and Science Diet.

Goldman Sachs Group, Inc. Goldman Sachs Group, Inc. is a global investment
banking and securities firm specializing in investment banking, trading and
principal investments, and asset management and securities services. The company
provides services to corporations, financial institutions, governments, and
high-net worth individuals.

Intel Corporation. Intel Corporation designs, manufactures, and sells
computer components and related products. The company's major products include
microprocessors, chipsets, embedded processors and microcontrollers, flash
memory products, graphics products, network and communications products, systems
management software, conferencing products, and digital imaging products.

Lehman Brothers Holdings, Inc. Lehman Brothers Holdings, Inc. is an
investment banking firm. The company's activities include capital raising for
clients through securities underwriting and direct placements, corporate
finance, merchant banking, securities sales and trading and research services.
Lehman Brothers operates worldwide.

Medtronic, Inc. Medtronic, Inc. provides device-based therapies that restore
health, extend life, and alleviate pain. The company's principal products
include those for bradycardia pacing, tachyarrhythmia management, atrial
fibrillation management, heart failure management, heart valve replacement,
malignant and non-malignant pain, and movement disorders. Medtronic's products
are sold worldwide.

Merrill Lynch & Company, Inc. Merrill Lynch & Company, Inc. provides a
variety of financial and investment services through offices around the world.
The company serves the needs of both individual and institutional clients with a
diverse range of financial services including personal financial planning,
trading and brokering, banking and lending, and insurance.

Oracle Corporation. Oracle Corporation supplies software for enterprise
information management. The company offers databases and relational servers,
application development and decision support tools, and enterprise business
applications. Oracle's software runs on network computers, personal digital
assistants, set-top devices, workstations, PCs, minicomputers, mainframes, and
massively parallel computers.

Sprint Corporation. Sprint Corporation provides telecommunications services.
The company's principal activities include long distance service, local service,
product distribution, and directory publishing activities. Sprint's other
activities include emerging businesses, interests in international
telecommunications companies, and interest in an Internet service provider.

SunTrust Banks, Inc. SunTrust Banks, Inc. is a super-regional bank holding
company. The company's subsidiary banks operate in Florida, Georgia, Alabama,
Maryland, Tennessee, Virginia, and the District of Columbia. SunTrust provides a
wide range of personal, corporate, and institutional financial services.

VERITAS Software Corporation. VERITAS Software Corporation designs,
develops, and markets enterprise storage management and high availability
products that manage both on-line and off-line data for business-critical
computing systems. The company's products are marketed to original equipment
manufacturers and end-user customers through resellers, value added resellers,
hardware distributors, and systems integrators.

Semiconductor Trusts

Altera Corporation. Altera Corporation designs, manufactures, and markets
programmable logic devices and associated development tools. Programmable logic
devices are semiconductor integrated circuits that offer on-site programmability
to customers. The company's products, including a variety of programmable logic
devices, serve the telecommunications, data communications, and industrial
applications markets.

Analog Devices, Inc. Analog Devices, Inc. designs, manufactures, and markets
integrated circuits used in analog and digital signal processing. The company's
products are used in communications, computer, industrial, instrumentation,
military/aerospace, automotive, and high-performance consumer electronics
applications. Analog Devices sells its products worldwide.

Applied Materials, Inc. Applied Materials, Inc. develops, manufactures,
markets, and services semiconductor wafer fabrication equipment and related
spare parts for the worldwide semiconductor industry. The company's customers
include semiconductor wafer manufacturers and semiconductor integrated circuit
manufacturers.

ASM Lithography Holding N.V. ASM Lithography Holding N.V. develops,
manufactures, markets and services photolithography projection systems, known as
wafer steppers and step and scan. The company supplies its products to
integrated circuit manufacturers that use them to produce semiconductors. ASM's
customers are located in the United States, Asia and Western Europe.

Brooks Automation, Inc. Brooks Automation, Inc develops, manufactures, and
supplies wafer and substrate handling robots, modules, software, controls, and
fully integrated cluster tool handling systems. The company markets its products
to the semiconductor and flat panel display process equipment industries. Brooks
also develops software products for the semiconductor manufacturing execution
systems market.

Conexant Systems, Inc. Conexant Systems, Inc provides semiconductor products
for communications electronics. The company offers products for use in wireless
communications, network access, network processing, digital entertainment,
personal imaging, and personal computing. Conexant has design, engineering,
marketing, sales, and service facilities in the United States and other
countries around the world.

Credence Systems Corporation. Credence Systems Corporation designs,
manufactures, sells, and services automatic test equipment used for testing
semiconductor integrated circuits. The company also develops, licenses, and
distributes related software products. Credence's customers include
semiconductor manufacturers as well as assembly and test services companies.

Cree, Inc. Cree, Inc develops and manufactures semiconductor materials and
electronic devices made from silicon carbide (SiC). The company uses proprietary
technology to make enabling compound semiconductors such as blue and green light
emitting diodes, SiC crystals used in the production of unique gemstones, and
SiC wafers that are sold for device production and research.

Cypress Semiconductor Corporation. Cypress Semiconductor Corporation
designs, develops, manufactures, and markets a line of digital and mixed-signal
integrated circuits. The company's circuits are used in the data communications,
telecommunications, computers, and instrumentation systems markets. Cypress'
products are marketed worldwide through a network of sales offices,
distributors, and sales representative firms.

Exar Corporation. Exar Corporation designs, develops, and markets analog and
mixed-signal integrated circuits for use in communications and video and imaging
products. The company also produces digital integrated circuits in
communications products, as well as general purpose analog integrated circuits.

KLA-Tencor Corporation. KLA-Tencor Corporation manufactures yield management
and process monitoring systems for the semiconductor industry. The company's
systems are used to analyze product and process quality at critical steps in the
manufacture of circuits. The systems also provide feedback so that fabrication
problems can be identified. KLA-Tencor operates sales, service, and application
centers worldwide.

Lam Research Corporation. Lam Research Corporation manufactures, markets,
and services semiconductor processing equipment used in the making of integrated
circuits. The company's products are used to deposit special films on a silicon
wafer and etch away portions of various films to create a circuit design. Lam
sells its products around the world.

LSI Logic Corporation. LSI Logic Corporation designs, develops,
manufactures, and markets integrated circuits and storage systems. The company
offers products and services for a variety of electronic systems applications
and are marketed to original equipment manufacturers in the networking,
telecommunications and wireless, computers, consumer products, and storage
industries.

Newport Corporation. Newport Corporation designs, manufactures, and markets
components, instruments, and integrated systems to fiber-optic communications,
semiconductor equipment, computer peripherals, and scientific research markets.
The company's customers include Fortune 500 corporations, technology companies,
and research laboratories in commercial, academic, and government sectors
worldwide.

Novellus Systems, Inc. Novellus Systems, Inc. manufactures, markets, and
services advanced automated wafer fabrication systems for the deposition of thin
films. The company supplies deposition systems used in the fabrication of
integrated circuits. Novellus has subsidiaries in the United Kingdom, France,
Germany, China, Japan, the Netherlands, Singapore, and Taiwan. PMC-Sierra, Inc.
PMC-Sierra, Inc. designs, develops, markets, and supports semiconductor
networking solutions. The company's products are used in the high speed
transmission and networking systems which are used to restructure the global
telecommunications and data communications infrastructure.

Qlogic Corporation. QLogic Corporation designs and supplies semiconductor
and board-level input/output and enclosure management products. The company's
products provide interface connections between computer systems and their
attached data storage peripherals, such as hard disk drives, tape drives, and
subsystems. QLogic also provides enclosure management products that monitor and
communicate information.

SanDisk Corporation. SanDisk Corporation supplies flash data storage
products. The company designs, manufactures, and markets industry-standard,
solid-state data, digital imaging, and audio storage products using its
patented, high-density flash memory and controller technology.

STMicroelectronics N.V. STMicroelectronics N.V. designs, develops,
manufactures, and markets semiconductor integrated circuits and discrete
devices. The company's products are used in the telecommunications, consumer,
automotive, computer, and industrial sectors. Customers are located in North
America, Europe, Asia/Pacific, and Japan.

Taiwan Semiconductor Manufacturing Company, Limited. Taiwan Semiconductor
Company, Limited manufactures integrated circuits based on its proprietary
designs. The company offers a comprehensive set of integrated circuit
fabrication processes to manufacture CMOS logic, mixed-mode, volatile and
non-volatile memory and BiCMOS chips. Taiwan Semiconductor is an affiliate of
Philips Electronics N.V.

Teradyne, Inc. Teradyne, Inc. manufactures automatic test systems and
related software for the electronics and communications industries. The
company's products include systems to test semiconductors, circuit boards,
telephone lines and networks, and software. Teradyne also manufactures
backplanes and associated connectors used in electronic systems.

Texas Instruments, Inc. Texas Instruments, Inc. provides semiconductor
products, as well as designs and supplies digital signal processing and analog
technologies. The company also conducts businesses in materials and controls,
educational and productivity solutions, and digital imaging. Texas Instruments
has manufacturing or sales operations in countries around the world.

Xilinx, Inc. Xilinx, Inc. designs, develops, and markets complete
programmable logic solutions. The company's solutions include advanced
integrated circuits, software design tools, predefined system functions
delivered as cores of logic, and field engineering support. Xilinx sells its
products through several channels of distribution to customers in the United
States and overseas.

REPORT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

To the Board of Directors of Van Kampen Funds Inc. and the Unitholders of Van
Kampen Focus Portfolios, Series 225:

We have audited the accompanying statements of condition and the related
portfolios of Van Kampen Focus Portfolios, Series 225 as of May 2, 2000. The
statements of condition and portfolios are the responsibility of the Sponsor.
Our responsibility is to express an opinion on such financial statements based
on our audit.

We conducted our audit in accordance with auditing standards generally
accepted in the United States. Those standards require that we plan and perform
the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements. Our
procedures included confirmation of an irrevocable letter of credit deposited to
purchase securities by correspondence with the Trustee. An audit also includes
assessing the accounting principles used and significant estimates made by the
Sponsor, as well as evaluating the overall financial statement presentation.

We believe our audit provides a reasonable basis for our opinion. In our
opinion, the financial statements referred to above present fairly, in all
material respects, the financial position of Van Kampen Focus Portfolios, Series
225 as of May 2, 2000, in conformity with accounting principles generally
accepted in the United States.

GRANT THORNTON LLP
Chicago, Illinois
May 2, 2000

STATEMENTS OF CONDITION
As of May 2, 2000

Bandwidth Bandwidth Biotechnology Biotechnology
& Telecom- & Telecom- & &
munications munications Pharmaceutical Pharmaceutical
Series A Series B Series A Series B
--------------- --------------- --------------- --------------
INVESTMENT IN SECURITIES
<S> <C> <C> <C> <C>
Contracts to purchase Securities (1) $ 148,135 $ 148,135 $ 153,054 $ 153,054
--------------- --------------- --------------- --------------
Total $ 148,135 $ 148,135 $ 153,054 $ 153,054
=============== =============== =============== ==============

LIABILITIES AND INTEREST
OF UNITHOLDERS
Liabilities--
Organizational costs (2) $ 137 $ 234 $ 141 $ 236
Deferred sales charge liability (3) 2,918 5,237 3,015 5,411
Interest of Unitholders--
Cost to investors (4) 149,640 149,640 154,610 154,610
Less: Gross underwriting commission and
organizational costs (2)(4)(5) 4,560 6,976 4,712 7,203
--------------- --------------- --------------- --------------
Net interest to Unitholders (4) 145,080 142,664 149,898 147,407
--------------- --------------- --------------- --------------
Total $ 148,135 $ 148,135 $ 153,054 $ 153,054
=============== =============== =============== ==============
</TABLE>

(1) The value of the Securities is determined by Interactive Data Corporation
on the bases set forth under "Public Offering--Offering Price". The
contracts to purchase Securities are collateralized by separate irrevocable
letters of credit which have been deposited with the Trustee.

(2) A portion of the Public Offering Price represents an amount sufficient to
pay for all or a portion of the costs incurred in establishing a Trust. The
amount of these costs are set forth in the "Fee Table." A distribution will
be made as of the close of the initial offering period to an account
maintained by the Trustee from which this obligation of the investors will
be satisfied.

(3) Represents the amount of mandatory distributions from a Trust on the bases
set forth under "Public Offering".

(4) The aggregate public offering price and the aggregate sales charge are
computed on the bases set forth under "Public Offering-- Offering Price".

(5) Assumes the maximum sales charge.

STATEMENTS OF CONDITION
As of May 2, 2000

Global Global Great
Wireless Wireless International
Series A Series B Firms Trust
--------------- --------------- ---------------
INVESTMENT IN SECURITIES
<S> <C> <C> <C>
Contracts to purchase Securities (1) $ 150,429 $ 150,429 $ 393,672
-----------------------------------------------------------
Total $ 150,429 $ 150,429 $ 393,672
===========================================================

LIABILITIES AND INTEREST OF UNITHOLDERS
Liabilities--
Organizational costs (2) $ 139 $ 238 $ 151
Deferred sales charge liability (3) 2,963 5,318 13,918
Interest of Unitholders--
Cost to investors (4) 151,950 151,950 397,650
Less: Gross underwriting commission and
organizational costs (2)(4)(5) 4,623 7,077 18,047
-----------------------------------------------------------
Net interest to Unitholders (4) 147,327 144,873 379,603
-----------------------------------------------------------
Total $ 150,429 $ 150,429 $ 393,672
===========================================================
</TABLE>

(3) Represents the amount of mandatory distributions from a Trust on the bases
set forth under "Public Offering".

(4) The aggregate public offering price and the aggregate sales charge are
computed on the bases set forth under "Public Offering-- Offering Price".

(5) Assumes the maximum sales charge.

STATEMENTS OF CONDITION
As of May 2, 2000

Roaring Roaring Semi- Semi-
2000s 2000s conductor conductor
Series A Series B Series A Series B
--------------- --------------- --------------- --------------
INVESTMENT IN SECURITIES
<S> <C> <C> <C> <C>
Contracts to purchase Securities (1) $ 148,286 $ 148,286 $ 147,412 $ 147,412
--------------- --------------- --------------- --------------
Total $ 148,286 $ 148,286 $ 147,412 $ 147,412
=============== =============== =============== ==============

LIABILITIES AND INTEREST OF UNITHOLDERS
Liabilities--
Organizational costs (2) $ 356 $ 372 $ 225 $ 457
Deferred sales charge liability (3) 2,921 5,243 2,904 5,212
Interest of Unitholders--
Cost to investors (4) 149,790 149,790 148,910 148,910
Less: Gross underwriting commission and
organizational costs (2)(4)(5) 4,781 7,119 4,627 7,167
--------------- --------------- --------------- --------------
Net interest to Unitholders (4) 145,009 142,671 144,283 141,743
--------------- --------------- --------------- --------------
Total $ 148,286 $ 148,286 $ 147,412 $ 147,412
=============== =============== =============== ==============
</TABLE>

(3) Represents the amount of mandatory distributions from a Trust on the bases
set forth under "Public Offering".

(4) The aggregate public offering price and the aggregate sales charge are
computed on the bases set forth under "Public Offering-- Offering Price".

(5) Assumes the maximum sales charge.

THE TRUSTS
- --------------------------------------------------------------------------------

The Trusts were created under the laws of the State of New York pursuant to a
Trust Indenture and Trust Agreement (the "Trust Agreement"), dated the date of
this Prospectus (the "Initial Date of Deposit"), among Van Kampen Funds Inc., as
Sponsor, Van Kampen Investment Advisory Corp., as Supervisor, The Bank of New
York, as Trustee, and American Portfolio Evaluation Services, a division of Van
Kampen Investment Advisory Corp., as Evaluator.
The Trusts offer investors the opportunity to purchase Units representing
proportionate interests in portfolios of actively traded equity securities. A
Trust may be an appropriate medium for investors who desire to participate in a
portfolio of stocks with greater diversification than they might be able to
acquire individually.
On the Initial Date of Deposit, the Sponsor deposited delivery statements
relating to contracts for the purchase of the Securities and an irrevocable
letter of credit in the amount required for these purchases with the Trustee. In
exchange for these contracts the Trustee delivered to the Sponsor documentation
evidencing the ownership of Units of the Trusts. Unless otherwise terminated as
provided in the Trust Agreement, the Trusts will terminate on the Mandatory
Termination Date and any remaining Securities will be liquidated or distributed
by the Trustee within a reasonable time. As used in this Prospectus the term
"Securities" means the securities (including contracts to purchase these
securities) listed in "Portfolio" for each Trust and any additional securities
deposited into each Trust.

Additional Units of a Trust may be issued at any time by depositing in the
Trust (i) additional Securities, (ii) contracts to purchase Securities together
with cash or irrevocable letters of credit or (iii) cash (or a letter of credit)
with instructions to purchase additional Securities. As additional Units are
issued by a Trust, the aggregate value of the Securities will be increased and
the fractional undivided interest represented by each Unit will be decreased.
The Sponsor may continue to make additional deposits into a Trust following the
Initial Date of Deposit provided that the additional deposits will be in amounts
which will maintain, as nearly as practicable, the same percentage relationship
among the number of shares of each Security in the Trustportfolio that existed
immediately prior to the subsequent deposit (an equal dollar amount of each
Security in the Great International Firms Trust portfolio). Due to round lot
requirements in certain foreign securities markets and market value
fluctuations, the Great International Firms Trust may not be able to invest
equally in each Security on the Initial or any subsequent Date of Deposit.
Investors may experience a dilution of their investments and a reduction in
their anticipated income because of fluctuations in the prices of the Securities
between the time of the deposit and the purchase of the Securities and because
the Trusts will pay the associated brokerage or acquisition fees.

Each Unit of a Trust initially offered represents an undivided interest in
that Trust. To the extent that any Units are redeemed by the Trustee or
additional Units are issued as a result of additional Securities being deposited
by the Sponsor, the fractional undivided interest in that Trust represented by
each unredeemed Unit will increase or decrease accordingly, although the actual
interest in the Trust will remain unchanged. Units will remain outstanding until
redeemed upon tender to the Trustee by Unitholders, which may include the
Sponsor, or until the termination of the Trust Agreement.
Each Trust consists of (a) the Securities (including contracts for the
purchase thereof) listed under the applicable "Portfolio" as may continue to be
held from time to time in the Trust, (b) any additional Securities acquired and
held by the Trust pursuant to the provisions of the Trust Agreement and (c) any
cash held in the related Income and Capital Accounts. Neither the Sponsor nor
the Trustee shall be liable in any way for any failure in any of the Securities.

OBJECTIVES AND SECURITIES SELECTION
- --------------------------------------------------------------------------------

Each Trust seeks to increase the value of your investment by investing in a
portfolio of stocks. We cannot guarantee that a Trust will achieve its
objective. We describe the objective and selection criteria for each Trust in
the individual Trust sections beginning on page 4.

You should note that we applied the selection criteria to the Securities for
inclusion in the Trusts as of the Initial Date of Deposit. After this date, the
Securities may no longer meet the selection criteria. Should a Security no
longer meet the selection criteria, we will generally not remove the Security
from its Trust portfolio.

The Sponsor selected each Roaring 2000s Trust portfolio based on concepts
presented in The Roaring 2000s and research compiled by Harry S. Dent. Mr. Dent
did not select the stocks for the portfolios, does not endorse the Trusts and
will not supervise the portfolios. The opinions and forecasts of Mr. Dent
expressed in his books and elsewhere are not necessarily those of Van Kampen
Funds Inc. and may not actually come to pass. Mr. Dent is being compensated by
the Sponsor for his research. The Roaring 2000sSM is the exclusive property of
The H.S. Dent Foundation. The Roaring 2000sSM is a service mark of the H.S. Dent
Foundation. Each Roaring 2000s Trust has licensed the use of this service mark
from the H.S. Dent Foundation.

A balanced investment portfolio incorporates various style and capitalization
characteristics. We offer unit trusts with a variety of styles and
capitalizations to meet your needs. We determine style characteristics (growth
or value) based on the criteria used in selecting the Trust portfolio.
Generally, a growth portfolio includes companies in a growth phase of their
business with increasing earnings. A value portfolio generally includes
companies with low relative price-earnings ratios that we believe are
undervalued. We determine market capitalizations as follows based on the
weighted median market capitalization of a portfolio: Small-Cap -- less than
$1.7 billion; Mid-Cap -- $1.7 billion to $10.8 billion; and Large-Cap -- over
$10.8 billion. We determine all style and capitalization characteristics as of
the Initial Date of Deposit and the characteristics may vary thereafter. We will
not remove a Security from a Trust as a result of any change in characteristics.

RISK FACTORS
- --------------------------------------------------------------------------------

Price Volatility. The Trusts invest in stocks of U.S. and foreign companies.
The value of Units will fluctuate with the value of these stocks and may be more
or less than the price you originally paid for your Units. The market value of
stocks sometimes moves up or down rapidly and unpredictably. Because the Trusts
are unmanaged, the Trustee will not sell stocks in response to market
fluctuations as is common in managed investments. In addition, because some
Trusts hold a relatively small number of stocks, you may encounter greater
market risk than in a more diversified investment. As with any investment, we
cannot guarantee that the performance of a Trust will be positive over any
period of time.
Dividends. Common stocks represent ownership interests in the issuers and are
not obligations of the issuers. Accordingly, common stockholders have a right to
receive dividends only after the company has provided for payment of its
creditors, bondholders and preferred stockholders. Common stocks do not assure
dividend payments. Dividends are paid only when declared by an issuer's board of
directors and the amount of any dividend may vary over time.
Single Industry. Many of the Trusts invest in a single industry or in a
limited number of industries. Any negative impact on the related industry will
have a greater impact on the value of Units than on a portfolio diversified over
several industries. You should understand the risks of these industries before
you invest.

Telecommunications Issuers. The Bandwidth & Telecommunications, Global
Wireless and Greate International Firms Trusts invest significantly in
telecommunications companies. These companies are subject to substantial
governmental regulation. For example, the United States government and state
governments regulate permitted rates of return and the kinds of services that a
company may offer. This industry has experienced substantial deregulation in
recent years. Deregulation may lead to fierce competition for market share and
can have a negative impact on certain companies. Competitive pressures are
intense and telecommunications stocks can experience rapid volatility. Certain
telecommunications products may become outdated very rapidly. A company's
performance can be hurt if the company fails to keep pace with technological
advances. Certain smaller companies in the portfolio may involve greater risk
than larger, established issuers. Smaller companies may have limited product
lines, markets or financial resources. Their securities may trade in lower
volumes than larger companies. As a result, the prices of these securities may
fluctuate more than the prices of other issuers. You should also review the
following section discussing technology companies because these companies may
involve similar risks.
Technology Issuers. The Great International Firms, Roaring 2000s and
Semiconductor Trusts invest significantly in technology companies. These
companies face risks related to rapidly changing technology, rapid product
obsolescence, cyclical market patterns, evolving industry standards and frequent
new product introductions. An unexpected change in technology can have a
significant negative impact on a company. The failure of a company to introduce
new products or technologies or keep pace with rapidly changing technology, can
have a negative impact on the company's results. Technology stocks tend to
experience substantial price volatility and speculative trading. Announcements
about new products, technologies, operating results or marketing alliances can
cause stock prices to fluctuate dramatically. At times, however, extreme price
and volume fluctuations are unrelated to the operating performance of a company.
This can impact your ability to redeem your Units at a price equal to or greater
than what you paid.
The market for certain products may have only recently begun to develop, is
rapidly evolving or is characterized by increasing suppliers. Key components of
some technology products are available only from limited sources. This can
impact the cost of and ability to acquire these components. Some technology
companies serve highly concentrated customer bases with a limited number of
large customers. Any failure to meet the standard of these customers can result
in a significant loss or reduction in sales. Many products and technologies are
incorporated into other products. As a result, some companies are highly
dependent on the performance of other technology companies. We cannot guarantee
that these customers will continue to place additional orders or will place
orders in similar quantities as in the past.
Health Care Issuers. The Biotechnology & Pharmaceutical and Roaring 2000s
Trusts invest significantly in health care companies. These issuers include
companies involved in advanced medical devices and instruments, drugs and
biotechnology, managed care, hospital management/health services and medical
supplies. These companies face substantial government regulation and approval
procedures. Congress and the president have proposed a variety of legislative
changes concerning health care issuers from time to time. Government regulation,
and any change in regulation, can have a significantly unfavorable effect on the
price and availability of products and services.
Drug and medical products companies also face the risk of increasing
competition from new products or services, generic drug sales, termination of
patent protection for drug or medical supply products and the risk that a
product will never come to market. The research and development costs of
bringing a new drug or medical product to market are substantial. This process
involves lengthy government review with no guarantee of approval. These
companies may have losses and may not offer proposed products for several years,
if at all. The failure to gain approval for a new drug or product can have a
substantial negative impact on a company and its stock.
Health care facility operators face risks related to demand for services, the
ability of the facility to provide required services, confidence in the
facility, management capabilities, competition, efforts by insurers and
government agencies to limit rates, expenses, the cost and possible
unavailability of malpractice insurance, and termination or restriction of
government financial assistance (such as Medicare, Medicaid or similar
programs).
Financial Services Industry. The Roaring 2000s Trusts invest significantly in
banks and thrifts, insurance companies and investment firms. Banks, thrifts and
their holding companies are especially subject to the adverse effects of
economic recession; volatile interest rates; portfolio concentrations in
geographic markets and in commercial and residential real estate loans; and
competition from new entrants in their fields of business. In addition, banks,
thrifts and their holding companies are extensively regulated at both the
federal and state level and may be adversely affected by increased regulations.
Banks and thrifts will face increased competition from nontraditional lending
sources as regulatory changes, such as the recently enacted financial services
overhaul legislation, permit new entrants to offer various financial products.
Technological advances such as the Internet allow these nontraditional lending
sources to cut overhead and permit the more efficient use of customer data.
Banks are already facing tremendous pressure from mutual funds, brokerage firms
and other financial service providers in the competition to furnish services
that were traditionally offered by banks.
Brokerage firms, broker/dealers, investment banks, finance companies and
mutual fund companies compete with banks and thrifts to provide traditional
financial service products, in addition to their traditional services, such as
brokerage and investment advice. In addition, all financial service companies
face shrinking profit margins due to new competitors, the cost of new technology
and the pressure to compete globally.
Companies involved in the insurance industry underwrite, sell or distribute
property and casualty, life or health insurance. Many factors affect insurance
company profits, including interest rate movements, the imposition of premium
rate caps, competition and pressure to compete globally. Property and casualty
insurance profits may also be affected by weather ca tastrophes and other
disasters. Life and health insurance profits may be affected by mortality rates.
Already extensively regulated, insurance companies' profits may also be
adversely affected by increased government regulations or tax law changes.
Foreign Stocks. Because the Global Wireless and Great International Firms
Trusts invest in stocks of foreign companies, these Trusts involve additional
risks that differ from an investment in domestic stocks. Other Trusts may also
invest in foreign companies that involve the same risks. These risks include the
risk of losses due to future political and economic developments, international
trade conditions, foreign withholding taxes and restrictions on foreign
investments and exchange of securities. These Trusts also involve the risk that
fluctuations in exchange rates between the U.S. dollar and foreign currencies
may negatively affect the value of the stocks. These Trusts involve the risk
that information about the stocks is not publicly available or is inaccurate due
to the absence of uniform accounting and financial reporting standards. In
addition, some foreign securities markets are less liquid than U.S. markets.
This could cause a Trust to buy stocks at a higher price or sell stocks at a
lower price than would be the case in a highly liquid market. Foreign securities
markets are often more volatile and involve higher trading costs than U.S.
markets, and foreign companies, securities markets and brokers are also
generally not subject to the same level of supervision and regulation as in the
U.S. Certain stocks may be held in the form of American Depositary Receipts or
other similar receipts ("ADRs"). ADRs represent receipts for foreign common
stock deposited with a custodian (which may include the Trustee). The ADRs in
the Trusts, if any, trade in the U.S. in U.S. dollars and are registered with
the Securities and Exchange Commission. ADRs generally involve the same types of
risks as foreign common stock held directly. Some ADRs may experience less
liquidity than the underlying common stocks traded in their home market.
Europe. The Global Wireless and Great International Firms Trusts invest in
stocks principally traded in Europe. These Trusts involve additional risks that
differ from an investment in United States companies. In recent years, many
European countries have participated in the European Economic and Monetary Union
(EMU) seeking to develop a unified European economy. For this reason and others,
many European countries have experienced significant political, social and
economic change in recent years. Any negative consequences resulting from these
changes could affect the value of your Trust.
On January 1, 1999, eleven EMU member countries introduced a new European
currency called the Euro. This may result in uncertainties for European
securities markets and operation of your Trust. This introduction requires the
redenomination of European debt and equity securities over a period of time.
This could result in various accounting differences and/or tax treatments that
otherwise would not likely occur. As part of the Euro conversion, participating
countries will no longer control their own monetary policies by directing
independent interest rates or currency transactions. Instead, a new European
Central Bank has authority to direct monetary policy, including money supply of
the national currencies of the participating countries to the Euro. Certain EMU
members, including the United Kingdom, are not implementing the Euro at this
time. This could raise additional questions and complications within European
markets. European markets could face significant difficulties if the Euro
introduction does not take place as planned. These difficulties could include
such things as severe currency fluctuations and market disruptions. No one can
predict whether all phases of the conversion will take place as scheduled or
whether future difficulties will occur. No one can predict the impact of the
conversion. All of these issues could have a negative impact on the value of
your Units.
Pacific Region. The Global Wireless and Great International Firms Trusts
invest in stocks that principally trade in Pacific region countries. These
Trusts involve additional risks that differ from an investment in United States
companies. Social, political and economic instability has been significantly
greater in Pacific region countries than that typically associated with the
United States and Western European countries. Any instability could
significantly disrupt Pacific region markets and could adversely affect the
value of Units. Pacific region countries are in various stages of economic
development. Some economies are substantially less developed than the U.S.
economy. Adverse conditions in these countries can negatively impact the
economies of countries in the region with more developed markets.
Many of these countries depend significantly on international trade. As a
result, protective trade barriers and the economic conditional of their trading
partners can hurt these economies. These countries may also be sensitive to
world commodity prices and vulnerable to recession in other countries. While
some Pacific region countries have experienced rapid growth, many countries have
immature financial sectors, economic problems or archaic legal systems. Pacific
region economies have experienced significant difficulties in recent years. Some
of these difficulties include substantial declines in the value of currencies,
gross domestic product and corporate earnings, political turmoil and stock
market volatility. In 1997, a significant drop in Thailand's currency set off a
wave of currency depreciations throughout South and Southeast Asia. Most of the
area's stock markets fell dramatically in reaction to these events. Consumer
demand in these countries has been weak due to a general reduction in global
growth. Interest rates and inflation have also increased in many of these
countries.

No FDIC Guarantee. An investment in your Trust is not a deposit of any bank
and is not insured or guaranteed by the Federal Deposit Insurance Corporation or
any other government agency.

PUBLIC OFFERING
- --------------------------------------------------------------------------------

General. Units are offered at the Public Offering Price which includes the
underlying value of the Securities, the initial sales charge, and cash, if any,
in the Income and Capital Accounts. The "Fee Table" describes the sales charges
in detail. If any deferred sales charge payment date is not a business day, we
will charge the payment on the next business day. If you purchase Units after
the initial deferred sales charge payment, you will only pay that portion of the
payments not yet collected. A portion of the Public Offering Price includes an
amount of Securities to pay for all or a portion of the costs incurred in
establishing your Trust, including the cost of preparing documents relating to
the Trust (such as the prospectus, trust agreement and closing documents,
federal and state registration fees, the initial fees and expenses of the
Trustee and legal and audit expenses). Beginning on January 10, 2001, the
secondary market sales charge for Series B Trusts and the Great International
Firms Trust will be 4.50% and will not include deferred payments. The sales
charge for these Trusts will reduce by 0.5% on each subsequent May 2 to a
minimum of 3.00%. The initial offering period sales charge is reduced as
follows:

Great
International
Firms and
Series A Series B
Transaction Trust Trust
Amount* Sales Charge Sales Charge
-------------- -------------- --------------
$50,000 - $99,999 2.70% 4.25%
$100,000 - $249,999 2.50 4.00
$250,000 - $499,999 2.25 3.50
$500,000 - $999,999 2.00 2.50
$1,000,000 or more 1.50 1.50

- ---------------
*The breakpoint sales charges are also applied on a Unit basis utilizing a
breakpoint equivalent in the above table of $10 per Unit and will be applied on
whichever basis is more favorable to the investor.

Any sales charge reduction is the responsibility of the selling broker,
dealer or agent. An investor may aggregate purchases of Units of the Trusts for
purposes of qualifying for volume purchase discounts listed above. The reduced
sales charge structure will also apply on all purchases by the same person from
any one dealer of units of Van Kampen-sponsored unit investment trusts which are
being offered in the initial offering period (a) on any one day (the "Initial
Purchase Date") or (b) on any day subsequent to the Initial Purchase Date if the
units purchased are of a unit investment trust purchased on the Initial Purchase
Date. In the event units of more than one trust are purchased on the Initial
Purchase Date, the aggregate dollar amount of such purchases will be used to
determine whether purchasers are eligible for a reduced sales charge. Such
aggregate dollar amount will be divided by the public offering price per unit of
each respective trust purchased to determine the total number of units which
such amount could have purchased of each individual trust. Purchasers must then
consult the applicable trust's prospectus to determine whether the total number
of units which could have been purchased of a specific trust would have
qualified for a reduced sales charge and the amount of such reduction. To
determine the applicable sales charge reduction it is necessary to accumulate
all purchases made on the Initial Purchase Date and all purchases made in
accordance with (b) above. Units purchased in the name of the spouse of a
purchaser or in the name of a child of such purchaser ("immediate family
members") will be deemed to be additional purchases by the purchaser for the
purposes of calculating the applicable sales charge. The reduced sales charges
will also be applicable to a trustee or other fiduciary purchasing securities
for one or more trust estate or fiduciary accounts. If you purchase Units on
more than one day to achieve the discounts described in this paragraph, the
discount allowed on any single day will apply only to Units purchased on that
day (a retroactive discount is not given on all prior purchases).
A portion of the sales charge is waived for certain accounts described in
this paragraph. Purchases by these accounts are subject only to the portion of
the deferred sales charge that is retained by the Sponsor. Please refer to the
section called "Wrap Fee and Advisory Accounts" for additional information on
these purchases. Units may be purchased in the primary or secondary market at
the Public Offering Price less the concession the Sponsor typically allows to
brokers and dealers for purchases by (1) investors who purchase Units through
registered investment advisers, certified financial planners and registered
broker-dealers who in each case either charge periodic fees for brokerage
services, financial planning, investment advisory or asset management service,
or provide such services in connection with the establishment of an investment
account for which a comprehensive "wrap fee" charge is imposed, (2) bank trust
departments investing funds over which they exercise exclusive discretionary
investment authority and that are held in a fiduciary, agency, custodial or
similar capacity, (3) any person who for at least 90 days, has been an officer,
director or bona fide employee of any firm offering Units for sale to investors
or their immediate family members (as described above) and (4) officers and
directors of bank holding companies that make Units available directly or
through subsidiaries or bank affiliates. Notwithstanding anything to the
contrary in this Prospectus, such investors, bank trust departments, firm
employees and bank holding company officers and directors who purchase Units
through this program will not receive sales charge reductions for quantity
purchases.
During the initial offering period of the Trusts offered in this prospectus,
unitholders of any Van Kampen-sponsored unit investment trust may utilize their
redemption or termination proceeds to purchase Units of all Trusts offered in
this prospectus at the Public Offering Price per Unit less 1%.
Employees, officers and directors (including their spouses, children,
grandchildren, parents, grandparents, siblings, mothers-in-law, fathers-in-law,
sons-in-law, daughters-in-law, and trustees, custodians or fiduciaries for the
benefit of such persons) of the Van Kampen Funds Inc. and its affiliates,
dealers and their affiliates and vendors providing services to the Sponsor may
purchase Units at the Public Offering Price less the applicable dealer
concession.

Your Trust will charge the deferred sales charge per Unit regardless of any
discounts. However, if you are eligible to receive a discount such that the
sales charge you must pay is less than the applicable deferred sales charge, you
will be credited the difference between your sales charge and the deferred sales
charge at the time you buy your Units. If you elect to have distributions
reinvested into additional Units of your Trust, in addition to the reinvestment
Units you receive you will also be credited additional Units with a dollar value
sufficient to cover the amount of any remaining deferred sales charge to be
collected on such Units at the time of reinvestment. The dollar value of these
Units will fluctuate over time.

The minimum purchase is 100 Units (25 Units for retirement accounts) but may
vary by selling firm. However, in connection with fully disclosed transactions
with the Sponsor, the minimum purchase requirement will be that number of Units
set forth in the contract between the Sponsor and the related broker or agent.
Offering Price. The Public Offering Price of Units will vary from the amounts
stated under "Summary of Essential Financial Information" in accordance with
fluctuations in the prices of the underlying Securities in the Trusts. The
initial price of the Securities was determined by Interactive Data Corporation,
a firm regularly engaged in the business of evaluating, quoting or appraising
comparable securities. The Evaluator will generally determine the value of the
Securities as of the Evaluation Time on each business day and will adjust the
Public Offering Price of Units accordingly. This Public Offering Price will be
effective for all orders received prior to the Evaluation Time on each business
day. The Evaluation Time is the close of the New York Stock Exchange on each
Trust business day. Orders received by the Trustee or Sponsor for purchases,
sales or redemptions after that time, or on a day which is not a business day,
will be held until the next determination of price. The term "business day", as
used herein and under "Rights of Unitholders--Redemption of Units", excludes
Saturdays, Sundays and holidays observed by the New York Stock Exchange. The
term "business day" also excludes any day on which more than 33% of the
Securities are not traded on their principal trading exchange due to a customary
business holiday on that exchange.
The aggregate underlying value of the Securities during the initial offering
period is determined on each business day by the Evaluator in the following
manner: If the Securities are listed on a national or foreign securities
exchange or the Nasdaq Stock Market, Inc., this evaluation is generally based on
the closing sale prices on that exchange or market unless it is determined that
these prices are inappropriate as a basis for valuation) or, if there is no
closing sale price on that exchange or market, at the closing asked prices. If
the Securities are not listed on a national or foreign securities exchange or
the Nasdaq Stock Market, Inc. or, if so listed and the principal market therefor
is other than on the exchange or market, the evaluation shall generally be based
on the current asked price on the over-the-counter market (unless it is
determined that these prices are inappropriate as a basis for evaluation). If
current asked prices are unavailable, the evaluation is generally determined (a)
on the basis of current asked prices for comparable securities, (b) by
appraising the value of the Securities on the asked side of the market or (c) by
any combination of the above. The value of any foreign securities is based on
the applicable currency exchange rate as of the Evaluation Time. The value of
the Securities for purposes of secondary market transactions and redemptions is
described under "Rights of Unitholders--Redemption of Units".
In offering the Units to the public, neither the Sponsor nor any
broker-dealers are recommending any of the individual Securities but rather the
entire pool of Securities in a Trust, taken as a whole, which are represented by
the Units.
Unit Distribution. Units will be distributed to the public by the Sponsor,
broker-dealers and others at the Public Offering Price. Units repurchased in the
secondary market, if any, may be offered by this Prospectus at the secondary
market Public Offering Price in the manner described above.
The Sponsor intends to qualify Units for sale in a number of states. Brokers,
dealers and others will be allowed a concession or agency commission in
connection with the distribution of Units during the initial offering period as
described below.

Great
International
Firms and
Series A Series B
Transaction Trust Trust
Amount* Concession Concession
-------------- -------------- --------------
Less than $50,000 2.25% 3.50%
$50,000 - $99,999 2.00 3.25
$100,000 - $249,999 1.75 3.00
$250,000 - $499,999 1.50 2.50
$500,000 - $999,999 1.25 1.50
$1,000,000 or more 0.75 0.75

- ---------------
*The breakpoint concessions or agency commissions are also applied on a Unit
basis using a breakpoint equivalent of $10 per Unit and are applied on whichever
basis is more favorable to the distributor.

In addition to the regular concession or agency commission earned by selling
firms, during the initial offering period any firm that distributes 500,000 -
999,999 Units will receive additional compensation of $.005 per Unit; any firm
that distributes 1,000,000 - 1,999,999 Units will receive $.01 per Unit; any
firm that distributes 2,000,000 - 2,999,999 Units will receive $.015 per Unit;
and any firm that distributes 3,000,000 Units or more will receive $.02 per
Unit. A firm may aggregate Units of a Series A Trust and a Series B Trust of the
same industry sector type to qualify for these compensation levels but may not
aggregate among different sectors. For example, Units of Global Wireless Trust,
Series 3A and Series 3B may be aggregated but Units of Global Wireless Trust,
Series 3A may not be aggregated with Units of Semiconductor Trust, Series 2B.

Any discount provided to investors will be borne by the selling dealer or
agent as indicated under "General" above. For transactions involving unitholders
of other Van Kampen unit investment trusts who use their redemption or
termination proceeds to purchase Units of the Trusts, the total concession or
agency commission will amount to 1.30% per Unit for Series A Trusts and 2.50%
per Unit for Series B Trusts and the Great International Firms Trust. For all
secondary market transactions the total concession or agency commission will
amount to 70% of the sales charge. Notwithstanding anything to the contrary
herein, in no case shall the total of any concessions, agency commissions and
any additional compensation allowed or paid to any broker, dealer or other
distributor of Units with respect to any individual transaction exceed the total
sales charge applicable to such transaction. The Sponsor reserves the right to
reject, in whole or in part, any order for the purchase of Units and to change
the amount of the concession or agency commission to dealers and others from
time to time.
Broker-dealers of the Trusts, banks and/or others may be eligible to
participate in a program in which such firms receive from the Sponsor a nominal
award for each of their representatives who have sold a minimum number of units
of unit investment trusts created by the Sponsor during a specified time period.
In addition, at various times the Sponsor may implement other programs under
which the sales forces of brokers, dealers, banks and/or others may be eligible
to win other nominal awards for certain sales efforts, or under which the
Sponsor will reallow to such brokers, dealers, banks and/or others that sponsor
sales contests or recognition programs conforming to criteria established by the
Sponsor, or participate in sales programs sponsored by the Sponsor, an amount
not exceeding the total applicable sales charges on the sales generated by such
persons at the public offering price during such programs. Also, the Sponsor in
its discretion may from time to time pursuant to objective criteria established
by the Sponsor pay fees to qualifying entities for certain services or
activities which are primarily intended to result in sales of Units of the
Trusts. Such payments are made by the Sponsor out of its own assets, and not out
of the assets of any Trust. These programs will not change the price Unitholders
pay for their Units or the amount that a Trust will receive from the Units sold.

Sponsor Compensation. The Sponsor will receive a gross sales commission equal
to the total sales charge applicable to each transaction. With respect to the
Roaring 2000s Trusts Prudential Securities, Inc. will receive an additional
concession equal to 0.15% of the Public Offering Price of all Units it
distributes during the initial offering period rather than the additional
compensation described under "Unit Distribution". Any sales charge discount
provided to investors will be borne by the selling dealer or agent. In addition,
the Sponsor will realize a profit or loss as a result of the difference between
the price paid for the Securities by the Sponsor and the cost of the Securities
to each Trust on the Initial Date of Deposit as well as on subsequent deposits.
See "Notes to Portfolios". The Sponsor has not participated as sole underwriter
or as manager or as a member of the underwriting syndicates or as an agent in a
private placement for any of the Securities. The Sponsor may realize profit or
loss as a result of the possible fluctuations in the market value of the
Securities, since all proceeds received from purchasers of Units are retained by
the Sponsor. In maintaining a secondary market, the Sponsor will realize profits
or losses in the amount of any difference between the price at which Units are
purchased and the price at which Units are resold (which price includes the
applicable sales charge) or from a redemption of repurchased Units at a price
above or below the purchase price. Cash, if any, made available to the Sponsor
prior to the date of settlement for the purchase of Units may be used in the
Sponsor's business and may be deemed to be a benefit to the Sponsor, subject to
the limitations of the Securities Exchange Act of 1934.

The Sponsor or an affiliate may have participated in a public offering of one
or more of the Securities. The Sponsor, an affiliate or their employees may have
a long or short position in these Securities or related securities. An affiliate
may act as a specialist or market maker for these Securities. An officer,
director or employee of the Sponsor or an affiliate may be an officer or
director for issuers of the Securities.
Purchases and sales of Securities by your Trust may impact the value of the
Securities. This may especially be the case during the initial offering of
Units, upon Trust termination and in the course of satisfying large Unit
redemptions. Any publication of a list of Securities, or a list of anticipated
Securities, to be included in a Trust may also cause increased buying activity
in certain Securities. Once this information becomes public, investors may
purchase individual Securities appearing in such a publication and may do so
during or prior to the initial offering of Units. It is possible that these
investors could include investment advisory and brokerage firms of the Sponsor
or its affiliates or firms that are distributing Units. This activity may cause
your Trust to purchase stocks at a higher price than those buyers who effect
purchases prior to purchases by your Trust.
Market for Units. Although it is not obligated to do so, the Sponsor
currently intends to maintain a market for Units and to purchase Units at the
secondary market repurchase price (which is described under "Right of
Unitholders--Redemption of Units"). The Sponsor may discontinue purchases of
Units or discontinue purchases at this price at any time. In the event that a
secondary market is not maintained, a Unitholder will be able to dispose of
Units by tendering them to the Trustee for redemption at the Redemption Price.
See "Rights of Unitholders--Redemption of Units". Unitholders should contact
their broker to determine the best price for Units in the secondary market.
Units sold prior to the time the entire deferred sales charge has been collected
will be assessed the amount of any remaining deferred sales charge at the time
of sale. The Trustee will notify the Sponsor of any tendered of Units for
redemption. If the Sponsor's bid in the secondary market equals or exceeds the
Redemption Price per Unit, it may purchase the Units not later than the day on
which Units would have been redeemed by the Trustee. The Sponsor may sell
repurchased Units at the secondary market Public Offering Price per Unit.

RETIREMENT ACCOUNTS
- --------------------------------------------------------------------------------

Units are available for purchase in connection with certain types of
tax-sheltered retirement plans, including Individual Retirement Accounts for the
individuals, Simplified Employee Pension Plans for employees, qualified plans
for self-employed individuals, and qualified corporate pension and profit
sharing plans for employees. The minimum purchase for these accounts is reduced
to 25 Units but may vary by selling firm. The purchase of Units may be limited
by the plans' provisions and does not itself establish such plans.

WRAP FEE AND ADVISORY ACCOUNTS
- --------------------------------------------------------------------------------

Units may be available for purchase by investors who purchase Units through
registered investment advisers, certified financial planners and registered
broker-dealers who in each case either charge periodic fees for brokerage
services, financial planning, investment advisory or asset management service,
or provide such services in connection with the establishment of an investment
account for which a comprehensive "wrap fee" charge is imposed. You should
consult your financial professional to determine whether you can benefit from
these accounts. For these purchases you generally only pay the portion of the
sales charge that is retained by your Trust's Sponsor, Van Kampen Funds Inc.
This table illustrates the transaction fees you will pay as a percentage of the
public offering price per Unit.

Great
International
Firms and
Series A Series B
Trusts Trusts
--------- ---------
Fee paid on purchase 0.00% 0.00%
Deferred sponsor retention 0.70 1.00
--------- ---------
Total 0.70% 1.00%
========= =========

You should consult the "Public Offering--General" section for specific
information on this and other sales charge discounts.

RIGHTS OF UNITHOLDERS
- --------------------------------------------------------------------------------

Distributions. Dividends and any net proceeds from the sale of Securities
received by a Trust will generally be distributed to Unitholders on each
Distribution Date to Unitholders of record on the preceding Record Date. These
dates are listed under "Summary of Essential Financial Information". A person
becomes a Unitholder of record on the date of settlement (generally three
business days after Units are ordered). Unitholders may elect to receive
distributions in cash or to have distributions reinvested into additional Units.
Distributions may also be reinvested into Van Kampen mutual funds. See "Rights
of Unitholders--Reinvestment Option".
Dividends received by a Trust are credited to the Income Account of the
Trust. Other receipts (e.g., capital gains, proceeds from the sale of
Securities, etc.) are credited to the Capital Account. Proceeds received on the
sale of any Securities, to the extent not used to meet redemptions of Units or
pay deferred sales charges, fees or expenses, will be distributed to
Unitholders. Proceeds received from the disposition of any Securities after a
record date and prior to the following distribution date will be held in the
Capital Account and not distributed until the next distribution date. Any
distribution to Unitholders consists of each Unitholder's pro rate share of the
available cash in the Income and Capital Accounts as of the related Record Date.
Reinvestment Option. Unitholders may have distributions automatically
reinvested in additional Units under the Automatic Reinvestment Option without a
sales charge (to the extent Units may be lawfully offered for sale in the state
in which the Unitholder resides) through two options, if available. Brokers and
dealers can use the Dividend Reinvestment Service through Depository Trust
Company or purchase the Automatic Reinvestment Option CUSIP, if available. To
participate in this reinvestment option, a Unitholder must file with the Trustee
a written notice of election, together with any certificate representing Units
and other documentation that the Trustee may then require, at least five days
prior to the related Record Date. A Unitholder's election will apply to all
Units owned by the Unitholder and will remain in effect until changed by the
Unitholder. If Units are unavailable for reinvestment, distributions will be
paid in cash. Purchases of additional Units made pursuant to the reinvestment
plan will be made at the net asset value for Units as of the Evaluation Time on
the Distribution Date.
In addition, under the Guaranteed Reinvestment Option Unitholders may elect
to have distributions automatically reinvested in certain Van Kampen mutual
funds (the "Reinvestment Funds"). Each Reinvestment Fund has investment
objectives which differ from those of the Trusts. The prospectus relating to
each Reinvestment Fund describes its investment policies and how to begin
reinvestment. A Unitholder may obtain a prospectus for the Reinvestment Funds
from the Sponsor. Purchases of shares of a Reinvestment Fund will be made at a
net asset value computed on the Distribution Date. Unitholders with an existing
Guaranteed Reinvestment Option account (whereby a sales charge is imposed on
distribution reinvestments) may transfer their existing account into a new
account which allows purchases of Reinvestment Fund shares at net asset value.
A participant may elect to terminate his or her reinvestment plan and receive
future distributions in cash by notifying the Trustee in writing no later than
five days before a distribution date. The Sponsor, each Reinvestment Fund, and
its investment adviser shall have the right to suspend or terminate these
reinvestment plans at any time.
Redemption of Units. A Unitholder may redeem all or a portion of his Units by
tender to the Trustee at its Unit Investment Trust Division, 101 Barclay Street,
20th Floor, New York, New York 10286. Certificates must be tendered to the
Trustee, duly endorsed or accompanied by proper instruments of transfer with
signature guaranteed (or by providing satisfactory indemnity in connection with
lost, stolen or destroyed certificates) and by payment of applicable
governmental charges, if any. On the seventh day following the tender, the
Unitholder will be entitled to receive in cash an amount for each Unit equal to
the Redemption Price per Unit next computed on the date of tender. The "date of
tender" is deemed to be the date on which Units are received by the Trustee,
except that with respect to Units received by the Trustee after the Evaluation
Time or on a day which is not a Trust business day, the date of tender is deemed
to be the next business day.
Unitholders tendering 1,000 or more Units of a Trust for redemption may
request an in kind distribution of Securities equal to the Redemption Price per
Unit on the date of tender. Trusts generally do not offer in kind distributions
of portfolio securities that are held in foreign markets. An in kind
distribution will be made by the Trustee through the distribution of each of the
Securities in book-entry form to the account of the Unitholder's broker-dealer
at Depository Trust Company. Amounts representing fractional shares will be
distributed in cash. The Trustee may adjust the number of shares of any Security
included in a Unitholder's in kind distribution to facilitate the distribution
of whole shares.
The Trustee may sell Securities to satisfy Unit redemptions. To the extent
that Securities are redeemed in kind or sold, the size of a Trust will be, and
the diversity of a Trust may be, reduced. Sales may be required at a time when
Securities would not otherwise be sold and may result in lower prices than might
otherwise be realized. The price received upon redemption may be more or less
than the amount paid by the Unitholder depending on the value of the Securities
at the time of redemption. Special federal income tax consequences will result
if a Unitholder requests an in kind distribution. See "Taxation".
The Redemption Price per Unit and the secondary market repurchase price per
Unit are equal to the pro rate share of each Unit in each Trust determined on
the basis of (i) the cash on hand in the Trust, (ii) the value of the Securities
in the Trust and (iii) dividends receivable on the Securities in the Trust
trading ex-dividend as of the date of computation, less (a) amounts representing
taxes or other governmental charges payable out of the Trust, (b) the accrued
expenses of the Trust and (c) any unpaid deferred sales charge payments. During
the initial offering period, the redemption price and the secondary market
repurchase price will also include estimated organizational costs. For these
purposes, the Evaluator may determine the value of the Securities in the
following manner: If the Securities are listed on a national or foreign
securities exchange or the Nasdaq Stock Market, Inc., this evaluation is
generally based on the closing sale prices on that exchange or market (unless it
is determined that these prices are inappropriate as a basis for valuation) or,
if there is no closing sale price on that exchange or market, at the closing bid
prices. If the Securities are not so listed or, if so listed and the principal
market therefor is other than on the exchange or market, the evaluation may be
based on the current bid price on the over-the-counter market. If current bid
prices are unavailable or inappropriate, the evaluation may be determined (a) on
the basis of current bid prices for comparable securities, (b) by appraising the
Securities on the bid side of the market or (c) by any combination of the above.
The value of any foreign securities is based on the applicable currency exchange
rate as of the Evaluation Time.
The right of redemption may be suspended and payment postponed for any period
during which the New York Stock Exchange is closed, other than for customary
weekend and holiday closings, or any period during which the SEC determines that
trading on that Exchange is restricted or an emergency exists, as a result of
which disposal or evaluation of the Securities is not reasonably practicable, or
for other periods as the SEC may permit.
Certificates. Ownership of Units is evidenced in book entry form unless a
Unitholder makes a written request to the Trustee that ownership be in
certificate form. Units are transferable by making a written request to the
Trustee and, in the case of Units in certificate form, by presentation of the
certificate to the Trustee properly endorsed or accompanied by a written
instrument or instruments of transfer. A Unitholder must sign the written
request, and certificate or transfer instrument, exactly as his name appears on
the records of the Trustee and on the face of any certificate with the signature
guaranteed by a participant in the Securities Transfer Agents Medallion Program
("STAMP") or a signature guarantee program accepted by the Trustee. In certain
instances the Trustee may require additional documents such as, but not limited
to, trust instruments, certificates of death, appointments as executor or
administrator or certificates of corporate authority. Fractional certificates
will not be issued. The Trustee may require a Unitholder to pay a reasonable fee
for each certificate reissued or transferred and to pay any governmental charge
that may be imposed in connection with each transfer or interchange. Destroyed,
stolen, mutilated or lost certificates will be replaced upon delivery to the
Trustee of satisfactory indemnity, evidence of ownership and payment of expenses
incurred. Mutilated certificates must be surrendered to the Trustee for
replacement.
Reports Provided. Unitholders will receive a statement of dividends and other
amounts received by a Trust for each distribution. Within a reasonable time
after the end of each year, each person who was a Unitholder during that year
will receive a statement describing dividends and capital received, actual Trust
distributions, Trust expenses, a list of the Securities and other Trust
information. Unitholders may obtain the Evaluator's evaluations of the
Securities upon request.

TRUST ADMINISTRATION
- --------------------------------------------------------------------------------

Portfolio Administration. The Trusts are not managed funds and, except as
provided in the Trust Agreement, Securities generally will not be sold or
replaced. The Sponsor may, however, direct that Securities be sold in certain
limited circumstances to protect the Trust based on advice from the Supervisor.
These situations may include events such as the issuer having defaulted on
payment of any of its outstanding obligations or the price of a Security has
declined to such an extent or other credit factors exist so that in the opinion
of the Sponsor retention of the Security would be detrimental to the Trust. If a
public tender offer has been made for a Security or a merger or acquisition has
been announced affecting a Security, the Trustee may either sell the Security or
accept a tender offer for cash if the Supervisor determines that the sale or
tender is in the best interest of Unitholders. The Trustee will distribute any
cash proceeds to Unitholders. In addition, the Trustee may sell Securities to
redeem Units or pay Trust expenses or deferred sales charges. If securities or
property are acquired by a Trust, the Sponsor may direct the Trustee to sell the
securities or property and distribute the proceeds to Unitholders or to accept
the securities or property for deposit in the Trust. Should any contract for the
purchase of any of the Securities fail, the Sponsor will (unless substantially
all of the moneys held in the Trust to cover the purchase are reinvested in
substitute Securities in accordance with the Trust Agreement) refund the cash
and sales charge attributable to the failed contract to all Unitholders on or
before the next distribution date.

With respect to the Great International Firms Trust only, the Sponsor may
direct the reinvestment of proceeds of the sale of Securities if the sale is the
direct result of serious adverse credit factors which, in the opinion of the
Sponsor, would make retention of the Securities detrimental to the Trust. In
such a case, the Sponsor may, but is not obligated to, direct the reinvestment
of sale proceeds in any other securities that meet the criteria for inclusion in
the Trust on the Initial Date of Deposit. The Sponsor may also instruct the
Trustee to take action necessary to ensure that the Trust continues to satisfy
the qualifications of a regulated investment company and to avoid imposition of
tax on undistributed income of the Trust.

When your Trust sells Securities, the composition and diversity of the
Securities in the Trust may be altered. In order to obtain the best price for a
Trust, it may be necessary for the Supervisor to specify minimum amounts
(generally 100 shares) in which blocks of Securities are to be sold. In
effecting purchases and sales of a Trust's portfolio securities, the Sponsor may
direct that orders be placed with and brokerage commissions be paid to brokers,
including brokers which may be affiliated with the Trusts, the Sponsor or
dealers participating in the offering of Units. In addition, in selecting among
firms to handle a particular transaction, the Sponsor may take into account
whether the firm has sold or is selling units of unit investment trusts which it
sponsors.
Amendment of the Trust Agreement. The Trustee and the Sponsor may amend the
Trust Agreement without the consent of Unitholders to correct any provision
which may be defective or to make other provisions that will not adversely
affect Unitholders (as determined in good faith by the Sponsor and the Trustee).
The Trust Agreement may not be amended to increase the number of Units or permit
acquisition of securities in addition to or substitution for the Securities
(except as provided in the Trust Agreement). The Trustee will notify Unitholders
of any amendment.
Termination. Each Trust will terminate on the Mandatory Termination Date or
upon the sale or other disposition of the last Security held in the Trust. A
Trust may be terminated at any time with consent of Unitholders representing
two-thirds of the outstanding Units or by the Trustee when the value of the
Trust is less than $500,000 ($3,000,000 if the value of the Trust has exceeded
$15,000,000) (the "Minimum Termination Value"). Unitholders will be notified of
any termination. The Trustee may begin to sell Securities in connection with a
Trust termination nine business days before, and no later than, the Mandatory
Termination Date. Approximately thirty days before this date, the Trustee will
notify Unitholders of the termination and provide a form enabling qualified
Unitholders to elect an in kind distribution of Securities. See "Rights of
Unitholders--Redemption of Units". This form must be returned at least five
business days prior to the Mandatory Termination Date. Unitholders will receive
a final cash distribution within a reasonable time after the Mandatory
Termination Date. All distributions will be net of Trust expenses and costs.
Unitholders will receive a final distribution statement following termination.
The Information Supplement contains further information regarding termination of
the Trusts. See "Additional Information".
Limitations on Liabilities. The Sponsor, Evaluator, Supervisor and Trustee
are under no liability for taking any action or for refraining from taking any
action in good faith pursuant to the Trust Agreement, or for errors in judgment,
but shall be liable only for their own willful misfeasance, bad faith or gross
negligence (negligence in the case of the Trustee) in the performance of their
duties or by reason of their reckless disregard of their obligations and duties
hereunder. The Trustee is not be liable for depreciation or loss incurred by
reason of the sale by the Trustee of any of the Securities. In the event of the
failure of the Sponsor to act under the Trust Agreement, the Trustee may act
thereunder and is not be liable for any action taken by it in good faith under
the Trust Agreement. The Trustee is not liable for any taxes or other
governmental charges imposed on the Securities, on it as Trustee under the Trust
Agreement or on a Trust which the Trustee may be required to pay under any
present or future law of the United States of America or of any other taxing
authority having jurisdiction. In addition, the Trust Agreement contains other
customary provisions limiting the liability of the Trustee. The Trustee, Sponsor
and Supervisor may rely on any evaluation furnished by the Evaluator and have no
responsibility for the accuracy thereof. Determinations by the Evaluator shall
be made in good faith upon the basis of the best information available to it.

Sponsor. Van Kampen Funds Inc., a Delaware corporation, is the Sponsor of the
Trust. The Sponsor is an indirect subsidiary of Morgan Stanley Dean Witter & Co.
Van Kampen Funds Inc. specializes in the underwriting and distribution of unit
investment trusts and mutual funds with roots in money management dating back to
1926. The Sponsor is a member of the National Association of Securities Dealers,
Inc. and has its principal offices at 1 Parkview Plaza, P.O. Box 5555, Oakbrook
Terrace, Illinois 60181-5555, (630) 684-6000. As of November 30, 1999, the total
stockholders' equity of Van Kampen Funds Inc. was $141,554,861 (audited). The
Information Supplement contains additional information about the Sponsor.

If the Sponsor shall fail to perform any of its duties under the Trust
Agreement or become incapable of acting or shall become bankrupt or its affairs
are taken over by public authorities, then the Trustee may (i) appoint a
successor Sponsor at rates of compensation deemed by the Trustee to be
reasonable and not exceeding amounts prescribed by the Securities and Exchange
Commission, (ii) terminate the Trust Agreement and liquidate the Trusts as
provided therein or (iii) continue to act as Trustee without terminating the
Trust Agreement.
Trustee. The Trustee is The Bank of New York, a trust company organized under
the laws of New York. The Bank of New York has its unit investment trust
division offices at 101 Barclay Street, New York, New York 10286 (800) 221-7668.
The Bank of New York is subject to supervision and examination by the
Superintendent of Banks of the State of New York and the Board of Governors of
the Federal Reserve System, and its deposits are insured by the Federal Deposit
Insurance Corporation to the extent permitted by law. Additional information
regarding the Trustee is set forth in the Information Supplement, including the
Trustee's qualifications and duties, its ability to resign, the effect of a
merger involving the Trustee and the Sponsor's ability to remove and replace the
Trustee. See "Additional Information".
Performance Information. The Sponsor may from time to time in its advertising
and sales materials compare the then current estimated returns on the Trusts and
returns over specified time periods on other similar Van Kampen trusts (which
may show performance net of expenses and charges which the Trusts would have
charged) with returns on other taxable investments such as the common stocks
comprising the Dow Jones Industrial Average, the S&P 500, other investment
indices, corporate or U.S. government bonds, bank CDs, money market accounts or
money market funds, or with performance data from Lipper Analytical Services,
Inc., Morningstar Publications, Inc. or various publications, each of which has
characteristics that may differ from those of the Trusts. Information on
percentage changes in the dollar value of Units may be included from time to
time in advertisements, sales literature, reports and other information
furnished to current or prospective Unitholders. Total return figures may not be
averaged and may not reflect deduction of the sales charge, which would decrease
return. No provision is made for any income taxes payable. Past performance may
not be indicative of future results. The Trust portfolios are not managed and
Unit price and return fluctuate with the value of common stocks in the
portfolios, so there may be a gain or loss when Units are sold. As with other
performance data, performance comparisons should not be considered
representative of the Trust's relative performance for any future period.

TAXATION
- --------------------------------------------------------------------------------

Great International Firms Trust
The Great International Firms Trust intends to elect and qualify on a
continuing basis for special federal income tax treatment as a "regulated
investment company" under the Internal Revenue Code of 1986, as amended (the
"Code"). If the Trust so qualifies and timely distributes to Unitholders 90% or
more of its taxable income (without regard to its net capital gain, i.e., the
excess of its net long-term capital gain over its net short-term capital loss),
it will not be subject to federal income tax on the portion of its taxable
income (including any net capital gain) that it distributes to Unitholders. In
addition, to the extent the Trust timely distributes to Unitholders at least 98%
of its taxable income (including any net capital gain), it will not be subject
to the 4% excise tax on certain undistributed income of "regulated investment
companies." Because the Trust intends to timely distribute its taxable income
(including any net capital gain), it is anticipated that the Trust will not be
subject to federal income tax or the excise tax.
Distributions to Unitholders of the Trust's taxable income, other than
distributions which are designated as capital gain dividends, will be taxable as
ordinary income to Unitholders, except that to the extent that distributions to
a Unitholder in any year exceed the Trust's current and accumulated earnings and
profits, they will be treated as a return of capital and will reduce the
Unitholder's basis in his Units and, to the extent that they exceed his basis,
will be treated as a gain from the sale of his Units as discussed below.
Although distributions generally will be treated as distributed when paid,
distributions declared in October, November or December payable to Unitholders
of record on a specified date in one of those months and paid during January of
the following year will be treated as having been distributed by the Trust (and
received by the Unitholder) on December 31 of the year such distributions are
declared.
Distributions of the Trust's net capital gain which are properly designated
as capital gain dividends by the Trust will be taxable to Unitholders as
long-term capital gain, regardless of the length of time the Units have been
held by a Unitholder. A Unitholder may recognize a taxable gain or loss if the
Unitholder sells or redeems his Units. Any gain or loss arising from (or treated
as arising from) the sale or redemption of Units will generally be a capital
gain or loss, except in the case of a dealer or a financial institution. The
Internal Revenue Service Restructuring and Reform Act of 1998 (the "1998 Tax
Act") provides that for taxpayers other than corporations, net capital gain
(which is defined as net long-term capital gain over net short-term capital loss
for the taxable year) is generally subject to a maximum marginal stated tax rate
of 20% (10% in the case of certain taxpayers in the lowest tax bracket). Capital
gain or loss is long-term if the holding period for the asset is more than one
year, and is short-term if the holding period for the asset is one year or less.
The date on which a Unit is acquired (i.e., the "trade date") is excluded for
purposes for determining the holding period of the Unit. Capital gains realized
from assets held for one year or less are taxed at the same rates as ordinary
income. Note that if a Unitholder holds Units for six months or less and
subsequently sells such Units at a loss, the loss will be treated as a long-term
capital loss to the extent that any long-term capital gain distribution is made
with respect to such Units during the six-month period or less that the
Unitholder owns the Units.

In addition, please note that capital gains may be recharacterized as
ordinary income in the case of certain financial transactions that are
considered "conversion transactions" effective for transactions entered into
after April 30, 1993. Unitholders and prospective investors should consult with
their tax advisers regarding the potential effect of this provision on their
investment in Units. The Taxpayer Relief Act of 1997 (the "1997 Tax Act")
includes provisions that treat certain transactions designed to reduce or
eliminate risk of loss and opportunities for gain (e.g. short sales, offsetting
notional principal contracts, futures or forward contracts or similar
transactions) as constructive sales for purposes of recognition of gain (but not
loss) and for purposes of determining the holding period.

Generally, the tax basis of a Unitholder includes sales charges, and such
charges are not deductible. A portion of the sales charge for the Trust is
deferred. The income (or proceeds from redemption) a Unitholder must take into
account for federal income tax purposes is not reduced by amounts deducted to
pay the deferred sales charge.
Distributions which are taxable as ordinary income to Unitholders will
constitute dividends for federal income tax purposes. When Units are held by
corporate Unitholders, Trust distributions may qualify for the 70% dividends
received deduction, subject to limitations otherwise applicable to the
availability of the deduction, to the extent the distribution is attributable to
dividends received by the Trust from United States corporations (other than real
estate investment trusts) and is designated by the Trust as being eligible for
such deduction. To the extent dividends received by the Trust are attributable
to foreign corporations, a corporation that owns Units will not be entitled to
the dividends received deduction with respect to its pro rata portion of such
dividends, since the dividends received deduction is generally available only
with respect to dividends paid by domestic corporations. The Trust will provide
each Unitholder with information annually concerning what part of the Trust
distributions are eligible for the dividends received deduction.
The Trust may elect to pass through to the Unitholders the foreign income and
similar taxes paid by the Trust in order to enable such Unitholders to take a
credit (or deduction) for foreign income taxes paid by the Trust. If such an
election is made, Unitholders of the Trust, because they are deemed to own a pro
rata portion of the foreign securities held by the Trust, must include in their
gross income, for federal income tax purposes, both their portion of dividends
received by the Trust and also their portion of the amount which the Trust deems
to be the Unitholders' portion of foreign income taxes paid with respect to, or
withheld from, dividends, interest or other income of the Trust from its foreign
investments. Unitholders may then subtract from their federal income tax the
amount of such taxes withheld, or else treat such foreign taxes as deductions
from gross income; however, as in the case of investors receiving income
directly from foreign sources, the above described tax credit or deduction is
subject to certain limitations. The 1997 Tax Act imposes a required holding
period for such credits. Unitholders should consult their tax advisers regarding
this election and its consequences to them.
Under the Code, certain miscellaneous itemized deductions, such as investment
expenses, tax return preparation fees and employee business expenses, will be
deductible by individuals only to the extent they exceed 2% of adjusted gross
income. Miscellaneous itemized deductions subject to this limitation under
present law do not include expenses incurred by the Trust so long as the Units
are held by or for 500 or more persons at all times during the taxable year or
another exception is met. In the event the Units are held by fewer than 500
persons, additional taxable income may be realized by the individual (and other
noncorporate) Unitholders in excess of the distributions received from the
Trust.
Distributions reinvested into additional Units of the Trust will be taxed to
a Unitholder in the manner described above (i.e., as ordinary income, long-term
capital gain or as a return of capital).
The federal tax status of each year's distributions will be reported to
Unitholders and to the Internal Revenue Service. Each Unitholder will be
requested to provide the Unitholder's taxpayer identification number to the
Trustee and to certify that the Unitholder has not been notified that payments
to the Unitholder are subject to back-up withholding. If the proper taxpayer
identification number and appropriate certification are not provided when
requested, distributions by the Trust to such Unitholder (including amounts
received upon the redemption of Units) will be subject to back-up withholding.
The foregoing discussion relates only to the federal income tax status of the
Trust and to the tax treatment of distributions by the Trust to United States
Unitholders.
A Unitholder who is a foreign investor (i.e., an investor other than a United
States citizen or resident or a United States corporation, partnership, estate
or trust) should be aware that, generally, subject to applicable tax treaties,
distributions from the Trust which constitute dividends for Federal income tax
purposes (other than dividends which the Trust designates as capital gain
dividends) will be subject to United States income taxes, including withholding
taxes. However, distributions received by a foreign investor from the Trust that
are designated by the Trust as capital gain dividends should not be subject to
United States Federal income taxes, including withholding taxes, if all of the
following conditions are met (i) the capital gain dividend is not effectively
connected with the conduct by the foreign investor of a trade or business within
the United States, (ii) the foreign investor (if an individual) is not present
in the United States for 183 days or more during his or her taxable year, and
(iii) the foreign investor provides all certification which may be required of
his status (foreign investors may contact the Sponsor to obtain a Form W-8 which
must be filed with the Trustee and refiled every three calendar years
thereafter). Foreign investors should consult their tax advisers with respect to
United States tax consequences of ownership of Units. Units in the Trust and
Trust distributions may also be subject to state and local taxation and
Unitholders should consult their tax advisers in this regard.
All Other Trusts
The following is a general discussion of certain of the federal income tax
consequences of the purchase, ownership and disposition of the Units of all
Trusts other than the Great International Firms Trust. The summary is limited to
investors who hold the Units as "capital assets" (generally, property held for
investment within the meaning of Section 1221 of the Internal Revenue Code of
1986 (the "Code")). Unitholders should consult their tax advisers in determining
the federal, state, local and any other tax consequences of the purchase,
ownership and disposition of Units in the Trust. For purposes of the following
discussion and opinion, it is assumed that each Security in the Trust is equity
for federal income tax purposes.
In the opinion of Chapman and Cutler, special counsel for the Sponsor, under
existing law:
1. The Trust is not an association taxable as a corporation for federal
income tax purposes; each Unitholder will be treated as the owner of a pro rata
portion of each of the assets of the Trust under the Code; and the income of the
Trust will be treated as income of the Unitholders thereof under the Code. Each
Unitholder will be considered to have received his pro rata share of income
derived from each Security when such income is considered to be received by the
Trust.
2. Each Unitholder will have a taxable event when the Trust disposes of a
Security (whether by sale, exchange, liquidation, redemption, or otherwise) or
upon the sale or redemption of Units by such Unitholder (except to the extent an
in kind distribution of stock is received by such Unitholder as described
below). The price a Unitholder pays for his Units, generally including sales
charges, is allocated among his pro rata portion of each Security held by the
Trust (in proportion to the fair market values thereof on the valuation date
nearest the date the Unitholder purchase his Units) in order to determine his
initial tax basis for his pro rata portion of each Security held by the Trust.
Unitholders should consult their own tax advisers with regard to calculation of
basis. For federal income tax purposes, a Unitholder's pro rata portion of
dividends as defined by Section 316 of the Code paid by a corporation with
respect to a Security held by the Trust are taxable as ordinary income to the
extent of such corporation's current and accumulated "earnings and profits". A
Unitholder's pro rata portion of dividends paid on such Security which exceeds
such current and accumulated earnings and profits will first reduce a
Unitholder's tax basis in such Security, and to the extent that such dividends
exceed a Unitholder's tax basis in such Equity Security shall generally be
treated as capital gain. In general, the holding period for such capital gain
will be determined by the period of time a Unitholder has held his Units.
3. A Unitholder's portion of gain, if any, upon the sale or redemption of
Units or the disposition of Securities held by the Trust will generally be
considered a capital gain, except in the case of a dealer or a financial
institution. A Unitholder's portion of loss, if any, upon the sale or redemption
of Units or the disposition of Securities held by the Trust will generally be
considered a capital loss (except in the case of a dealer or a financial
institution). Unitholders should consult their tax advisers regarding the
recognition of such capital gains and losses for federal income tax purposes.
Deferred Sales Charge. Generally, the tax basis of a Unitholder includes
sales charges, and such charges are not deductible. A portion of the sales
charge for the Trust is deferred. The income (or proceeds from redemption) a
Unitholder must take into account for federal income tax purposes is not reduced
by amounts deducted to pay the deferred sales charge. Unitholders should consult
their own tax advisers as to the income tax consequences of the deferred sales
charge.
Dividends Received Deduction. A Unitholder will be considered to have
received all of the dividends paid on his pro rata portion of each Security when
such dividends are received by the Trust regardless of whether such dividends
are used to pay a portion of a deferred sales charge. Unitholders will be taxed
in this manner regardless of whether distributions from the Trust are actually
received by the Unitholder or are automatically reinvested. A corporation that
owns Units will generally be entitled to a 70% dividends received deduction with
respect to such Unitholder's pro rata portion of dividends received by the Trust
(to the extent such dividends are taxable as ordinary income, as discussed
above, and are attributable to domestic corporations) in the same manner as if
such corporation directly owned the Securities paying such dividends (other than
corporate Unitholders, such as "S" corporations, which are not eligible for the
deduction because of their special characteristics and other than for purposes
of special taxes such as the accumulated earnings tax and the personal holding
corporation tax). However, a corporation owning Units should be aware that
Sections 246 and 246A of the Code impose additional limitations on the
eligibility of dividends for the 70% dividends received deduction. These
limitations include a requirement that stock (and therefore Units) must
generally be held at least 46 days (as determined under Section 246(c) of the
Code). Final regulations have been issued which address special rules that must
be considered in determining whether the 46 day holding requirement is met.
Moreover, the allowable percentage of the deduction will be reduced from 70% if
a corporate Unitholder owns certain stock (or Units) the financing of which is
directly attributable to indebtedness incurred by such corporation.
To the extent dividends received by the Trust are attributable to foreign
corporations, a corporation that owns Units will not be entitled to the
dividends received deduction with respect to its pro rata portion of such
dividends, since the dividends received deduction is generally available only
with respect to dividends paid by domestic corporations. Unitholders should
consult with their tax advisers with respect to the limitations on and possible
modifications to the dividends received deduction.
Limitations on Deductibility of Trust Expenses by Unitholders. Each
Unitholder's pro rata share of each expense paid by the Trust is deductible by
the Unitholder to the same extent as though the expense had been paid directly
by him. As a result of the Tax Reform Act of 1986, certain miscellaneous
itemized deductions, such as investment expenses, tax return preparation fees
and employee business expenses will be deductible by an individual only to the
extent they exceed 2% of such individual's adjusted gross income. Unitholders
may be required to treat some or all of the expenses of the Trust as
miscellaneous itemized deductions subject to this limitation. Unitholders should
consult with their own tax advisers regarding the deductibility of Trust
expenses.
Recognition of Taxable Gain or Loss Upon Disposition of Securities by the
Trust or Disposition of Units. As discussed above, a Unitholder may recognize
taxable gain (or loss) when a Security is disposed of by the Trust or if the
Unitholder disposes of a Unit. The Internal Revenue Service Restructing and
Reform Act of 1998 (the "1998 Tax Act") provides that for taxpayers other than
corporations, net capital gain (which is defined as net long-term capital gain
over net short-term capital loss for the taxable year) realized from property
(with certain exclusions) is subject to a maximum marginal stated tax rate of
20% (10% in the case of certain taxpayers in the lowest tax bracket). Capital
gain or loss is long-term if the holding period for the asset is more than one
year, and is short-term if the holding period for the asset is one year or less.
The date on which a Unit is acquired (i.e., the "trade date") is excluded for
purposes of determining the holding period of the Unit. Capital gains realized
from assets held for one year or less are taxed at the same rates as ordinary
income.
In addition, please note that capital gains may be recharacterized as
ordinary income in the case of certain financial transactions that are
considered "conversion transactions" effective for transactions entered into
after April 30, 1993. Unitholders and prospective investors should consult with
their tax advisers regarding the potential effect of this provision on their
investment in Units.
If a Unitholder disposes of a Unit he is deemed thereby to have disposed of
his entire pro rata interest in all assets of the Trust including his pro rata
portion of all Securities represented by a Unit.
The Taxpayer Relief Act of 1997 (the "1997 Tax Act") includes provisions that
treat certain transactions designed to reduce or eliminate risk of loss and
opportunities for gain (e.g., short sales, offsetting notional principal
contracts, futures or forward contracts or similar transactions) as constructive
sales for purposes of recognition of gain (but not of loss) and for purposes of
determining the holding period. Unitholders should consult their own tax
advisers with regard to any such constructive sales rules.
Special Tax Consequences of In Kind Distributions Upon Redemption of Units or
Termination of the Trust. As discussed in "Rights of Unitholders--Redemption of
Units", under certain circumstances a Unitholder tendering Units for redemption
may request an in kind distribution. A Unitholder may also under certain
circumstances request an in kind distribution upon the termination of the Trust.
See "Rights of Unitholders--Redemption of Units. As previously discussed, prior
to the redemption of Units or the termination of the Trust, a Unitholder is
considered as owning a pro rata portion of each of the Trust's assets for
federal income tax purposes. The receipt of an in kind distribution will result
in a Unitholder receiving whole shares of stock plus, possibly, cash.
The potential tax consequences that may occur under an in kind distribution
with respect to each Security held by the Trust will depend on whether or not a
Unitholder receives cash in addition to Securities. A "Security" for this
purpose is a particular class of stock issued by a particular corporation. A
Unitholder will not recognize gain or loss if a Unitholder only receives
Securities in exchange for his or her pro rata portion in the Securities held by
the Trust. However, if a Unitholder also receives cash in exchange for a
fractional share of such Security held by the Trust, such Unitholder will
generally recognize gain or loss based upon the difference between the amount of
cash received by the Unitholder and his tax basis in such fractional share of a
Security held by the Trust.
Because the Trust will own many Securities, a Unitholder who requests an in
kind distribution will have to analyze the tax consequences with respect to each
Security owned by the Trust. The amount of taxable gain (or loss) recognized
upon such exchange will generally equal the sum of the gain (or loss) recognized
under the rules described above by such Unitholder with respect to each Security
owned by the Trust. Unitholders who request an in kind distribution are advised
to consult their tax advisers in this regard.
Computation of the Unitholder's Tax Basis. Initially, a Unitholder's tax
basis in his Units will generally equal the price paid by such Unitholder of his
Units. The cost of the Units is allocated among the Securities held in the Trust
in accordance with the proportion of the fair market values of such Securities
on the valuation date nearest the date the Units are purchased in order to
determine such Unitholder's tax basis for his pro rata portion of each Security.
A Unitholder's tax basis in his Units and his pro rata portion of a Security
held by the Trust will be reduced to the extent dividends paid with respect to
such Security are received by the Trust which are not taxable as ordinary income
as described above.
Other Matters. Each Unitholder will be requested to provide the Unitholder's
taxpayer identification number to the Trustee and to certify that the Unitholder
has not been notified that payments to the Unitholder are subject to back-up
withholding. If the proper taxpayer identification number and appropriate
certification are not provided when requested, distributions by the Trust to
such Unitholder (including amounts received upon the redemption of Units) will
be subject to back-up withholding. Distributions by the Trust (other than those
that are not treated as United States source income, if any) will generally be
subject to United States income taxation and withholding in the case of Units
held by non-resident alien individuals, foreign corporations or other non-United
States persons. Such persons should consult their tax advisers.
In general, income that is not effectively connected to the conduct of a
trade or business within the United States that is earned by non-U.S.
Unitholders and derived from dividends of foreign corporations will not be
subject to U.S. withholding tax provided that less than 25 percent of the gross
income of the foreign corporations for a three-year period ending with the close
of its taxable year preceding payment was effectively connected to the conduct
of a trade or business within the United States. In addition, such earnings may
be exempt from U.S. withholding pursuant to a specific treaty between the United
States and a foreign country. Non-U.S. Unitholders should consult their own tax
advisers regarding the imposition of U.S. withholding on distributions from the
Trust.
It should be noted that payments to the Trust of dividends on Securities that
are attributable to foreign corporations may be subject to foreign withholding
taxes and Unitholders should consult their tax advisers regarding the potential
tax consequences relating to the payment of any such withholding taxes by the
Trust. Any dividends withheld as a result thereof will nevertheless be treated
as income to the Unitholders. Because, under the grantor trust rules, an
investor is deemed to have paid directly his share of foreign taxes that have
been paid or accrued, if any, an investor may be entitled to a foreign tax
credit or deduction for United States tax purposes with respect to such taxes.
The 1997 Tax Act imposes a required holding period for such credits. Investors
should consult their tax advisers with respect to foreign withholding taxes and
foreign tax credits.
At the termination of the Trust, the Trustee will furnish to each Unitholder
of the Trust a statement containing information relating to the dividends
received by the Trust on the Securities, the gross proceeds received by the
Trust from the disposition of any Security (resulting from redemption or the
sale of any Security), and the fees and expenses paid by the Trust. The Trustee
will also furnish annual information returns to Unitholders and to the Internal
Revenue Service.
In the opinion of special counsel to the Trust for New York tax matters, the
Trust is not an association taxable as a corporation and the income of the Trust
will be treated as the income of the Unitholders under the existing income tax
laws of the State and City of New York.
The foregoing discussion relates only to the tax treatment of U.S.
Unitholders ("U.S. Unitholders") with regard to federal and certain aspects of
New York State and City income taxes. Unitholders may be subject to taxation in
New York or in other jurisdictions and should consult their own tax advisers in
this regard. As used herein, the term "U.S. Unitholder" means an owner of a Unit
of the Trust that (a) is (i) for United States federal income tax purposes a
citizen or resident of the United States, (ii) a corporation, partnership or
other entity created or organized in or under the laws of the United States or
of any political subdivision thereof, or (iii) an estate or trust the income of
which is subject to United States federal income taxation regardless of its
source or (b) does not qualify as a U.S. Unitholder in paragraph (a) but whose
income from a Unit is effectively connected with such Unitholder's conduct of a
United States trade or business. The term also includes certain former citizens
of the United States whose income and gain on the Units will be taxable.
Unitholders should consult their tax advisers regarding potential foreign, state
or local taxation with respect to the Units.

TRUST OPERATING EXPENSES
- --------------------------------------------------------------------------------

Compensation of Sponsor, Supervisor and Evaluator. The Sponsor will not
receive any fees in connection with its activities relating to the Trusts.
However, the Supervisor and Evaluator, which are affiliates of the Sponsor, will
receive the annual fee for portfolio supervisory and evaluation services set
forth in the "Fee Table". These fees may exceed the actual costs of providing
these services to the Trusts but at no time will the total amount received for
supervisory and evaluation services rendered to all Van Kampen unit investment
trusts in any calendar year exceed the aggregate cost of providing these
services in that year.
Trustee's Fee. For its services the Trustee will receive the fee from each
Trust set forth in the "Fee Table" (which includes the estimated amount of
miscellaneous Trust expenses). The Trustee benefits to the extent there are
funds in the Capital and Income Accounts since these Accounts are non-interest
bearing to Unitholders and the amounts earned by the Trustee are retained by the
Trustee. Part of the Trustee's compensation for its services to each Trust is
expected to result from the use of these funds.

Miscellaneous Expenses. The following additional charges are or may be
incurred by a Trust: (a) normal expenses (including the cost of mailing reports
to Unitholders) incurred in connection with the operation of such Trust, (b)
fees of the Trustee for extraordinary services, (c) expenses of the Trustee
(including legal and auditing expenses) and of counsel designated by the
Sponsor, (d) various governmental charges, (e) expenses and costs of any action
taken by the Trustee to protect a Trust and the rights and interests of
Unitholders, (f) indemnification of the Trustee for any loss, liability or
expenses incurred in the administration of a Trust without negligence, bad faith
or wilful misconduct on its part, (g) foreign custodial and transaction fees,
(h) costs associated with liquidating the securities held in a Trust portfolio,
(i) any offering costs incurred after the end of the initial offering period and
(j) expenditures incurred in contacting Unitholders upon termination of a Trust.
Each Trust may pay the expenses of updating its registration statement each
year. Unit investment trust sponsors have historically paid these expenses. The
Roaring 2000s Trusts will also pay a license fee to the Harry S. Dent Foundation
for use of certain service marks.

General. The fees and expenses of a Trust will accrue on a daily basis. The
deferred sales charge, fees and expenses are generally paid out of the Capital
Account of the related Trust. When these amounts are paid by or owing to the
Trustee, they are secured by a lien on the related Trust's portfolio. It is
expected that Securities will be sold to pay these amounts which will result in
capital gains or losses to Unitholders. See "Taxation". The Supervisor's,
Evaluator's and Trustee's fees may be increased without approval of the
Unitholders by amounts not exceeding proportionate increases under the category
"All Services Less Rent of Shelter" in the Consumer Price Index or, if this
category is not published, in a comparable category.

OTHER MATTERS
- --------------------------------------------------------------------------------

Legal Opinions. The legality of the Units offered hereby has been passed upon
by Chapman and Cutler, 111 West Monroe Street, Chicago, Illinois 60603, as
counsel for the Sponsor. Winston & Strawn has acted as counsel to the Trustee
and as special counsel for New York tax matters.
Independent Certified Public Accountants. The statements of condition and the
related portfolios included in this Prospectus have been audited by Grant
Thornton LLP, independent certified public accountants, as set forth in their
report in this Prospectus, and are included herein in reliance upon the
authority of said firm as experts in accounting and auditing.

ADDITIONAL INFORMATION
- --------------------------------------------------------------------------------

This Prospectus does not contain all the information set forth in the
Registration Statement filed by the Trust with the SEC. The Information
Supplement, which has been filed with the SEC, includes more detailed
information concerning the Securities, investment risks and general information
about the Trust. Information about your Trust (including the Information
Supplement) can be reviewed and copied at the SEC's Public Reference Room in
Washington, D.C. You may obtain information about the Public Reference Room by
calling 1-202-942-8090. Reports and other information about your Trust are
available on the EDGAR Database on the SEC's Internet site at
http://www.sec.gov. Copies of this information may be obtained, after paying a
duplication fee, by electronic request at the following e-mail address:
[email protected] or by writing the SEC's Public Reference Section, Washington,
D.C. 20549-0102.

TABLE OF CONTENTS
- --------------------------------------------------------------------------------

Title Page
----- ----
Summary of Essential Financial Information.. 2
Fee Table................................... 3
Bandwidth & Telecommunications Trusts....... 4
Biotechnology & Pharmaceutical Trusts....... 7
Global Wireless Trusts...................... 10
Great International Firms Trust............. 13
The Roaring 2000s Trusts.................... 15
Semiconductor Trusts........................ 18
Notes to Portfolios......................... 21
The Securities.............................. 22
Report of Independent Certified
Public Accountants....................... 40
Statements of Condition .................... 41
The Trusts.................................. A-1
Objectives and Securities Selection......... A-1
Risk Factors................................ A-2
Public Offering............................. A-5
Retirement Accounts......................... A-9
Wrap Fee and Advisory Accounts.............. A-10
Rights of Unitholders....................... A-10
Trust Administration........................ A-12
Taxation.................................... A-14
Trust Operating Expenses.................... A-20
Other Matters............................... A-21
Additional Information...................... A-21

- --------------
When Units of the Trusts are no longer available this prospectus may be used as
a preliminary prospectus for a future Trust. If this prospectus is used for
future Trusts you should note the following:

The information in this prospectus is not complete with respect to future Trust
series and may be changed. No person may sell Units of future Trusts until a
registration statement is filed with the Securities and Exchange Commission and
is effective. This prospectus is not an offer to sell Units and is not
soliciting an offer to buy Units in any state where the offer or sale is not
permitted.

EMSPRO225

#37693

#36661

#37749

#36676

#36679

#37247

PROSPECTUS

- --------------------------------------------------------------------------------

MAY 2, 2000

Van Kampen
Focus Portfolios(SM)

Bandwidth & Telecommunications
Trust, Series 10A
Bandwidth & Telecommunications
Trust, Series 10B

Biotechnology & Pharmaceutical
Trust, Series 10A
Biotechnology & Pharmaceutical
Trust, Series 10B

Global Wireless Trust, Series 3A
Global Wireless Trust, Series 3B

Great International Firms Trust,
Series 12

The Roaring 2000sSM Trust, Series 6A
The Roaring 2000sSM Trust, Series 6B

Semiconductor Trust, Series 2A
Semiconductor Trust, Series 2B

Van Kampen Funds Inc.

1 Parkview Plaza
P.O.Box 5555
Oakbrook Terrace, Illinois 60181-5555

Please retain this prospectus for future reference.

Van Kampen
Information Supplement
Van Kampen Focus Portfolios, Series 225

- --------------------------------------------------------------------------------

This Information Supplement provides additional information concerning the
risks and operations of the Trust which is not described in the Prospectus. This
Information Supplement should be read in conjunction with the Prospectus. This
Information Supplement is not a prospectus, does not include all of the
information that an investor should consider before investing in a Trust and may
not be used to offer or sell Units without the Prospectus. Copies of the
Prospectus can be obtained by contacting the Sponsor at 1 Parkview Plaza, P.O.
Box 5555, Oakbrook Terrace, Illinois 60181-5555 or by contacting your broker.
This Information Supplement is dated as of the date of the Prospectus and all
capitalized terms have been defined in the Prospectus.

Table of Contents

Page
Risk Factors 2
The Trusts 9
Sponsor Information 11
Trustee Information 12
Trust Termination 13

RISK FACTORS
Price Volatility. Because the Trusts invest in common stocks of U.S. and
foreign companies, you should understand the risks of investing in common stocks
before purchasing Units. These risks include the risk that the financial
condition of the company or the general condition of the stock market may worsen
and the value of the stocks (and therefore Units) will fall. Common stocks are
especially susceptible to general stock market movements. The value of common
stocks often rises or falls rapidly and unpredictably as market confidence and
perceptions of companies change. These perceptions are based on factors
including expectations regarding government economic policies, inflation,
interest rates, economic expansion or contraction, political climates and
economic or banking crises. The value of Units will fluctuate with the value of
the stocks in a Trust and may be more or less than the price you originally paid
for your Units. As with any investment, we cannot guarantee that the performance
of a Trust will be positive over any period of time. Because the Trusts are
unmanaged, the Trustee will not sell stocks in response to market fluctuations
as is common in managed investments. In addition, because some Trusts hold a
relatively small number of stocks, you may encounter greater market risk than in
a more diversified investment.
Dividends. Common stocks represent ownership interests in a company and are
not obligations of the company. Accordingly, common stockholders have a right to
receive payments from the company that is subordinate to the rights of
creditors, bondholders or preferred stockholders of the company. This means that
common stockholders have a right to receive dividends only if a company's board
of directors declares a dividend and the company has provided for payment of all
of its creditors, bondholders and preferred stockholders. If a company issues
additional debt securities or preferred stock, the owners of these securities
will have a claim against the company's assets before common stockholders if the
company declares bankruptcy or liquidates its assets even though the common
stock was issued first. As a result, the company may be less willing or able to
declare or pay dividends on its common stock.

Foreign Stocks. Because certain Trusts invest in foreign common stocks,
they involve additional risks that differ from an investment in domestic stocks.
Investments in foreign securities may involve a greater degree of risk than
those in domestic securities. There is generally less publicly available
information about foreign companies in the form of reports and ratings similar
to those that are published about issuers in the United States. Also, foreign
issuers are generally not subject to uniform accounting, auditing and financial
reporting requirements comparable to those applicable to United States issuers.
With respect to certain foreign countries, there is the possibility of adverse
changes in investment or exchange control regulations, expropriation,
nationalization or confiscatory taxation, limitations on the removal of funds or
other assets of a Trust, political or social instability, or diplomatic
developments which could affect United States investments in those countries.
Moreover, industrial foreign economies may differ favorably or unfavorably from
the United States' economy in terms of growth of gross national product, rate of
inflation, capital reinvestment, resource self-sufficiency and balance of
payments position. Foreign securities markets are generally not as developed or
efficient as those in the United States. While growing in volume, they usually
have substantially less volume than the New York Stock Exchange, and securities
of some foreign issuers are less liquid and more volatile than securities of
comparable United States issuers. Fixed commissions on foreign exchanges are
generally higher than negotiated commissions on United States exchanges. There
is generally less government supervision and regulation of securities exchanges,
brokers and listed issuers than in the United States.
Foreign Currencies. Certain Trusts also involve the risk that fluctuations
in exchange rates between the U.S. dollar and foreign currencies may negatively
affect the value of the stocks. For example, if a foreign stock rose 10% in
price but the U.S. dollar gained 5% against the related foreign currency, a U.S.
investor's return would be reduced to about 5%. This is because the foreign
currency would "buy" fewer dollars or, conversely, a dollar would buy more of
the foreign currency. Many foreign currencies have fluctuated widely against the
U.S. dollar for a variety of reasons such as supply and demand of the currency,
investor perceptions of world or country economies, political instability,
currency speculation by institutional investors, changes in government policies,
buying and selling of currencies by central banks of countries, trade balances
and changes in interest rates. A Trust's foreign currency transactions will be
conducted with foreign exchange dealers acting as principals on a spot (i.e.,
cash) buying basis. These dealers realize a profit based on the difference
between the price at which they buy the currency (bid price) and the price at
which they sell the currency (offer price). The Evaluator will estimate the
currency exchange rates based on current activity in the related currency
exchange markets, however, due to the volatility of the markets and other
factors, the estimated rates may not be indicative of the rate a Trust might
obtain had the Trustee sold the currency in the market at that time.
Liquidity. Whether or not the stocks in a Trust are listed on a stock
exchange, the stocks may delist from the exchange or principally trade in an
over-the-counter market. As a result, the existence of a liquid trading market
could depend on whether dealers will make a market in the stocks. We cannot
guarantee that dealers will maintain a market or that any market will be liquid.
The value of the stocks could fall if trading markets are limited or absent.
Additional Units. The Sponsor may create additional Units of a Trust by
depositing into the Trust additional stocks or cash with instructions to
purchase additional stocks. A cash deposit could result in a dilution of your
investment and anticipated income because of fluctuations in the price of the
stocks between the time of the deposit and the purchase of the stocks and
because the Trust will pay brokerage fees.
Voting. Only the Trustee may sell or vote the stocks in a Trust. While you
may sell or redeem your Units, you may not sell or vote the stocks in your
Trust. The Sponsor will instruct the Trustee how to vote the stocks. The Trustee
will vote the stocks in the same general proportion as shares held by other
shareholders if the Sponsor fails to provide instructions.

Technology Issuers. Certain Trusts are concentrated in issuers within the
technology industry. A portfolio concentrated in a single industry may present
more risk than a portfolio broadly diversified over several industries. These
Trusts, and therefore Unitholders, may be particularly susceptible to a negative
impact resulting from adverse market conditions or other factors affecting
technology issuers because any negative impact on the technology industry will
not be diversified among issuers within other unrelated industries. Accordingly,
an investment in Units should be made with an understanding of the
characteristics of the technology industry and the risks which such an
investment may entail.
Technology companies generally include companies involved in the development,
design, manufacture and sale of computers, computer related equipment, computer
networks, communications systems, telecommunications products, electronic
products, and other related products, systems and services. The market for
technology products and services, especially those specifically related to the
Internet, is characterized by rapidly changing technology, rapid product
obsolescence, cyclical market patterns, evolving industry standards and frequent
new product introductions. The success of the issuers of the Securities depends
in substantial part on the timely and successful introduction of new products.
An unexpected change in one or more of the technologies affecting an issuer's
products or in the market for products based on a particular technology could
have a material adverse affect on an issuer's operating results. Furthermore,
there can be no assurance that the issuers of the Securities will be able to
respond timely to compete in the rapidly developing marketplace.
The market for certain technology products and services may have only
recently begun to develop, is rapidly evolving and is characterized by an
increasing number of market entrants. Additionally, certain technology companies
may have only recently commenced operations or offered equity securities to the
public. Such companies are in the early stage of development and have a limited
operating history on which to analyze future operating results. It is important
to note that following its initial public offering a security is likely to
experience substantial stock price volatility and speculative trading.
Accordingly, there can be no assurance that upon redemption of Units or
termination of a Trust a Unitholder will receive an amount greater than or equal
to the Unitholder's initial investment.
Based on trading history, factors such as announcements of new products or
development of new technologies and general conditions of the industry have
caused and are likely to cause the market price of technology common stocks to
fluctuate substantially. In addition, technology company stocks have experienced
extreme price and volume fluctuations that often have been unrelated to the
operating performance of such companies. This market volatility may adversely
affect the market price of the Securities and therefore the ability of a
Unitholder to redeem units, or roll over Units into a new trust, at a price
equal to or greater than the original price paid for such Units.
Some key components of certain products of technology issuers are currently
available only from single sources. There can be no assurance that in the future
suppliers will be able to meet the demand for components in a timely and cost
effective manner. Accordingly, an issuer's operating results and customer
relationships could be adversely affected by either an increase in price for, or
and interruption or reduction in supply of, any key components. Additionally,
many technology issuers are characterized by a highly concentrated customer base
consisting of a limited number of large customers who may require product
vendors to comply with rigorous and constantly developing industry standards.
Any failure to comply with such standards may result in a significant loss or
reduction of sales. Because many products and technologies are incorporated into
other related products, certain companies are often highly dependent on the
performance of other computer, electronics and communications companies. There
can be no assurance that these customers will place additional orders, or that
an issuer of Securities will obtain orders of similar magnitude as past orders
form other customers. Similarly, the success of certain companies is tied to a
relatively small concentration of products or technologies with intense
competition between companies. Accordingly, a decline in demand of such
products, technologies or from such customers could have a material adverse
impact on issuers of the Securities.

Telecommunications Issuers. Because certain Trusts are concentrated in the
telecommunications industry, the value of the Units of these Trusts may be
susceptible to factors affecting the telecommunications industry. The
telecommunications industry is subject to governmental regulation and the
products and services of telecommunications companies may be subject to rapid
obsolescence. These factors could affect the value of Units. Telephone companies
in the United States, for example, are subject to both state and federal
regulations affecting permitted rates of returns and the kinds of services that
may be offered. Certain types of companies represented in a Trust portfolio are
engaged in fierce competition for a share of the market of their products. As a
result, competitive pressures are intense and the stocks are subject to rapid
price volatility. While a Trust portfolio concentrates on the securities of
established suppliers of traditional telecommunication products and services, a
Trust may also invest in smaller telecommunications companies which may benefit
from the development of new products and services. These smaller companies may
present greater opportunities for capital appreciation, and may also involve
greater risk than large, established issuers. Such smaller companies may have
limited product lines, market or financial resources, and their securities may
trade less frequently and in limited volume than the securities of larger, more
established companies. As a result, the prices of the securities of such smaller
companies may fluctuate to a greater degree than the prices of securities of
other issuers.
Health Care Issuers. An investment in Units of certain Trusts should be made
with an understanding of the problems and risks inherent in the healthcare
industry in general. Healthcare companies involved in advanced medical devices
and instruments, drugs and biotech, managed care, hospital management/health
services and medical supplies have potential risks unique to their sector of the
healthcare field. These companies are subject to governmental regulation of
their products and services, a factor which could have a significant and
possibly unfavorable effect on the price and availability of such products or
services. Furthermore, such companies face the risk of increasing competition
from new products or services, generic drug sales, termination of patent
protection for drug or medical supply products and the risk that technological
advances will render their products obsolete. The research and development costs
of bringing a drug to market are substantial, and include lengthy governmental
review processes with no guarantee that the product will ever come to market.
Many of these companies may have losses and not offer certain products for
several years. Such companies may also have persistent losses during a new
product's transition from development to production, and revenue patterns may be
erratic. In addition, healthcare facility operators may be affected by events
and conditions including, among other things, demand for services, the ability
of the facility to provide the services required, physicians' confidence in the
facility, management capabilities, competition with other hospitals, efforts by
insurers and governmental agencies to limit rates, legislation establishing
state rate-setting agencies, expenses, government regulation, the cost and
possible unavailability of malpractice insurance and the termination or
restriction of governmental financial assistance, including that associated with
Medicare, Medicaid and other similar third-party payor programs.
Legislative proposals concerning healthcare are proposed in Congress from
time to time. These proposals span a wide range of topics, including cost and
price controls (which might include a freeze on the prices of prescription
drugs), national health insurance, incentives for competition in the provision
of healthcare services, tax incentives and penalties related to healthcare
insurance premiums and promotion of pre-paid healthcare plans. The Sponsor is
unable to predict the effect of any of these proposals, if enacted, on the
issuers of Securities in the Trust.
Financial Services Issuers. An investment in Units of certain Trusts should
be made with an understanding of the problems and risks inherent in the bank and
financial services sector in general.
Banks, thrifts and their holding companies are especially subject to the
adverse effects of economic recession, volatile interest rates, portfolio
concentrations in geographic markets and in commercial and residential real
estate loans, and competition from new entrants in their fields of business.
Banks and thrifts are highly dependent on net interest margin. Recently, bank
profits have come under pressure as net interest margins have contracted, but
volume gains have been strong in both commercial and consumer products. There is
no certainty that such conditions will continue. Bank and thrift institutions
had received significant consumer mortgage fee income as a result of activity in
mortgage and refinance markets. As initial home purchasing and refinancing
activity subsided, this income diminished. Economic conditions in the real
estate markets, which have been weak in the past, can have a substantial effect
upon banks and thrifts because they generally have a portion of their assets
invested in loans secured by real estate. Banks, thrifts and their holding
companies are subject to extensive federal regulation and, when such
institutions are state- chartered, to state regulation as well. Such regulations
impose strict capital requirements and limitations on the nature and extent of
business activities that banks and thrifts may pursue. Furthermore, bank
regulators have a wide range of discretion in connection with their supervisory
and enforcement authority and may substantially restrict the permissible
activities of a particular institution if deemed to pose significant risks to
the soundness of such institution or the safety of the federal deposit insurance
fund. Regulatory actions, such as increases in the minimum capital requirements
applicable to banks and thrifts and increases in deposit insurance premiums
required to be paid by banks and thrifts to the Federal Deposit Insurance
Corporation ("FDIC"), can negatively impact earnings and the ability of a
company to pay dividends. Neither federal insurance of deposits nor governmental
regulations, however, insures the solvency or profitability of banks or their
holding companies, or insures against any risk of investment in the securities
issued by such institutions.
The statutory requirements applicable to and regulatory supervision of banks,
thrifts and their holding companies have increased significantly and have
undergone substantial change in recent years. To a great extent, these changes
are embodied in the Financial Institutions Reform, Recovery and Enforcement Act;
enacted in August 1989, the Federal Deposit Insurance Corporation Improvement
Act of 1991, the Resolution Trust Corporation Refinancing, Restructuring, and
Improvement Act of 1991 and the regulations promulgated under these laws. Many
of the regulations promulgated pursuant to these laws have only recently been
finalized and their impact on the business, financial condition and prospects of
the Securities in the Trust's portfolio cannot be predicted with certainty. The
recently enacted financial-services overhaul legislation will allow banks,
securities firms and insurance companies to form one-stop financial
conglomerates marketing a wide range of financial service products to investors.
This legislation will likely result in increased merger activity and heightened
competition among existing and new participants in the field. Efforts to expand
the ability of federal thrifts to branch on an interstate basis have been
initially successful through promulgation of regulations, and legislation to
liberalize interstate banking has recently been signed into law. Under the
legislation, banks will be able to purchase or establish subsidiary banks in any
state, one year after the legislation's enactment. Since mid-1997, banks have
been allowed to turn existing banks into branches. Consolidation is likely to
continue. The Securities and Exchange Commission and the Financial Accounting
Standards Board require the expanded use of market value accounting by banks and
have imposed rules requiring market accounting for investment securities held in
trading accounts or available for sale. Adoption of additional such rules may
result in increased volatility in the reported health of the industry, and
mandated regulatory intervention to correct such problems. Additional
legislative and regulatory changes may be forthcoming. For example, the bank
regulatory authorities have proposed substantial changes to the Community
Reinvestment Act and fair lending laws, rules and regulations, and there can be
no certainty as to the effect, if any, that such changes would have on the
Securities in the Trust's portfolio. In addition, from time to time the deposit
insurance system is reviewed by Congress and federal regulators, and proposed
reforms of that system could, among other things, further restrict the ways in
which deposited moneys can be used by banks or reduce the dollar amount or
number of deposits insured for any depositor. Such reforms could reduce
profitability as investment opportunities available to bank institutions become
more limited and as consumers look for savings vehicles other than bank
deposits. Banks and thrifts face significant competition from other financial
institutions such as mutual funds, credit unions, mortgage banking companies and
insurance companies, and increased competition may result from legislative
broadening of regional and national interstate banking powers as has been
recently enacted. Among other benefits, the legislation allows banks and bank
holding companies to acquire across previously prohibited state lines and to
consolidate their various bank subsidiaries into one unit. The Sponsor makes no
prediction as to what, if any, manner of bank and thrift regulatory actions
might ultimately be adopted or what ultimate effect such actions might have on
the Trust's portfolio.
The Federal Bank Holding Company Act of 1956 generally prohibits a bank
holding company from (1) acquiring, directly or indirectly, more than 5% of the
outstanding shares of any class of voting securities of a bank or bank holding
company, (2) acquiring control of a bank or another bank holding company, (3)
acquiring all or substantially all the assets of a bank, or (4) merging or
consolidating with another bank holding company, without first obtaining Federal
Reserve Board ("FRB") approval. In considering an application with respect to
any such transaction, the FRB is required to consider a variety of factors,
including the potential anti-competitive effects of the transaction, the
financial condition and future prospects of the combining and resulting
institutions, the managerial resources of the resulting institution, the
convenience and needs of the communities the combined organization would serve,
the record of performance of each combining organization under the Community
Reinvestment Act and the Equal Credit Opportunity Act, and the prospective
availability to the FRB of information appropriate to determine ongoing
regulatory compliance with applicable banking laws. In addition, the federal
Change In Bank Control Act and various state laws impose limitations on the
ability of one or more individuals or other entities to acquire control of banks
or bank holding companies.
The FRB has issued a policy statement on the payment of cash dividends by
bank holding companies. In the policy statement, the FRB expressed its view that
a bank holding company experiencing earnings weaknesses should not pay cash
dividends which exceed its net income or which could only be funded in ways that
would weaken its financial health, such as by borrowing. The FRB also may impose
limitations on the payment of dividends as a condition to its approval of
certain applications, including applications for approval of mergers and
acquisitions. The Sponsor makes no prediction as to the effect, if any, such
laws will have on the Securities or whether such approvals, if necessary, will
be obtained.
Companies involved in the insurance industry are engaged in underwriting,
reinsuring, selling, distributing or placing of property and casualty, life or
health insurance. Other growth areas within the insurance industry include
brokerage, reciprocals, claims processors and multiline insurance companies.
Insurance company profits are affected by interest rate levels, general economic
conditions, and price and marketing competition. Property and casualty insurance
profits may also be affected by weather catastrophes and other disasters. Life
and health insurance profits may be affected by mortality and morbidity rates.
Individual companies may be exposed to material risks including reserve
inadequacy and the inability to collect from reinsurance carriers. Insurance
companies are subject to extensive governmental regulation, including the
imposition of maximum rate levels, which may not be adequate for some lines of
business. Proposed or potential tax law changes may also adversely affect
insurance companies' policy sales, tax obligations, and profitability. In
addition to the foregoing, profit margins of these companies continue to shrink
due to the commoditization of traditional businesses, new competitors, capital
expenditures on new technology and the pressures to compete globally.
In addition to the normal risks of business, companies involved in the
insurance industry are subject to significant risk factors, including those
applicable to regulated insurance companies, such as: (i) the inherent
uncertainty in the process of establishing property-liability loss reserves,
particularly reserves for the cost of environmental, asbestos and mass tort
claims, and the fact that ultimate losses could materially exceed established
loss reserves which could have a material adverse effect on results of
operations and financial condition; (ii) the fact that insurance companies have
experienced, and can be expected in the future to experience, catastrophe losses
which could have a material adverse impact on their financial condition, results
of operations and cash flow; (iii) the inherent uncertainty in the process of
establishing property-liability loss reserves due to changes in loss payment
patterns caused by new claims settlement practices; (iv) the need for insurance
companies and their subsidiaries to maintain appropriate levels of statutory
capital and surplus, particularly in light of continuing scrutiny by rating
organizations and state insurance regulatory authorities, and in order to
maintain acceptable financial strength or claims-paying ability rating; (v) the
extensive regulation and supervision to which insurance companies' subsidiaries
are subject, various regulatory initiatives that may affect insurance companies,
and regulatory and other legal actions; (vi) the adverse impact that increases
in interest rates could have on the value of an insurance company's investment
portfolio and on the attractiveness of certain of its products; (vii) the need
to adjust the effective duration of the assets and liabilities of life insurance
operations in order to meet the anticipated cash flow requirements of its
policyholder obligations; and (vii) the uncertainty involved in estimating the
availability of reinsurance and the collectibility of reinsurance recoverables.
The state insurance regulatory framework has, during recent years, come under
increased federal scrutiny, and certain state legislatures have considered or
enacted laws that alter and, in many cases, increase state authority to regulate
insurance companies and insurance holding company systems. Further, the National
Association of Insurance Commissioners ("NAIC") and state insurance regulators
are re-examining existing laws and regulations, specifically focusing on
insurance companies, interpretations of existing laws and the development of new
laws. In addition, Congress and certain federal agencies have investigated the
condition of the insurance industry in the various regulatory initiatives that
may affect insurance companies, and regulatory and other legal actions; (vi) the
adverse impact that increases in interest rates could have on the value of an
insurance company's investment portfolio and on the attractiveness of certain of
its products; (vii) the need to adjust the effective duration of the assets and
liabilities of life insurance operations in order to meet the anticipated cash
flow requirements of its policyholder obligations; and (viii) the uncertainty
involved in estimating the availability of reinsurance and the collectibility of
reinsurance recoverables.
The state insurance regulatory framework has, during recent years, come under
increased federal scrutiny, and certain state legislatures have considered or
enacted laws that alter and, in many cases, increase state authority to regulate
insurance companies and insurance holding company systems. Further, the National
Association of Insurance Commissioners ("NAIC") and state insurance regulators
are re-examining existing laws and regulations, specifically focusing on
insurance companies, interpretations of existing laws and the development of new
laws. In addition, Congress and certain federal agencies have investigated the
condition of the insurance industry in the United States to determine whether to
promulgate additional federal regulation. The Sponsor is unable to predict
whether any state or federal legislation will be enacted to change the nature or
scope of regulation of the insurance industry, or what effect, if any, such
legislation would have on the industry.
All insurance companies are subject to state laws and regulations that
require diversification of their investment portfolios and limit the amount of
investments in certain investment categories. Failure to comply with these laws
and regulations would cause non-conforming investments to be treated as
non-admitted assets for purposes of measuring statutory surplus and, in some
instances, would require divestiture. Environmental pollution clean-up is the
subject of both federal and state regulation. By some estimates, there are
thousands of potential waste sites subject to clean up. The insurance industry
is involved in extensive ligation regarding coverage issues. The Comprehensive
Environmental Response Compensation and Liability Act of 1980 ("Superfund") and
comparable state statutes ("mini-Superfund") govern the clean-up and restoration
by "Potentially Responsible Parties" ("PRP's"). Superfund and the
mini-Superfunds ("Environmental Clean-up Laws or "ECLs") establish a mechanism
to pay for clean-up of waste sites if PRP's fail to do so, and to assign
liability to PRP's. The extent of liability to be allocated to PRP is dependent
on a variety of factors. Further, the number of waste sites subject to clean-up
is unknown. Very few sites have been subject to clean-up to date. The extent of
clean-up necessary and the assignment of liability has not been established. The
insurance industry is disrupting many such claims. Key coverage issues include
whether Superfund response costs are considered damages under the policies, when
and how coverage is triggered, applicability of pollution exclusions, the
potential for joint and several liability and definition of an occurrence.
Similar coverage issues exist for clean up and waste sites not covered under
Superfund. To date, courts have been inconsistent in their rulings on these
issues. An insurer's exposure to liability with regard to its insureds which
have been, or may be, named as PRPs is uncertain. Superfund reform proposals
have been introduced in Congress, but none have been enacted. There can be no
assurance that any Superfund reform legislation will be enacted or that any such
legislation will provide for a fair, effective and cost-efficient system for
settlement of Superfund related claims.
Proposed federal legislation which would permit banks greater participation
in the insurance business could, if enacted, present an increased level of
competition for the sale of insurance products. In addition, while current
federal income tax law permits the tax-deferred accumulation of earnings on the
premiums paid by an annuity owner and holders of certain savings-oriented life
insurance products, no assurance can be given that future tax law will continue
to allow such tax deferrals. If such deferrals were not allowed, consumer demand
for the affected products would be substantially reduced. In addition, proposals
to lower the federal income tax rates through a form of flat tax or otherwise
could have, if enacted, a negative impact on the demand for such products.

An investment in Units should also be made with an understanding of the
problems and risks of companies engaged in investment banking/brokerage and
investment management. Such companies include brokerage firms, broker/dealers,
investment banks, finance companies and mutual fund companies. Earnings and
share prices of companies in this industry are quite volatile, and often exceed
the volatility levels of the market as a whole. Recently, ongoing consolidation
in the industry and the strong stock market has benefited stocks which investors
believe will benefit from greater investor and issuer activity. Major
determinants of future earnings of these companies are the direction of the
stock market, investor confidence, equity transaction volume, the level and
direction of long-term and short-term interest rates, and the outlook for
emerging markets. Negative trends in any of these earnings determinants could
have a serious adverse effect on the financial stability, as well as the stock
prices, of these companies. Furthermore, there can be no assurance that the
issuers of the Equity Securities will be able to respond in a timely manner to
compete in the rapidly developing marketplace. In addition to the foregoing,
profit margins of these companies continue to shrink due to the commoditization
of traditional businesses, new competitors, capital expenditures on new
technology and the pressures to compete globally.

THE TRUSTS
In seeking the Trusts' objectives, the Sponsor considered the ability of
the Securities to outpace inflation. While inflation is currently relatively
low, the United States has historically experienced periods of double-digit
inflation. While the prices of securities will fluctuate, over time securities
have outperformed the rate of inflation, and other less risky investments, such
as government bonds and U.S. Treasury bills. Past performance is, however, no
guarantee of future results.
Investors should note that the above criteria were applied to the
Securities for inclusion in the Trusts as of the Initial Date of Deposit. Should
a Security no longer meet the criteria used for selection for a Trust, such
Security will not as a result thereof be removed from a Trust portfolio.
The table below illustrates the performance of the Standard & Poor's 500
Index, the Standard & Poor's Pharmaceutical Index, and the Nasdaq Biotechnology
Index.

S&P S & P Nasdaq
Pharmaceutical 500 Biotechnology
Index Index Index
-------- -------- -----------
1994 16.43% 1.32% (18.44%)
1995 59.22 37.44 88.54
1996 24.09 22.90 (0.33)
1997 50.27 33.30 (0.07)
1998 47.26 28.50 44.28
1999 (11.56) 20.99 101.84

Performance is measured from December 31, 1993 because that is the first date
that information is available for the Nasdaq Biotechnology Index. The S&P 500
and the S&P Pharmaceutical Index performance includes the reinvestment of
dividends. The Nasdaq Biotechnology Index performance does not include the
reinvestment of dividends as these stocks do not typically pay dividends are
that information is not available for the index. Source: FactSet Research
Systems, Inc. and Bloomberg.

When it comes to equity investing, many people only consider U.S. stocks.
However, hundreds of well-known businesses exist outside of the United States
that are leaders in their respective markets and industries. Ignoring these
foreign firms may mean passing up an important investment opportunity.
International equities can add diversity and growth potential to your Portfolio.
The Great International Firms Trust provides access to foreign stocks, is
diversified and is backed by Van Kampen's comprehensive research. This Trust may
provide capital appreciation potential from a portfolio of stocks from around
the world.

The table below illustrates that no single stock market has dominated over
time and that foreign markets have generally offered returns superior to those
available in the U.S. The table shows the total returns of the top performing
stock markets in developed countries for each of the years indicated (as
represented by Morgan Stanley Capital International indices) compared with the
U.S. market (as represented by the Standard and Poor's 500 Index).

TOTAL RETURNS OF WORLD'S TOP PERFORMING DEVELOPED EQUITY MARKETS

1995 1996
------------------ -----------------
Switzerland: 44.12% Spain: 40.05%
USA: 37.14% Sweden: 37.21%
Sweden: 33.36% Portugal: 35.70%
Spain: 29.83% Finland: 33.94%
Netherlands: 27.71% Hong Kong: 33.08%

1997 1998
------------------ -----------------
Portugal: 46.74% Finland: 121.64%
Switzerland: 44.25% Belgium: 67.75%
Italy: 35.48% Italy: 52.52%
Denmark: 34.52% Spain: 49.90%
USA: 33.38% France: 41.54%

1997
------------------
Finland: 150.71%
Malaysia: 107.24%
Singapore: 97.08%
Sweden: 77.76%
Japan: 60.56%

All figures do not take into consideration taxes or any sales charges,
commissions or fees that an investor would incur in connection with these
investments. The S&P 500 Index measures the performance of 500 stocks from 83
industrial groups. U.S. Treasury bonds are considered long-term investments and
are subject to price fluctuations. The value of long-term bonds decline as
interest rates rise. Stock indices are unmanaged, statistical composites and do
not include payment of any sales charges or fees an investor would pay to
purchase the securities they represent. Furthermore, an investment cannot be
made in an index. U.S. Treasury bills are short-term obligations of the U.S.
government that are purchased at a discount and mature at face value. U.S.
government securities are backed by the full faith and credit of the government.
The Consumer Price Index is a statistical measure of the annual rate of
inflation; it is not an investment. The historical performance of these indices
is shown for illustrative purposes only; it is not meant to forecast, imply or
guarantee the future performance of any particular investment vehicle or the
Trust. Securities in which the Trust invests will be different from those in
these indices. Common stocks involve greater risks than government bonds and
CDs, as they are more volatile and have greater potential for loss of principal.

Harry S. Dent, Jr. believes that the economy may be on the edge of economic
change that may change how people communicate and fundamentally alter how and
where people live and work. At the same time, Mr. Dent believes the Baby Boom
generation will reach its peak earning, spending and productivity years. Mr.
Dent believes that the convergence of these two events could spark the trends of
the years ahead.

The Roaring 2000sSM Trusts were designed to benefit from the insights,
philosophies and strategies found in the book, "The Roaring 2000s," by Harry S.
Dent, Jr.
Family spending cycles of each new generation of consumers and workers drive
the economy. Birth rates, because they show how many people are in a generation,
may be a leading indicator of the economy. As a generation develops and moves
into its peak family spending cycle, the economy may rise.
To account for the number of people at their peak spending age at a given
time, Mr. Dent lags the birth index forward 46.5 years (the average person
historically hits their peak spending at approximately 46.5 years of age). After
consideration of this lag, the birth index and the Dow Jones Industrial Average,
adjusted for inflation, have exhibited a close correlation in the past. Mr. Dent
believes that this "Spending Wave" may enable a connection to be made, helping
to forecast the economy in the future. Of course, past performance is no
guarantee of future results.
Based on the cycles discussed previously, Mr. Dent has identified various
sectors of our economy that may be primed for growth potential. The Roaring
2000s Trusts seek to capitalize on trends impacting four main sectors,
including:

o Technology - New Technologies may be shaping new standards in the way
people work and live. Businesses may be beginning to prepare for
downshifts in the labor force by investing in labor saving technology
that could improve productivity and lower costs.

o Financial Services - The Baby Boomers may be forced to become
investors and, therefore, may need to seek financial advice.
Additionally, choices for investing are numerous and complicated. As
our economy grows, so may additional opportunities for investment
vehicles.

o Health Care - As the Baby Boomers age, health care may become
increasingly important as needs statistically begin to rise. As people
age they tend to spend more of their income on health care costs. As
technologies increase, Americans may find more options and choices in
this sector than ever before.

o U.S. Multinational Companies - A global marketplace is emerging and
many U.S.-based companies appear to be experiencing new sales growth
through the elimination of geographical barriers that once inhibited
sales. Now, through technology increases, multinational companies may
be emerging as market leaders internationally as well as domestically.

The Sponsor selected each portfolio based on concepts presented in The
Roaring 2000s and research compiled by Mr. Dent. Mr. Dent did not select the
stocks for the portfolios, does not endorse the Trusts and will not supervise
the portfolios. The opinions and forecasts of Mr. Dent expressed in his books
and elsewhere are not necessarily those of Van Kampen Funds Inc. and may not
actually come to pass. Mr. Dent is being compensated by the Sponsor for his
research. The Roaring 2000sSM is the exclusive property of The H.S. Dent
Foundation. The Roaring 2000sSM is a service mark of the H.S. Dent Foundation.
Each Trust has licensed the use of this service mark from the H.S. Dent
Foundation.

The Roaring 2000sSM is the exclusive property of The H.S. Dent Foundation.
The Roaring 2000sSM is a service mark of the H.S. Dent Foundation and has been
licensed for use by Van Kampen Funds Inc.

This fund is not sponsored, endorsed, sold or promoted by the H.S. Dent
Foundation. The H.S. Dent Foundation makes no representation or warranty,
express or implied, to the owners of this fund or any member of the public
regarding the advisability of investing in funds generally or in this fund
particularly. The H.S. Dent Foundation is the licensor of certain trademarks,
service marks and trade names of the H.S. Dent Foundation. The H.S. Dent
Foundation is not responsible for and has not participated in the determination
of the timing of, prices at, or quantities of this fund to be issued. The H.S.
Dent Foundation has no obligation or liability to owners of this fund in
connection with the administration, marketing or trading of this fund.
NEITHER The H.S. DENT Foundation NOR ANY OTHER RELATED PARTY GUARANTEES THE
ACCURACY AND/OR THE COMPLETENESS OF ANY DATA INCLUDED THEREIN. NEITHER The H.S.
DENT Foundation NOR ANY OTHER RELATED PARTY MAKES ANY WARRANTY, EXPRESS OR
IMPLIED, AS TO RESULTS TO BE OBTAINED BY LICENSEE, LICENSEE'S CUSTOMERS AND
COUNTERPARTIES, OWNERS OF THE FUND, OR ANY OTHER PERSON OR ENTITY FROM THE USE
OF ANY DATA INCLUDED HEREIN IN CONNECTION WITH THE RIGHTS LICENSED HEREUNDER OR
FOR ANY OTHER USE. NEITHER The H.S. DENT Foundation NOR ANY OTHER RELATED PARTY
MAKES ANY EXPRESS OR IMPLIED WARRANTIES, AND The H.S. DENT Foundation HEREBY
EXPRESSLY DISCLAIMS ALL WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A
PARTICULAR PURPOSE WITH RESPECT TO ITS SERVICE MARKS. WITHOUT LIMITING ANY OF
THE FORE-GOING, IN NO EVENT SHALL The H.S. DENT Foundation OR ANY OTHER RELATED
PARTY HAVE ANY LIABILITY FOR ANY DIRECT, INDIRECT, SPECIAL, PUNITIVE,
CONSEQUENTIAL OR ANY OTHER DAMAGES (INCLUDING LOST PROFITS) EVEN IF NOTIFIED OF
THE POSSIBILITY OF SUCH DAMAGES.

SPONSOR INFORMATION
Van Kampen Funds Inc., a Delaware corporation, is the Sponsor of the Trust.
The Sponsor is an indirect subsidiary of Van Kampen Investments Inc. Van Kampen
Investments Inc. is a wholly owned subsidiary of MSAM Holdings II, Inc., which
in turn is a wholly owned subsidiary of Morgan Stanley Dean Witter & Co.
("MSDW").

MSDW, together with various of its directly and indirectly owned
subsidiaries, is engaged in a wide range of financial services through three
primary businesses: securities, asset management and credit services. These
principal businesses include securities underwriting, distribution and trading;
merger, acquisition, restructuring and other corporate finance advisory
activities; merchant banking; stock brokerage and research services; credit
services; asset management; trading of futures, options, foreign exchange
commodities and swaps (involving foreign exchange, commodities, indices and
interest rates); and real estate advice, financing and investing.
Van Kampen Funds Inc. specializes in the underwriting and distribution of
unit investment trusts and mutual funds with roots in money management dating
back to 1926. The Sponsor is a member of the National Association of Securities
Dealers, Inc. and has its principal offices at 1 Parkview Plaza, P.O. Box 5555,
Oakbrook Terrace, Illinois 60181-5555, (630) 684-6000. As of November 30, 1999,
the total stockholders' equity of Van Kampen Funds Inc. was $141,554,861
(audited). (This paragraph relates only to the Sponsor and not to the Trust or
to any other Series thereof. The information is included herein only for the
purpose of informing investors as to the financial responsibility of the Sponsor
and its ability to carry out its contractual obligations. More detailed
financial information will be made available by the Sponsor upon request.)
As of March 31, 2000, the Sponsor and its Van Kampen affiliates managed or
supervised more than $100 billion of investment products. The Sponsor and its
Van Kampen affiliates managed $84.2 billion of assets for more than 63 open-end
mutual funds, 39 closed-end funds and more than 2,700 unit trusts as of March
31, 2000. All of Van Kampen's open-end funds, closed-ended funds and unit
investment trusts are professionally distributed by leading financial firms
nationwide. Since 1976, the Sponsor has serviced over two million investor
accounts, opened through retail distribution firms.

TRUSTEE INFORMATION
The Trustee is The Bank of New York, a trust company organized under the
laws of New York. The Bank of New York has its unit investment trust division
offices at 101 Barclay Street, New York, New York 10286 (800) 221-7668. The Bank
of New York is subject to supervision and examination by the Superintendent of
Banks of the State of New York and the Board of Governors of the Federal Reserve
System, and its deposits are insured by the Federal Deposit Insurance
Corporation to the extent permitted by law.

The duties of the Trustee are primarily ministerial in nature. It did not
participate in the selection of Securities for the Trust portfolios.

In accordance with the Trust Agreement, the Trustee shall keep proper books
of record and account of all transactions at its office for each Trust. Such
records shall include the name and address of, and the number of Units of each
Trust held by, every Unitholder. Such books and records shall be open to
inspection by any Unitholder at all reasonable times during the usual business
hours. The Trustee shall make such annual or other reports as may from time to
time be required under any applicable state or federal statute, rule or
regulation. The Trustee is required to keep a certified copy or duplicate
original of the Trust Agreement on file in its office available for inspection
at all reasonable times during the usual business hours by any Unitholder,
together with a current list of the Securities held in each Trust.

Under the Trust Agreement, the Trustee or any successor trustee may resign
and be discharged of its responsibilities created by the Trust Agreement by
executing an instrument in writing and filing the same with the Sponsor. The
Trustee or successor trustee must mail a copy of the notice of resignation to
all Unitholders then of record, not less than 60 days before the date specified
in such notice when such resignation is to take effect. The Sponsor upon
receiving notice of such resignation is obligated to appoint a successor trustee
promptly. If, upon such resignation, no successor trustee has been appointed and
has accepted the appointment within 30 days after notification, the retiring
Trustee may apply to a court of competent jurisdiction for the appointment of a
successor. The Sponsor may remove the Trustee and appoint a successor trustee as
provided in the Trust Agreement at any time with or without cause. Notice of
such removal and appointment shall be mailed to each Unitholder by the Sponsor.
Upon execution of a written acceptance of such appointment by such successor
trustee, all the rights, powers, duties and obligations of the original trustee
shall vest in the successor. The resignation or removal of a Trustee becomes
effective only when the successor trustee accepts its appointment as such or
when a court of competent jurisdiction appoints a successor trustee.
Any corporation into which a Trustee may be merged or with which it may be
consolidated, or any corporation resulting from any merger or consolidation to
which a Trustee shall be a party, shall be the successor trustee. The Trustee
must be a banking corporation organized under the laws of the United States or
any state and having at all times an aggregate capital, surplus and undivided
profits of not less than $5,000,000.

TRUST TERMINATION
A Trust may be liquidated at any time by consent of Unitholders
representing 66 2/3% of the Units of such Trust then outstanding or by the
Trustee when the value of the Securities owned by a Trust, as shown by any
evaluation, is less than $500,000 ($3,000,000 if the value of the Trust has
exceeded $15,000,000). A Trust will be liquidated by the Trustee in the event
that a sufficient number of Units of such Trust not yet sold are tendered for
redemption by the Sponsor, so that the net worth of such Trust would be reduced
to less than 40% of the value of the Securities at the time they were deposited
in such Trust. If a Trust is liquidated because of the redemption of unsold
Units by the Sponsor, the Sponsor will refund to each purchaser of Units the
entire sales charge paid by such purchaser. The Trust Agreement will terminate
upon the sale or other disposition of the last Security held thereunder, but in
no event will it continue beyond the Mandatory Termination Date.
Commencing during the period beginning nine business days prior to, and no
later than, the Mandatory Termination Date, Securities will begin to be sold in
connection with the termination of the Trusts. The Sponsor will determine the
manner, timing and execution of the sales of the Securities. The Sponsor shall
direct the liquidation of the Securities in such manner as to effectuate orderly
sales and a minimal market impact. In the event the Sponsor does not so direct,
the Securities shall be sold within a reasonable period and in such manner as
the Trustee, in its sole discretion, shall determine. At least 30 days before
the Mandatory Termination Date the Trustee will provide written notice of any
termination to all Unitholders of the appropriate Trust and in the case of a
Trust will include with such notice a form to enable Unitholders owning 1,000 or
more Units to request an in kind distribution of the U.S.-traded Securities. To
be effective, this request must be returned to the Trustee at least five
business days prior to the Mandatory Termination Date. On the Mandatory
Termination Date (or on the prior business day if a holiday) the Trustee will
deliver each requesting Unitholder's pro rata number of whole shares of the
U.S.-traded Securities in a Trust to the account of the broker-dealer or bank
designated by the Unitholder at Depository Trust Company. The value of the
Unitholder's fractional shares of the Securities will be paid in cash.
Unitholders with less than 1,000 Units, Unitholders in a Trust with 1,000 or
more Units not requesting an in kind distribution will receive a cash
distribution from the sale of the remaining Securities within a reasonable time
following the Mandatory Termination Date. Regardless of the distribution
involved, the Trustee will deduct from the funds of the appropriate Trust any
accrued costs, expenses, advances or indemnities provided by the Trust
Agreement, including estimated compensation of the Trustee, costs of liquidation
and any amounts required as a reserve to provide for payment of any applicable
taxes or other governmental charges. Any sale of Securities in a Trust upon
termination may result in a lower amount than might otherwise be realized if
such sale were not required at such time. The Trustee will then distribute to
each Unitholder of each Trust his pro rata share of the balance of the Income
and Capital Accounts of such Trust.
Within 60 days of the final distribution Unitholders will be furnished a
final distribution statement of the amount distributable. At such time as the
Trustee in its sole discretion will determine that any amounts held in reserve
are no longer necessary, it will make distribution thereof to Unitholders in the
same manner.

CONTENTS OF REGISTRATION STATEMENTS

This Amendment to the Registration Statement comprises the following papers and
documents:

The facing sheet
The Prospectus
The signatures
The consents of independent public accountants and legal counsel

The following exhibits:

1.1 Copy of Trust Agreement.

3.1 Opinion and consent of counsel as to legality of securities being
registered.

3.2 Opinion of counsel as to the federal income tax status of
securities being registered.

3.3 Opinion and consent of counsel as to New York tax status of
securities being registered.

4.1 Consent of Interactive Data Corporation.

4.2 Consent of Independent Certified Public Accountants.

SIGNATURES

The Registrant, Van Kampen Focus Portfolios, Series 225, hereby
identifies Van Kampen Merritt Equity Opportunity Trust, Series 1, Series 2,
Series 4 and Series 7 and Van Kampen American Capital Equity Opportunity Trust,
Series 13, Series 14, Series 57 and Series 89 for purposes of the
representations required by Rule 487 and represents the following: (1) that the
portfolio securities deposited in the series as to the securities of which this
Registration Statement is being filed do not differ materially in type or
quality from those deposited in such previous series; (2) that, except to the
extent necessary to identify the specific portfolio securities deposited in, and
to provide essential financial information for, the series with respect to the
securities of which this Registration Statement is being filed, this
Registration Statement does not contain disclosures that differ in any material
respect from those contained in the registration statements for such previous
series as to which the effective date was determined by the Commission or the
staff; and (3) that it has complied with Rule 460 under the Securities Act of
1933.

Pursuant to the requirements of the Securities Act of 1933, the
Registrant, Van Kampen Focus Portfolios, Series 225 has duly caused this
Amendment to the Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Chicago and State of
Illinois on the 2nd day of May 2000.

Van Kampen Focus Portfolios, Series 225
By Van Kampen Funds Inc.

By Christine K. Putong
------------------------------

Assistant Vice President

Pursuant to the requirements of the Securities Act of 1933, this
Amendment to the Registration Statement has been signed below on May 2, 2000 by
the following persons who constitute a majority of the Board of Directors of Van
Kampen Funds Inc.

SIGNATURE TITLE

Richard F. Powers III Chairman and Chief Executive )

Officer )

John H. Zimmerman III President and Chief Operating )

Officer )

William R. Rybak Executive Vice President and )
Chief Financial Officer )

A. Thomas Smith III Executive Vice President, )
General Counsel and Secretary )

Michael H. Santo Executive Vice President )

Christine K. Putong
----------------------------
(Attorney-in-fact*)

- --------------------------------------------------------------------------------
*An executed copy of each of the related powers of attorney is filed herewith or
was filed with the Securities and Exchange Commission in connection with the
Registration Statement on Form S-6 of Van Kampen Focus Portfolios, Series 136
(File No. 333-70897) and the same are hereby incorporated herein by this
reference.

EXHIBIT 1.1

VAN KAMPEN FOCUS PORTFOLIOS
SERIES 225
TRUST AGREEMENT

Dated: May 2, 2000

This Trust Agreement among Van Kampen Funds Inc., as Depositor,
American Portfolio Evaluation Services, a division of Van Kampen Investment
Advisory Corp., as Evaluator, Van Kampen Investment Advisory Corp., as
Supervisory Servicer, and The Bank of New York, as Trustee, sets forth certain
provisions in full and incorporates other provisions by reference to the
document entitled "Van Kampen American Capital Equity Opportunity Trust, Series
87 and Subsequent Series, Standard Terms and Conditions of Trust, Effective
January 27, 1998" (herein called the "Standard Terms and Conditions of Trust")
and such provisions as are set forth in full and such provisions as are
incorporated by reference constitute a single instrument. All references herein
to Articles and Sections are to Articles and Sections of the Standard Terms and
Conditions of Trust.

WITNESSETH THAT:

In consideration of the premises and of the mutual agreements herein
contained, the Depositor, Evaluator, Supervisory Servicer and Trustee agree as
follows:

PART I
STANDARD TERMS AND CONDITIONS OF TRUST

Subject to the provisions of Part II hereof, all the provisions
contained in the Standard Terms and Conditions of Trust are herein incorporated
by reference in their entirety and shall be deemed to be a part of this
instrument as fully and to the same extent as though said provisions had been
set forth in full in this instrument.

PART II
SPECIAL TERMS AND CONDITIONS OF TRUST

The following special terms and conditions are hereby agreed to:

1. The Securities defined in Section 1.01(24), listed in the Schedule
hereto, have been deposited in trust under this Trust Agreement.

2. The fractional undivided interest in and ownership of each Trust
represented by each Unit is an amount the numerator of which is one and the
denominator of which is the amount set forth under "Summary of Essential
Financial Information - Initial Number of Units" in the Prospectus. Such
fractional undivided interest may be (a) increased by the number of any
additional Units issued pursuant to Section 2.03, (b) increased or decreased in
connection with an adjustment to the number of Units pursuant to Section 2.03,
or (c) decreased by the number of Units redeemed pursuant to Section 5.02.

3. The terms "Capital Account Record Date" and "Income Account Record
Date" shall mean the "Record Dates" set forth under "Summary of Essential
Financial Information" in the Prospectus.

4. The terms "Capital Account Distribution Date" and "Income Account
Distribution Date" shall mean the "Distribution Dates" set forth under "Summary
of Essential Financial Information" in the Prospectus.

5. The term "Mandatory Termination Date" shall mean the "Mandatory
Termination Date" set forth under "Summary of Essential Financial Information"
in the Prospectus.

6. Notwithstanding anything to the contrary in the Standard Terms and
Conditions of Trust and subject to the requirements set forth in this paragraph,
unless the Prospectus otherwise requires, the Sponsor may, on any Business Day
(the "Trade Date"), subscribe for additional Units as follows:

(a) Prior to the Evaluation Time on such Business Day, the
Sponsor shall provide notice (the "Subscription Notice") to the
Trustee, by telephone or by written communication, of the Sponsor's
intention to subscribe for additional Units. The Subscription Notice
shall identify the additional Securities to be acquired (unless such
additional Securities are a precise replication of the then existing
portfolio) and shall either (i) specify the quantity of additional
Securities to be deposited by the Sponsor on the settlement date for
such subscription or (ii) instruct the Trustee to purchase additional
Securities with an aggregate value as specified in the Subscription
Notice.

(b) Promptly following the Evaluation Time on such Business Day,
the Sponsor shall verify with the Trustee the number of additional
Units to be created.

(c) Not later than the time on the settlement date for such
subscription when the Trustee is to deliver or assign the additional
Units created hereby, the Sponsor shall deposit with the Trustee (i)
any additional Securities specified in the Subscription Notice (or
contracts to purchase such additional Securities together with cash or
a letter of credit in the amount necessary to settle such contracts)
or (ii) cash or a letter of credit in an amount equal to the aggregate
value of the additional Securities specified in the Subscription
Notice, and adding and subtracting the amounts specified in the first
and second sentences of Section 5.01, computed as of the Evaluation
Time on the Business Day preceding the Trade Date divided by the
number of Units outstanding as of the Evaluation Time on the Business
Day preceding the Trade Date, times the number of additional Units to
be created.

(d) On the settlement date for such subscription, the Trustee
shall, in exchange for the Securities and cash or letter of credit
described above, deliver to, or assign in the name of or on the order
of, the Sponsor the number of Units verified by the Sponsor with the
Trustee.

7. Section 6.01(e) is hereby replaced with the following:

(e) (1) Subject to the provisions of subparagraph (2) of this
paragraph, the Trustee may employ agents, sub-custodians, attorneys,
accountants and auditors and shall not be answerable for the default
or misconduct of any such agents, sub-custodians, attorneys,
accountants or auditors if such agents, sub-custodians, attorneys,
accountants or auditors shall have been selected with reasonable care.
The Trustee shall be fully protected in respect of any action under
this Indenture taken or suffered in good faith by the Trustee in
accordance with the opinion of counsel, which may be counsel to the
Depositor acceptable to the Trustee, provided, however that this
disclaimer of liability shall not excuse the Trustee from the
responsibilities specified in subparagraph (2) below. The fees and
expenses charged by such agents, sub-custodians, attorneys,
accountants or auditors shall constitute an expense of the Trust
reimbursable from the Income and Capital Accounts of the affected
Trust as set forth in section 6.04 hereof.

(2) The Trustee may place and maintain in the care of an Eligible
Foreign Custodian (which is employed by the Trustee as a sub-custodian
as contemplated by subparagraph (1) of this paragraph (e) and which
may be an affiliate or subsidiary of the Trustee or any other entity
in which the Trustee may have an ownership interest) any investments
(including foreign currencies) for which the primary market is outside
the United States, and such cash and cash equivalents in amounts
reasonably necessary to effect the Trust's transactions in such
investments, provided that:

(a) The Trustee shall perform all duties assigned to the
Foreign Custody Manager by Rule 17f-5 under the Investment
Company Act of 1940 (17 CFR ss. 270.17f-5) ("Rule 17f-5"), as now
in effect or as such rule may be amended in the future. The
Trustee shall not delegate such duties.

(b) The Trustee shall exercise reasonable care, prudence and
diligence such as a person having responsibility for the
safekeeping of Trust assets would exercise, and shall be liable
to the Trust for any loss occurring as a result of its failure to
do so.

(c) The Trustee shall indemnify the Trust and hold the Trust
harmless from and against any risk of loss of Trust assets held
in accordance with the foreign custody contract.

(d) The Trustee shall maintain and keep current written
records regarding the basis for the choice or continued use of a
particular Eligible Foreign Custodian pursuant to this
subparagraph for a period of not less than six years from the end
of the fiscal year in which the Trust was terminated, the first
two years in an easily accessible place. Such records shall be
available for inspection by Unitholders and the Securities and
Exchange Commission at the Trustee's offices at all reasonable
times during its usual business hours.

(3) "Eligible Foreign Custodian" shall have the meaning assigned
to it in Rule 17f-5.

(4) "Foreign Custody Manager" shall have the meaning assigned to
it in Rule 17f-5.

8. Section 1.01 (1), (3) and (4) shall be replaced in their entirety by
the following:

(1) "Depositor" shall mean Van Kampen Funds Inc. and its
succesors in interest, or any successor depositor appointed as
hereinafter provided.

(3) "Evaluator" shall mean American Portfolio Evaluation Services
(a division of a Van Kampen Investment Advisory Corp.) and its
successors in interest, or any successor evaluator appointed as
hereinafter provided.

(4) "Supervisory Servicer" shall mean Van Kampen Investment
Advisory Corp. and its successors in interest, or any successor
portfolio supervisor appointed as hereinafter provided.

9. Section 3.15 of the Standard Terms and Conditions of Trust is hereby
replaced in its entirety by the following:

Section 3.15. Deferred Sales Charge. If the Prospectus related to
the Trust specifies a deferred sale charge, the Trustee shall, on each
Deferred Sales Charge Payment Date and as permitted by such
Prospectus, withdraw from the Capital Account an amount per Unit equal
to the Deferred Sales Charge Payment and credit such amount to a
special non-Trust account maintained at the Trustee out of which the
deferred sales charge will be distributed to the Depositor. If the
balance in the Capital Account is insufficient to make any such
withdrawal, the Trustee shall, as directed by the Depositor, either
advance funds in an amount equal to the proposed withdrawal and be
entitled to reimbursement of such advance upon the deposit of
additional moneys in the Capital Account, sell Securities and credit
the proceeds thereof to such special Depositor's account or credit (if
permitted by law) Securities in kind to such special Depositor's
Account. If a Unitholder redeems Units prior to full payment of the
deferred sales charge, the Trustee shall, if so provided in the
related Prospectus, on the Redemption Date, withhold from the
Redemption Price payable to such Unitholder an amount equal to the
unpaid portion of the deferred sales charge and distribute such amount
to such special Depositor's Account. The Depositor may at any time
instruct the Trustee in writing to distribute to the Depositor cash or
Securities previously credited to the special Depositor's account.
Amounts to be credited to the special Depositor's account with respect
to each Deferred Sales Charge Payment are due and payable to the
Depositor on the related Deferred Sales Charge Payment Date.

The term "Deferred Sales Charge Payment Dates" shall mean the
10th day of each month beginning September 10, 2000 and continuing
through January 10, 2001. If any Deferred Sales Charge Payment Date is
not a Business Day, that Deferred Sales Charge Payment Date shall be
deemed to be the next business day. The term "Deferred Sales Charge
Payment" shall mean a fraction of the total maximum deferred sales
charge specified in the Prospectus, the numerator of which is one and
the denominator of which is equal to the total number of Deferred
Sales Charge Payment Dates.

10. Section 3.07(a) of the Standard Terms and Conditions of Trust is
hereby amended by adding the following Section 3.07(a)(x) immediately after
Section 3.07(a)(ix):

"(x) that there has been a public tender offer made for a
Security or a merger or acquisition is announced affecting a Security,
and that in the opinion of the Supervisory Servicer the sale or tender
of the Security is in the best interest of the Unitholders."

11. Sections 4.01(b) and (c) of the Standard Terms and Conditions of
Trust are hereby replaced in their entirety by the following:

(b) During the initial offering period such Evaluation shall be
made in the following manner: if the Securities are listed on a
national or foreign securities exchange or traded on the Nasdaq Stock
Market, Inc., such Evaluation shall generally be based on the last
available closing sale price on or immediately prior to the Evaluation
Time on the exchange or market which is the principal market therefor,
which shall be deemed to be the New York Stock Exchange if the
Securities are listed thereon (unless the Evaluator deems such price
inappropriate as a basis for evaluation) or, if there is no such
available closing sale price on such exchange or market at the last
available asked price of the Equity Securities. If the Securities are
not listed such an exchange or traded on the Nasdaq Stock Market, Inc.
or, if so listed and the principal market therefor is other than on
such exchange or market, or there is no such available sale price on
such exchange or market, such Evaluation shall generally be based on
the following methods or any combination thereof whichever the
Evaluator deems appropriate: (i) in the case of Equity Securities, on
the basis of the current asked price on the over-the-counter market
(unless the Evaluator deems such price inappropriate as a basis for
evaluation), (ii) on the basis of current offering prices for the Zero
Coupon Obligations as obtained from investment dealers or brokers who
customarily deal in securities comparable to those held by the Fund,
(iii) if offering prices are not available for the Zero Coupon
Obligations or the Equity Securities, on the basis of offering or
asked price for comparable securities, (iv) by determining the
valuation of the Zero Coupon Obligations or the Equity Securities on
the offering or asked side of the market by appraisal or (v) by any
combination of the above. If the Trust holds Securities denominated in
a currency other than U.S. dollars, the Evaluation of such Security
shall be converted to U.S. dollars based on current offering side
exchange rates (unless the Evaluator deems such prices inappropriate
as a basis for valuation). The Evaluator may add to the Evaluation of
each Security which is principally traded outside of the United States
the amount of any commissions and relevant taxes associated with the
acquisition of the Security. As used herein, the closing sale price is
deemed to mean the most recent closing sale price on the relevant
securities exchange immediately prior to the Evaluation time. For each
Evaluation, the Evaluator shall also confirm and furnish to the
Trustee and the Depositor, on the basis of the information furnished
to the Evaluator by the Trustee as to the value of all Trust assets
other than Securities, the calculation of the Trust Evaluation to be
computed pursuant to Section 5.01.

(c) For purposes of the Trust Evaluations required by Section
5.01 in determining Redemption Value and Unit Value, Evaluation of the
Securities shall be made in the manner described in Section 4.01(b),
on the basis of current bid prices for the Zero Coupon Obligations,
the bid side value of the relevant currency exchange rate expressed in
U.S. dollars and, except in those cases in which the Equity Securities
are listed on a national or foreign securities exchange or traded on
the Nasdaq Stock Market, Inc. and the last available sale prices are
utilized, on the basis of the last available bid price of the Equity
Securities. In addition, the Evaluator (i) shall not make the addition
specified in the fourth sentence of Section 4.01(b) and (ii) may
reduce the Evaluation of each Security which is principally traded
outside of the United States by the amount of any liquidation costs
and any capital gains or other taxes which would be incurred by the
Trust upon the sale of such Security, such taxes being computed as if
the Security were sold on the date of the Evaluation.

IN WITNESS WHEREOF, the undersigned have caused this Trust Agreement to
be executed and their corporate seals to be hereto affixed and attested; all as
of the day, month and year first above written.

Van Kampen Funds Inc.

By James J. Boyne
- -----------------------------------------
Senior Vice President

American Portfolio Evaluation Services,
a division of Van Kampen Investment Advisory Corp.

By James J. Boyne
- -------------------------------------
Senior Vice President

Van Kampen Investment Advisory Corp.

By James J. Boyne
- ---------------------------------------
Senior Vice President

The Bank of New York

By Linda Bommer
- ----------------------------
Vice President

SCHEDULE A TO TRUST AGREEMENT
SECURITIES INITIALLY DEPOSITED IN
VAN KAMPEN FOCUS PORTFOLIOS, SERIES 225

(Note: Incorporated herein and made a part hereof is each "Portfolio" as set
forth in the Prospectus.)

EXHIBIT 3.1

CHAPMAN AND CUTLER
111 WEST MONROE STREET
CHICAGO, ILLINOIS 60603

May 2, 2000

Van Kampen Funds Inc.
One Parkview Plaza
Oakbrook Terrace, Illinois 60181

Re: Van Kampen Focus Portfolios, Series 225
---------------------------------------

Gentlemen:

We have served as counsel for Van Kampen Funds Inc. as Sponsor and
Depositor of Van Kampen Focus Portfolios, Series 225 (hereinafter referred to as
the "Trust"), in connection with the preparation, execution and delivery of a
Trust Agreement dated May 2, 2000, among Van Kampen Funds Inc., as Depositor,
American Portfolio Evaluation Services, a division of Van Kampen Investment
Advisory Corp., as Evaluator, Van Kampen Investment Advisory Corp., as
Supervisory Servicer, and The Bank of New York, as Trustee, pursuant to which
the Depositor has delivered to and deposited the Securities listed in the
Schedule to the Trust Agreement with the Trustee and pursuant to which the
Trustee has provided to or on the order of the Depositor documentation
evidencing ownership of Units of fractional undivided interest in and ownership
of the Trust (hereinafter referred to as the "Units"), created under said Trust
Agreement.

In connection therewith we have examined such pertinent records and
documents and matters of law as we have deemed necessary in order to enable us
to express the opinions hereinafter set forth.

Based upon the foregoing, we are of the opinion that:

1. The execution and delivery of the Trust Agreement and the
execution and issuance of certificates evidencing the Units in the
Trust have been duly authorized; and

2. The certificates evidencing the Units in the Trust, when duly
executed and delivered by the Depositor and the Trustee in accordance
with the aforementioned Trust Agreement, will constitute valid and
binding obligations of such Trust and the Depositor in accordance with
the terms thereof.

We hereby consent to the filing of this opinion as an exhibit to the
Registration Statement (File No. 333-35158) relating to the Units referred to
above and to the use of our name and to the reference to our firm in said
Registration Statement and in the related Prospectus.

Respectfully submitted,

CHAPMAN AND CUTLER

CHAPMAN AND CUTLER
111 WEST MONROE STREET
CHICAGO, ILLINOIS 60603

May 2, 2000

Van Kampen Funds Inc.
One Parkview Plaza
Oakbrook Terrace, Illinois 60181

The Bank of New York
101 Barclay Street
New York, New York 10286

Re: Van Kampen Focus Portfolios, Series 225
---------------------------------------

Gentlemen:

We have acted as counsel for Van Kampen Funds Inc., Depositor of Van
Kampen Focus Portfolios, Series 225 (the "Fund"), in connection with the
issuance of Units of fractional undivided interest in the Fund, under a Trust
Agreement dated May 2, 2000 (the "Indenture") among Van Kampen Funds Inc., as
Depositor, American Portfolio Evaluation Services, a division of Van Kampen
Investment Advisory Corp., as Evaluator, Van Kampen Investment Advisory Corp.,
as Supervisory Servicer, and The Bank of New York, as Trustee. The Fund is
comprised of the following separate unit investment trusts: Bandwidth &
Telecommunications Trust, Series 10A, Bandwidth & Telecommunications Trust,
Series 10B, Biotechnology & Pharmaceutical Trust, Series 10A, Biotechnology &
Pharmaceutical Trust, Series 10B, Global Wireless Trust, Series 3A, Global
Wireless Trust, Series 3B, Great International Firms Trust, Series 12, The
Roaring 2000s Trust, Series 6A, The Roaring 2000s Trust, Series 6B,
Semiconductor Trust, Series 2A and Semiconductor Trust, Series 2B (each a
"Trust"). The following discussion and opinion does not apply to Great
International Firms Trust, Series 12.

In this connection, we have examined the Registration Statement, the
Prospectus, the Indenture, and such other instruments and documents as we have
deemed pertinent.

The assets of the Trust will consist of a portfolio of equity
securities (the "Equity Securities") as set forth in the Prospectus. For
purposes of this opinion, it is assumed that each Equity Security is equity for
federal income tax purposes.

Based upon the foregoing and upon an investigation of such matters of
law as we consider to be applicable, we are of the opinion that, under existing
United States Federal income tax law:

(i) The Trust is not an association taxable as a corporation
for Federal income tax purposes but will be governed by the provisions
of subchapter J (relating to Trusts) of chapter 1, Internal Revenue
Code of 1986 (the "Code").

(ii) A Unitholder will be considered as owning a pro rata
share of each asset of the Trust in the proportion that the number of
Units held by him bears to the total number of Units outstanding. Under
subpart E, subchapter J of chapter 1 of the Code, income of the Trust
will be treated as income of each Unitholder in the proportion
described, and an item of Trust income will have the same character in
the hands of a Unitholder as it would have in the hands of the Trustee.
Each Unitholder will be considered to have received his pro rata share
of income derived from each Trust asset when such income is considered
to be received by the Trust. A Unitholder's pro rata portion of
distributions of cash or property by a corporation with respect to an
Equity Security ("dividends" as defined by Section 316 of the Code )
are taxable as ordinary income to the extent of such corporation's
current and accumulated "earnings and profits." A Unitholder's pro rata
portion of dividends which exceed such current and accumulated earnings
and profits will first reduce the Unitholder's tax basis in such Equity
Security, and to the extent that such dividends exceed a Unitholder's
tax basis in such Equity Security, shall be treated as gain from the
sale or exchange of property.

(iii) The price a Unitholder pays for his Units, generally
including sales charges, is allocated among his pro rata portion of
each Equity Security held by Trust (in proportion to the fair market
values thereof on the valuation date closest to the date the Unitholder
purchases his Units), in order to determine his tax basis for his pro
rata portion of each Equity Security held by the Trust.

(iv) Gain or loss will be recognized to a Unitholder (subject
to various nonrecognition provisions under the Code) upon redemption or
sale of his Units, except to the extent an in kind distribution of
stock is received by such Unitholder from the Trust as discussed below.
Such gain or loss is measured by comparing the proceeds of such
redemption or sale with the adjusted basis of his Units. Before
adjustment, such basis would normally be cost if the Unitholder had
acquired his Units by purchase. Such basis will be reduced, but not
below zero, by the Unitholder's pro rata portion of dividends with
respect to each Equity Security which are not taxable as ordinary
income.

(v) If the Trustee disposes of a Trust asset (whether by
sale, exchange, liquidation, redemption, payment on maturity or
otherwise) gain or loss will be recognized to the Unitholder (subject
to various nonrecognition provisions under the Code) and the amount
thereof will be measured by comparing the Unitholder's aliquot share of
the total proceeds from the transaction with his basis for his
fractional interest in the asset disposed of. Such basis is ascertained
by apportioning the tax basis for his Units (as of the date on which
his Units were acquired) among each of the Trust assets (as of the date
on which his Units were acquired) ratably according to their values as
of the valuation date nearest the date on which he purchased such
Units. A Unitholder's basis in his Units and of his fractional interest
in each Trust asset must be reduced, but not below zero, by the
Unitholder's pro rata portion of dividends with respect to the Equity
Security which is not taxable as ordinary income.

(vi) Under the Indenture, under certain circumstances, a
Unitholder tendering Units for redemption may request an in kind
distribution of Equity Securities upon the redemption of Units or upon
the termination of the Trust. As previously discussed, prior to the
redemption of Units or the termination of the Trust, a Unitholder is
considered as owning a pro rata portion of each of the Trust's assets.
The receipt of an in kind distribution will result in a Unitholder
receiving an undivided interest in whole shares of stock and possibly
cash. The potential federal income tax consequences which may occur
under an in kind distribution with respect to each Equity Security
owned by the Trust will depend upon whether or not a Unitholder
receives cash in addition to Equity Securities. An "Equity Security"
for this purpose is a particular class of stock issued by a particular
corporation. A Unitholder will not recognize gain or loss if a
Unitholder only receives Equity Securities in exchange for his or her
pro rata portion in the Equity Securities held by the Trust. However,
if a Unitholder also receives cash in exchange for a fractional share
of an Equity Security held by the Trust, such Unitholder will generally
recognize gain or loss based upon the difference between the amount of
cash received by the Unitholder and his tax basis in such fractional
share of an Equity Security held by the Trust. The total amount of
taxable gains (or losses) recognized upon such redemption will
generally equal the sum of the gain (or loss) recognized under the
rules described above by the redeeming Unitholder with respect to each
Equity Security owned by the Trust.

A domestic corporation owning Units in the Trust may be eligible for
the 70% dividends received deduction pursuant to Section 243(a) of the Code with
respect to such Unitholder's pro rata portion of dividends received by the Trust
(to the extent such dividends are taxable as ordinary income and are
attributable to domestic corporations), subject to the limitations imposed by
Sections 246 and 246A of the Code.

To the extent dividends received by the Trust are attributable to
foreign corporations, a corporation that owns Units will not be entitled to the
dividends received deduction with respect to its pro rata portion of such
dividends since the dividends received deduction is generally available only
with respect to dividends paid by domestic corporations.

Section 67 of the Code provides that certain itemized deductions, such
as investment expenses, tax return preparation fees and employee business
expenses will be deductible by individuals only to the extent they exceed 2% of
such individual's adjusted gross income. Unitholders may be required to treat
some or all of the expenses of the Trust as miscellaneous itemized deductions
subject to this limitation.

A Unitholder will recognize taxable gain (or loss) when all or part of
his pro rata interest in an Equity Security is either sold by the Trust or
redeemed or when a Unitholder disposes of his Units in a taxable transaction, in
each case for an amount greater (or less) than his tax basis therefor, subject
to various non-recognition provisions of the Code.

It should be noted that payments to the Trust of dividends on Equity
Securities that are attributable to foreign corporations may be subject to
foreign withholding taxes and Unitholders should consult their tax advisers
regarding the potential tax consequences relating to the payment of any such
withholding taxes by the Trust. Any dividends withheld as a result thereof will
nevertheless be treated as income to the Unitholders. Because under the grantor
trust rules, an investor is deemed to have paid directly his share of foreign
taxes that have been paid or accrued, if any, an investor may be entitled to a
foreign tax credit or deduction for United States tax purposes with respect to
such taxes. A required holding period is imposed for such credits.

Any gain or loss recognized on a sale or exchange will, under current
law, generally be capital gain or loss.

The scope of this opinion is expressly limited to the matters set forth
herein, and, except as expressly set forth above, we express no opinion with
respect to any other taxes, including foreign, state or local taxes or
collateral tax consequences with respect to the purchase, ownership and
disposition of Units.

Very truly yours,

CHAPMAN AND CUTLER

EXHIBIT 3.3

WINSTON & STRAWN
200 Park Avenue
New York, New York 10166-4193

May 2, 2000

Van Kampen Focus Portfolios, Series 225
c/o The Bank of New York, As Trustee
101 Barclay Street, 17 West
New York, New York 10286

Dear Sirs:

We have acted as special counsel for the Van Kampen Focus Portfolios,
Series 225 (the "Fund") consisting of Bandwidth & Telecommunications Trust,
Series 10A, Bandwidth & Telecommunications Trust, Series 10B, Biotechnology &
Pharmaceutical Trust, Series 10A, Biotechnology & Pharmaceutical Trust, Series
10B, Global Wireless Trust, Series 3A, Global Wireless Trust, Series 3B, The
Roaring 2000s Trust, Series 6A, The Roaring 2000s Trust, Series 6B,
Semiconductor Trust, Series 2A and Semiconductor Trust, Series 2B (individually
a "Trust" and, in the aggregate, the "Trusts") for purposes of determining the
applicability of certain New York taxes under the circumstances hereinafter
described.

The Fund is created pursuant to a Trust Agreement (the "Indenture"),
dated as of today (the "Date of Deposit") among Van Kampen Funds Inc. (the
"Depositor"), American Portfolio Evaluation Services, a division of an affiliate
of Depositor, as Evaluator, Van Kampen Investment Advisory Corp., an affiliate
of the Depositor, as Supervisory Servicer (the "Supervisory Servicer"), and The
Bank of New York, as trustee (the "Trustee"). As described in the prospectus
relating to the Fund dated today to be filed as an amendment to a registration
statement heretofore filed with the Securities and Exchange Commission under the
Securities Act of 1933, as amended (respectively the "Prospectus" and the
"Registration Statement") (File Number 333-35158), the objectives of the Fund
are to provide the potential for dividend income and capital appreciation
through investment in a fixed portfolio of actively traded equity securities of
the type denominated in the Trust's name. It is noted that no opinion is
expressed herein with regard to the Federal tax aspects of the securities, the
Trusts, units of the Trusts (the "Units"), or any interest, gains or losses in
respect thereof.

As more fully set forth in the Indenture and in the Prospectus, the
activities of the Trustee will include the following:

On the Date of Deposit, the Depositor will deposit with the Trustee
with respect to each Trust the securities and/or contracts and cash for the
purchase thereof together with an irrevocable letter of credit in the amount
required for the purchase price of the securities comprising the corpus of the
Trust as more fully set forth in the Prospectus.

The Trustee did not participate in the selection of the securities to
be deposited in the Trusts, and, upon the receipt thereof, will deliver to the
Depositor a registered certificate for the number of Units representing the
entire capital of the Trusts as more fully set forth in the Prospectus. The
Units, which are represented by certificates ("Certificates"), will be offered
to the public upon the effectiveness of the registration statement.

The duties of the Trustee, which are ministerial in nature, will
consist primarily of crediting the appropriate accounts with cash dividends
received by the Fund and with the proceeds from the disposition of securities
held in the Fund and the proceeds of the treasury obligation on maturity and the
distribution of such cash dividends and proceeds to the Unit holders. The
Trustee will also maintain records of the registered holders of Certificates
representing an interest in the Fund and administer the redemption of Units by
such Certificate holders and may perform certain administrative functions with
respect to an automatic reinvestment option.

Generally, equity securities held in the Trusts may be removed
therefrom by the Trustee at the direction of the Depositor upon the occurrence
of certain specified events which adversely affect the sound investment
character of the Fund, such as default by the issuer in payment of declared
dividends or of interest or principal on one or more of its debt obligations.

Prior to the termination of the Fund, the Trustee is empowered to sell
equity securities designated by the Supervisory Servicer only for the purpose of
redeeming Units tendered to it and of paying expenses for which funds are not
available. The Trustee does not have the power to vary the investment of any
Unit holder in the Fund, and under no circumstances may the proceeds of sale of
any equity securities held by the Fund be used to purchase new equity securities
to be held therein.

Article 9-A of the New York Tax Law imposes a franchise tax on business
corporations, and, for purposes of that Article, Section 208(1)(d) defines the
term "corporation" to include, among other things, "any business conducted by a
trustee or trustees wherein interest or ownership is evidenced by certificate or
other written instrument."

The Regulations promulgated under Section 208 provide as follows:

(b) The term corporation include. . . any business conducted by a
trustee or trustees wherein interest or ownership is evidenced by
certificate or other written instrument.

. . .

(2) A business conducted by a trustee or trustees in which
interest or ownership is evidenced by certificate or other written
instrument includes, but is not limited to, an association commonly
referred to as a business trust or Massachusetts trust. In determining
whether a trustee or trustees are conducting a business, the form of
the agreement is of significance but is not controlling. The actual
activities of the trustee or trustees, not their purposes and powers,
will be regarded as decisive factors in determining whether a trust is
subject to tax under Article 9-A of the Tax Law. The mere investment
of funds and the collection of income therefrom with incidental
replacement of securities and reinvestment of funds, does not
constitute the conduct of a business in the case of a business
conducted by a trustee or trustees. 20 NYCRR 1-2.5(b).

New York cases dealing with the question of whether a trust will be
subject to the franchise tax have also delineated the general rule that where a
trustee merely invests funds and collects and distributes the income therefrom,
the trust is not engaged in business and is not subject to the franchise tax.
Burrell v. Lynch, 274 A.D. 347, 84 N.Y.S.2d 171 (3rd Dept. 1948), order
resettled, 274 A.D. 1073, 85 N.Y.S.2d 705 (3rd Dept. 1949).

In an opinion of the Attorney General of the State of New York, 47 N.Y.
Att'y. Gen. Rep. 213 (Nov. 24, 1942), it was held that where the trustee of an
unincorporated investment trust was without authority to reinvest amounts
received upon the sales of securities and could dispose of securities making up
the trust only upon the happening of certain specified events or the existence
of certain specified conditions, the trust was not subject to the franchise tax.
See also Fibreboard Asbestos Compensation Trust (Advisory Opinion) Commission of
Taxation and Finance, TSB-A-97(3)(C) and TSB-A-97(1)I, January 21, 1997, CCH NY
St. Tax Rep.P. 402-649; and Petition of Richards, TSB-A-94(2)I, Commissioner of
Taxation and Finance, February 1, 1994, CCH 1993-1994 NY New Matters Transfer
Binder atP. 401-477.

In the instant situation, the Trustee is not empowered to, and we
assume will not, sell equity securities contained in the corpus of the Fund and
reinvest the proceeds therefrom. Further, the power to sell such equity
securities is limited to circumstances in which the credit-worthiness or
soundness of the issuer of such equity security is in question or in which cash
is needed to pay redeeming Unit holders or to pay expenses, or where the Fund is
liquidated subsequent to the termination of the Indenture. In substance, the
Trustee will merely collect and distribute income and will not reinvest any
income or proceeds, and the Trustee has no power to vary the investment of any
Unit holder in the Fund.

Under Subpart E of Part I, Subchapter J of Chapter 1 of the Internal
Revenue Code of 1986, as amended (the "Code"), the grantor of a trust will be
deemed to be the owner of the trust under certain circumstances, and therefore
taxable on his proportionate interest in the income thereof. Where this Federal
tax rule applies, the income attributed to the grantor will also be income to
him for New York income tax purposes. See TSB-M-78(9)(c), New York Department of
Taxation and Finance, June 23, 1978.

By letter dated today, Messrs. Chapman and Cutler, counsel for the
Depositor, rendered their opinion that each Unit holder will be considered as
owning a share of each asset of a Trust in the proportion that the number of
Units held by such holder bears to the total number of Units outstanding and the
income of a Trust will be treated as the income of each Unit holder in said
proportion pursuant to Subpart E of Part I, Subchapter J of Chapter 1 of the
Code.

Based on the foregoing and on the opinion of Messrs. Chapman and
Cutler, counsel for the Depositor, dated today, upon which we specifically rely,
we are of the opinion that under existing laws, rulings, and court decisions
interpreting the laws of the State and City of New York:

1. Each of the Trusts will not constitute an association taxable
as a corporation under New York law, and, accordingly, will not be
subject to tax on its income under the New York State franchise tax or
the New York City general corporation tax.

2. The income of the Trusts will be treated as the income of the
Unit holders under the income tax laws of the State and City of New
York.

3. Unit holders who are not residents of the State of New York
are not subject to the income tax laws thereof with respect to any
interest or gain derived from the Fund or any gain from the sale or
other disposition of the Units, except to the extent that such
interest or gain is from property employed in a business, trade,
profession or occupation carried on in the State of New York.

We hereby consent to the filing of this opinion letter as an exhibit to
the Registration Statement relating to the Units and to the use of our name and
the reference to our firm in the Registration Statement and in the Prospectus.

Very truly yours,

Winston & Strawn

EXHIBIT 4.1

INTERACTIVE DATA
FINANCIAL TIMES Information
100 William Street, 15th Floor, New York, NY 10038 USA
Tel: (212) 269-6300 Fax: (212) 771-6445

May 1, 2000

Van Kampen Funds Inc.
One Parkview Plaza
Oakbrook Terrace, IL 60181

Re: Bandwidth & Telecommunications Trust, Series 10A,
Bandwidth & Telecommunications Trust, Series 10B,
Biotechnology & Pharmaceutical Trust, Series 10A,
Biotechnology & Pharmaceutical Trust, Series 10B,
Global Wireless Trust, Series 3A,
Global Wireless Trust, Series 3B,
Great International Firms Trust, Series 12,
The Roaring 2000s Trust, Series 6A,
The Roaring 2000s Trust, Series 6B,
Semiconductor Trust, Series 2A and
Semiconductor Trust, Series 2B,
File No. 333-35158

Gentlemen:

We have examined the Registration Statement for the above captioned
Fund, a copy of which is attached hereto.

We hereby consent to the reference in the Prospectus and Registration
Statement for the above captioned Fund to Interactive Data Corporation, as the
Evaluator, and to the use of the Obligations prepared by us which are referred
to in such Prospectus and Statement.

You are authorized to file copies of this letter with the Securities
and Exchange Commission.

Very truly yours,

Steve Miano
Director Fixed Income Data Operations

EXHIBIT 4.2

INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS' CONSENT

We have issued our report dated April 18, 2000 on the statements of
condition and related securities portfolios of Van Kampen Focus Portfolios,
Series 222 as of April 18, 2000 contained in the Registration Statement on Form
S-6 and Prospectus. We consent to the use of our report in the Registration
Statement and Prospectus and to the use of our name as it appears under the
caption "Other Matters-Independent Certified Public Accountants."

Grant Thornton LLP

Chicago, Illinois
April 18, 2000